<SEC-DOCUMENT>0001193125-20-263689.txt : 20201005
<SEC-HEADER>0001193125-20-263689.hdr.sgml : 20201005
<ACCEPTANCE-DATETIME>20201005132403
ACCESSION NUMBER:		0001193125-20-263689
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20200930
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201005
DATE AS OF CHANGE:		20201005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Encompass Health Corp
		CENTRAL INDEX KEY:			0000785161
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				630860407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10315
		FILM NUMBER:		201222950

	BUSINESS ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242
		BUSINESS PHONE:		205-967-7116

	MAIL ADDRESS:	
		STREET 1:		9001 LIBERTY PARKWAY
		CITY:			BIRMINGHAM
		STATE:			AL
		ZIP:			35242

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH CORP
		DATE OF NAME CHANGE:	19950113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHSOUTH REHABILITATION CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d12659d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehc="http://www.encompasshealth.com/20200930" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-09-30_to_2020-09-30">Encompass Health Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-09-30_to_2020-09-30">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-09-30_to_2020-09-30">0000785161</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ehc-20200930.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-09-30_to_2020-09-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000785161</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-09-30</xbrli:startDate> <xbrli:endDate>2020-09-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-09-30_to_2020-09-30">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt:datemonthdayyearen">September&#160;30, 2020</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Encompass Health Corporation</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as specified in Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction of Incorporation)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-09-30_to_2020-09-30">001-10315</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-09-30_to_2020-09-30">63-0860407</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer Identification No.)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-09-30_to_2020-09-30">9001 Liberty Parkway</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-09-30_to_2020-09-30">Birmingham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:stateprovnameen">Alabama</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-09-30_to_2020-09-30">35242</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, including Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-09-30_to_2020-09-30">(205)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-09-30_to_2020-09-30">967-7116</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-09-30_to_2020-09-30">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-09-30_to_2020-09-30">EHC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934.&#160;&#160;&#160;&#160;Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-09-30_to_2020-09-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2020, Encompass Health Corporation (the &#8220;Company&#8221;) completed the public offering of $400,000,000 aggregate principal amount of the Company&#8217;s 4.625% Senior Notes due 2031 (the &#8220;Notes&#8221;), which Notes are guaranteed on a senior unsecured basis by certain of the Company&#8217;s subsidiaries (the &#8220;Guarantors&#8221;). The Notes and related guarantees have been registered with the Securities and Exchange Commission (the &#8220;SEC&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to the Company&#8217;s and the Guarantors&#8217; shelf registration statement on Form <span style="white-space:nowrap">S-3,</span> as amended (File <span style="white-space:nowrap">No.&#160;333-248942),</span> as supplemented by the Company&#8217;s and the Guarantors&#8217; prospectus supplement dated September&#160;30, 2020, previously filed with the SEC under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms of the Notes are governed by the previously executed Indenture, dated as of December&#160;1, 2009 (the &#8220;Base Indenture&#8221;), between the Company and Wells Fargo Bank, National Association, as successor to The Bank of Nova Scotia Trust Company of New York, as trustee (the &#8220;Trustee&#8221;), and a Tenth Supplemental Indenture, dated October&#160;5, 2020 (the &#8220;Tenth Supplemental Indenture&#8221;), among the Company, the subsidiary guarantors named therein, and the Trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief description of the terms of the Notes and the Indenture. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Maturity and Interest Payment Dates </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest on the Notes is payable semi-annually in arrears on April&#160;1 and October&#160;1 of each year, commencing on April&#160;1, 2021. The Notes will mature on April&#160;1, 2031. Interest on the Notes will accrue at the rate of&#160;4.625%&#160;per annum. Interest on the Notes will accrue from October&#160;5, 2020. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Redemption </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As set forth in the Tenth Supplemental Indenture, the Company may redeem some or all of the Notes (i)&#160;on or after April&#160;1, 2026, at the redemption prices specified in the Tenth Supplemental Indenture, or (ii)&#160;prior to April&#160;1, 2026, at a redemption price equal to 100% of the aggregate principal amount therefor, plus accrued and unpaid interest, if any, to the redemption date, plus a &#8220;make-whole&#8221; premium. At any time prior to April&#160;1, 2026, the Company may redeem up to 35% of the aggregate principal amount of the Notes in an amount not to exceed the amount of proceeds of one or more equity offerings, at a price equal to 104.625% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date, provided that at least 65% of the original aggregate principal amount of the Notes issued remains outstanding after the redemption. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Guarantees </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are jointly and severally guaranteed on a senior, unsecured basis by all of the Company&#8217;s existing and future subsidiaries that guarantee borrowings under its credit agreement and other capital markets debt. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Ranking </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes rank, along with the related guarantees, equal in right of payment to the Company&#8217;s current and future senior debt and senior in right of payment to any future subordinated debt. The Notes are effectively subordinated to the Company&#8217;s current and future secured debt, to the extent of the value of the assets securing such debt, and any liabilities of the Company&#8217;s nonguarantor subsidiaries. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Covenants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture relating to the Notes contains restrictive covenants that, among other things, limit the Company&#8217;s ability and the ability of certain of its subsidiaries to, among other things, incur or guarantee additional indebtedness; pay dividends on, or redeem or repurchase, its capital stock; make investments; and merge, consolidate, or transfer all or substantially all of its assets. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Change of Control </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a change of control, as defined in the Indenture, each holder of the Notes has the right to require the Company to repurchase some or all of such holder&#8217;s Notes at a purchase price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of repurchase. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Events of Default </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture also provides for events of default that, if any of them occurs, would permit or require the principal of and accrued interest on the Notes to become or to be declared due and payable. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Notes and the Indenture (including the form of the Note) is not intended to be complete and is qualified in its entirety by reference to such agreements, which are incorporated herein by reference and attached hereto as Exhibits 4.1 through 4.3. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation Under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information included in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2020, the Company and the Guarantors entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Truist Securities, Inc., acting on behalf of itself and as representative of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), and the Underwriters, pursuant to which the Company agreed to issue and sell to the Underwriters the Notes in an underwritten public offering. The Underwriting Agreement contains customary representations, warranties and covenants of the Company and the Guarantors, conditions to closing, indemnification obligations of the Company and the Guarantors and the Underwriters, and termination and other customary provisions. The Notes have been issued and sold pursuant to the Registration Statement and the related prospectus supplement dated September&#160;30, 2020. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends to use the net proceeds from the sale of the Notes, together with cash on hand, to redeem at par all $700&#160;million in aggregate principal amount of the Company&#8217;s outstanding 5.75% Senior Notes due 2024, with the remaining net proceeds to be used for working capital and other general corporate purposes. Pending the use of the net proceeds as described herein, the Company intends to use the net proceeds from the sale of the Notes to invest in short-term&#160;interest-bearing&#160;instruments. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement is not intended to be complete and is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit&#160;1.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriters and certain of their affiliates have performed, and may in the future perform, various commercial and investment banking and financial advisory services for the Company and its affiliates, for which they have received or may in the future receive customary fees and expenses. The Underwriters and/or certain of their affiliates act as agents and/or lenders under the Company&#8217;s credit agreement and receive and are expected to receive customary fees for their services as well as reimbursement for certain expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wells Fargo Bank, National Association, which is the Trustee under the Indenture and paying agent and registrar for the Notes, also serves as a lender under the Company&#8217;s credit agreement. Additionally, an affiliate of Wells Fargo Bank, National Association served as an underwriter in the offering of the Notes. Wells Fargo Bank, National Association and certain of its affiliates have performed, and may in the future perform, various commercial and investment banking and financial advisory services for the Company and its affiliates, for which they have received or may in the future receive customary fees and expenses. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expenses relating to the offering of the Notes are estimated to be as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">


<tr>

<td style="width:80%"></td>

<td style="vertical-align:bottom;width:12%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Amount&#160;to&#160;be&#160;paid</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC Registration Fee:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">43,640</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting Fees and Expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">75,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Fees and Expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">114,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing Expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee&#8217;s Fees and Expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">24,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rating Agency Fees:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">600,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous expenses:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom" align="right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Total:</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">$</span></td>
<td style="vertical-align:bottom" align="right"><span style="font-weight:bold">917,140</span></td>
<td style="white-space:nowrap;vertical-align:bottom"><span style="font-weight:bold">&#160;</span></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Statements contained in this Current Report on Form <span style="white-space:nowrap">8-K</span> that are not historical facts are forward-looking statements. In addition, the Company, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and the Company undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by the Company include, but are not limited to, the impact of the <span style="white-space:nowrap">COVID-19</span> pandemic on the Company&#8217;s operations, business, and financial condition, as well as its potential negative impact on the Company&#8217;s liquidity, particularly if the operations of acute-care hospitals and physician practices remain disrupted for a significant amount of time; the Company&#8217;s ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving the Company, including any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company&#8217;s or a vendor&#8217;s or partner&#8217;s information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company&#8217;s services by governmental or private payors; general conditions in the economy and capital markets, including any disruption, instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase to the debt ceiling, an international trade war or sovereign debt crisis, or a widespread outbreak of a contagious disease; and other factors which may be identified from time to time in the Company&#8217;s filings with the Securities and Exchange Commission and other public announcements, including the Company&#8217;s Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2019 and Forms <span style="white-space:nowrap">10-Q</span> for the quarters ended March&#160;31, 2020 and June&#160;30, 2020. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description of Exhibit</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex11.htm">Underwriting Agreement, dated September&#160;30, 2020, by and among Encompass Health Corporation, its subsidiary guarantors named therein, Truist Securities, Inc., as representative for the underwriters named therein and for itself, and Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs&#160;&amp; Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley&#160;&amp; Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC and Wells Fargo Securities, LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/785161/000078516110000011/exhibit_4-7110k.htm">Indenture, dated as of December&#160;1, 2009, by and between the Company and the Trustee (incorporated herein by reference to Exhibit 4.7.1 to the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the year ended December&#160;31, 2009). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex42.htm">Tenth Supplemental Indenture, dated as of October&#160;5, 2020, by and among the Company, the Guarantors and the Trustee (relating to the 4.625% Notes due 2031). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex42.htm">Form of Global Note representing the Notes (included in Exhibit 4.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex51.htm">Opinion of Maynard, Cooper and Gale, P.C. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex52.htm">Opinion of Bradley Arant Boult Cummings LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex53.htm">Opinion of Hawley Troxell Ennis&#160;&amp; Hawley LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex54.htm">Opinion of Snell&#160;&amp; Wilmer L.L.P. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex51.htm">Consent of Maynard, Cooper and Gale, P.C. (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex52.htm">Consent of Bradley Arant Boult Cummings LLP (included in Exhibit 5.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex53.htm">Consent of Hawley Troxell Ennis&#160;&amp; Hawley LLP (included in Exhibit 5.3). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d12659dex54.htm">Consent of Snell&#160;&amp; Wilmer L.L.P. (included in Exhibit 5.4). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File &#8211; the cover page iXBRL tags are embedded within the Inline XBRL document.</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:12%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">ENCOMPASS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patrick Darby</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Patrick Darby</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, General Counsel and Secretary</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: October&#160;5, 2020 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d12659dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$400,000,000 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENCOMPASS
HEALTH CORPORATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4.625% Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>UNDERWRITING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">New York, New York </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;30, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Representative of the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Several Underwriters listed in
Schedule 1 hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regions Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Truist Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3333 Peachtree Rd NE </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Atlanta, GA 30326 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation, a corporation organized under the laws of Delaware (the &#147;<U>Company</U>&#148;), proposes to issue and sell
to the several Underwriters listed in Schedule 1 hereto (the &#147;<U>Underwriters</U>&#148;), for whom you are acting as representative (the &#147;<U>Representative</U>&#148;), $400,000,000 aggregate principal amount of the Company&#146;s 4.625%
Senior Notes due 2031 (the &#147;<U>Securities</U>&#148;). The Securities will be issued pursuant to the indenture (the &#147;<U>Base Indenture</U>&#148;) dated as of December&nbsp;1, 2009, between the Company and Wells Fargo Bank, National
Association (successor to The Bank of Nova Scotia Trust Company of New York), as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by the tenth supplemental indenture thereto relating to the Securities, to be dated as of October&nbsp;5,
2020, among the Company, the subsidiary guarantors party thereto and the Trustee (the &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), and will be guaranteed on an unsecured senior
basis by each of the Guarantors listed in Schedule 2 hereto (the &#147;<U>Guarantors</U>,&#148; and such guarantees the &#147;<U>Guarantees</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">This Underwriting Agreement (this &#147;<U>Agreement</U>&#148;), the Indenture (including each Guarantee set forth therein) and the
Securities are herein referred to collectively as the &#147;<U>Transaction Documents</U>.&#148; The issuance and sale of the Securities and the issuance of the Guarantees together with all transactions contemplated herein and in the Disclosure
Package and the Final Prospectus are herein referred to collectively as the &#147;<U>Transactions</U>.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary
Prospectus or the Final Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item&nbsp;12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> which were filed under the Exchange Act on or
before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be; and any reference herein to the terms &#147;amend,&#148; &#147;amendment&#148;
or &#147;supplement&#148; with respect to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Final Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act after the
Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Prospectus or the Final Prospectus, as the case may be, deemed to be incorporated therein by reference. Certain terms used herein are defined in
Section&nbsp;22 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1. &nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. The Company and the Guarantors jointly and
severally represent and warrant to, and agree with, the several Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Statement and Prospectus</U>. The Company meets the requirements for use of <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> under the Act and has prepared and filed with the Commission an automatic shelf
registration statement (No. <FONT STYLE="white-space:nowrap">333-248942),</FONT> as defined in Rule 405, on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,</FONT> including a related Base Prospectus, for registration under the Act of the offering
and sale of the Securities. Such Registration Statement, including any amendments thereto filed prior to the Execution Time, became effective upon filing and has been filed with the Commission not earlier than three years prior to the Closing Date.
The Company has filed with the Commission, as part of an amendment to the Registration Statement or pursuant to Rule 424(b), one or more preliminary prospectus supplements relating to the Securities, each of which has previously been furnished to
the Underwriters. The Company will file with the Commission a final prospectus supplement relating to the Securities in accordance with Rule 424(b). Except to the extent the Underwriters shall agree in writing to a modification, such final
prospectus supplement shall be in all substantive respects in the form furnished to the Underwriters prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and other
changes (beyond that contained in the Base Prospectus and any Preliminary Prospectus) as the Company has advised the Underwriters, prior to the Execution Time, will be included or made therein. The Registration Statement, at the Execution Time,
meets the requirements set forth in Rule&nbsp;415(a)(1)(x). No order suspending the effectiveness of the Registration has been issued by the Commission and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Act against the Company
or related to the offering has been instituted or, to the Company&#146;s and the Guarantors&#146; knowledge, threatened by the Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with the Act and the Exchange Act</U>. On each Effective Date, the Registration
Statement did, and when the Preliminary Prospectus and Final Prospectus are first filed in accordance with Rule&nbsp;424(b) and on the Closing Date, the Preliminary Prospectus and Final Prospectus (and any supplement thereto) will, each comply in
all material respects with the applicable requirements of the Act, the Exchange Act and the Trust Indenture Act, and the respective rules and regulations thereunder; on each Effective Date and at the Execution Time, the Registration Statement did
not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on the date of any filing pursuant to
Rule&nbsp;424(b) and on the Closing Date, the Final Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Company makes no representations or warranties as to the information contained in or omitted from the Registration Statement or the
Final Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in the Registration Statement or the Final Prospectus
(or any supplement thereto), it being understood and agreed that the only such information furnished by or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;<U>Negative Assurance</U>. (i)&nbsp;The Disclosure Package, when taken together as a whole as of
the Execution Time and (ii)&nbsp;each electronic road show (if any) when taken together as a whole with the Disclosure Package as of the Execution Time, do not contain any untrue statement of a material fact or omit to state any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The preceding sentence does not apply to statements
in or omissions from the Disclosure Package based upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for use therein, it being understood and agreed that the only such
information furnished by or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;<U>Status as Well-Known Seasoned Issuer</U>. (i)&nbsp;At the time of filing the Registration
Statement, (ii)&nbsp;at the time of the most recent amendment thereto for the purposes of complying with Section&nbsp;10(a)(3) of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Sections 13 or
15(d) of the Exchange Act or form of prospectus), (iii)&nbsp;at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c)) made any offer relating to the Securities in reliance on the exemption
in Rule 163, and (iv)&nbsp;at the Execution Time (with such date being used as the determination date for purposes of this clause (iv)), the Company was or is (as the case may be) a &#147;well-known seasoned issuer&#148; as defined in Rule 405. The
Company agrees to pay the fees required by the Commission relating to the Securities within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;<U>Not an Ineligible Issuer</U>. (i)&nbsp;At the earliest time after the filing of the Registration
Statement that the Company or another offering participant made a <I>bona fide </I>offer (within the meaning of Rule 164(h)(2)) of the Securities and (ii)&nbsp;as of the Execution Time (with such date being used as the determination date for
purposes of this clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered
an Ineligible Issuer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &nbsp;&nbsp;&nbsp;&nbsp;<U>No Objection to Automatic Shelf</U>. The Company has not received
from the Commission any notice pursuant to Rule&nbsp;401(g)(2) objecting to use of the automatic shelf registration statement form. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus does not include any
information that conflicts with the information contained in the Registration Statement, including any document incorporated therein by reference and any prospectus supplement deemed to be a part thereof that has not been superseded or modified. The
foregoing sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for use therein,
it being understood and agreed that the only such information relating to any Underwriter furnished by or on behalf of the Underwriters consists of the information described as such in Section&nbsp;8(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Accounting Firm</U>. To the Company&#146;s knowledge, PricewaterhouseCoopers LLP,
who has audited the financial statements included in the Disclosure Package and the Final Prospectus, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the meaning of the Act and the rules
and regulations thereunder and the rules and regulations of the Public Company Accounting Oversight Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>. The financial statements, together with the related schedules and notes, included or incorporated by reference in the Disclosure Package and the Final Prospectus present fairly the financial
position of the Company and its consolidated subsidiaries at the dates indicated and the statement of operations, stockholders&#146; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial
statements have been prepared in conformity with U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;) applied on a consistent basis throughout the periods involved and comply as to form with the applicable accounting requirements
of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Act. The supporting schedules, if any, included in the Disclosure Package and the Final Prospectus present fairly in accordance with GAAP the information required to be stated
therein. The selected financial data included in, and the summary financial information in the &#147;Capitalization&#148; section of, the Disclosure Package and the Final Prospectus present fairly the information shown therein and have been compiled
on a basis consistent with that of the audited financial statements included in the Disclosure Package and the Final Prospectus. The interactive data in eXtensible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Business Reporting Language incorporated by reference in the Registration Statement, the Disclosure Package and the Final Prospectus fairly present the information called for in all material
respects and have been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Disclosure Package and the Final Prospectus, except as otherwise stated therein, (i)&nbsp;there has been no material
adverse change in the condition (financial or otherwise), or in the earnings or business affairs of the Company and its subsidiaries considered as one enterprise whether or not arising in the ordinary course of business (a &#147;<U>Material Adverse
Effect</U>&#148;), and (ii)&nbsp;there have been no transactions entered into by the Company or any of its subsidiaries other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries
considered as one enterprise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) &nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Formation and Powers</U>. The Company has been duly
organized and is validly existing as a corporation in good standing under the laws of the State of Delaware and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Disclosure
Package and the Final Prospectus, to enter into and perform its obligations under each of the Transaction Documents and for the consummation of the Transactions; and the Company is duly qualified as a foreign corporation to transact business and is
in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not
result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) &nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiary Formation and Powers</U>. Each subsidiary
of the Company has been duly organized and is a validly existing corporation, limited liability company or limited partnership, as the case may be, in good standing under the laws of the jurisdiction of its incorporation or formation, has the
corporate, limited liability company or limited partnership power and authority to own, lease and operate its properties and to conduct its business as described in the Disclosure Package and the Final Prospectus and is duly qualified as a foreign
corporation, limited liability company or limited partnership, as the case may be, to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure so to qualify or to be in good standing would not result in a Material Adverse Effect; except as otherwise disclosed in the Disclosure Package and the Final Prospectus or as would not result in a
Material Adverse Effect, all of the issued and outstanding capital stock or other equity interests of each subsidiary of the Company has been duly authorized and validly issued, is fully paid and, to the extent applicable, <FONT
STYLE="white-space:nowrap">non-assessable</FONT> and is owned by the Company, directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity; none of the outstanding shares of capital
stock of the subsidiaries of the Company was issued in violation of any preemptive or similar rights of any security holder of such subsidiary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) &nbsp;&nbsp;&nbsp;&nbsp;<U>Due Execution of Transaction Documents</U>. Each Transaction Document has been duly authorized,
executed and delivered by the Company and each of the Guarantors party thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) &nbsp;&nbsp;&nbsp;&nbsp;<U>Indenture
Authorization and Enforceability</U>. The Base Indenture has been duly authorized and executed by the Company and the Supplemental Indenture has been duly authorized by the Company and each of the Guarantors and, upon effectiveness of the
Registration Statement, the Indenture was duly qualified under the Trust Indenture Act. The Base Indenture was duly executed and delivered by and constitutes a valid and binding obligation of the Company and the Supplemental Indenture, when executed
and delivered by the parties thereto, will constitute a valid and binding obligation of the Company and each of the Guarantors party thereto, in the case of the Base Indenture and the Supplemental Indenture, enforceable against each of them in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers) or similar laws affecting the enforcement of creditors&#146; rights
generally or by equitable principles relating to enforceability (regardless of whether enforcement is considered in a proceeding in equity or at law) (collectively, the &#147;<U>Enforceability Exceptions</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) &nbsp;&nbsp;&nbsp;&nbsp;<U>Securities Authorization and Enforceability</U>. The Securities have been duly authorized by the
Company and, when duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be duly and validly issued and outstanding and will constitute valid and legally
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
binding obligations of the Company enforceable against the Company in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture;
and the Guarantees have been duly authorized by each of the Guarantors and, when the Securities have been duly executed, authenticated, issued and delivered as provided in the Indenture and paid for as provided herein, will be valid and legally
binding obligations of each of the Guarantors, enforceable against each of the Guarantors in accordance with their terms, subject to the Enforceability Exceptions, and will be entitled to the benefits of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) &nbsp;&nbsp;&nbsp;&nbsp;<U>Conformity to Disclosure</U>. Each Transaction Document and each of the Transactions conform in
all material respects to the description thereof contained in the Disclosure Package and the Final Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Violation of Laws</U>. None of the Company or any of its subsidiaries is in violation of any law, ordinance, governmental rule, regulation or court decree to which it is or its properties or assets may be subject,
including federal Medicare and Medicaid statutes or any regulations promulgated pursuant to such statutes, or other federal, state or local healthcare statutes or regulations, or has failed to obtain or maintain any license, permit, certificate,
franchise or other governmental authorization or permit necessary to the ownership of its properties or to the conduct of its business, except for such violations or failures that would not, individually or in the aggregate, result in a Material
Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) &nbsp;&nbsp;&nbsp;&nbsp;<U>Violation of Material Agreements</U>. Neither the Company nor any of its
subsidiaries is in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar governing documents) or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any
contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which any of them may be bound, or to which any of the property or
assets of the Company or any subsidiary is subject (collectively, &#147;<U>Agreements and Instruments</U>&#148;) except for such defaults that would not result in a Material Adverse Effect, and would not materially and adversely affect the
consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents; and the execution, delivery and performance of the Transaction Documents, the consummation of the
Transactions and compliance by the Company and the Guarantors with their respective obligations in connection therewith, have been duly authorized by all necessary corporate, limited liability company or limited partnership action and do not and
will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or
encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to, the Agreements and Instruments except for such conflicts, breaches or defaults or Repayment Events or liens, charges or encumbrances that, singly or in
the aggregate, would not result in a Material Adverse Effect, and would not materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations under the
Transaction Documents, nor will such action result in any violation of the provisions of (i)&nbsp;the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> (or similar governing documents) of the Company or any of its subsidiaries or
(ii)&nbsp;any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Company or any of its subsidiaries or any of their
assets, properties or operations except, with respect to clause&nbsp;(ii) only, such violations that would not, singly or in the aggregate, result in a Material Adverse Effect, and would not materially and adversely affect the consummation of the
Transactions or the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents. As used herein, a &#147;<U>Repayment Event</U>&#148; means any event or condition which gives the holder of any note,
debenture or other evidence of indebtedness (or any person acting on such holder&#146;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) &nbsp;&nbsp;&nbsp;&nbsp;<U>Labor</U>. No labor dispute with the employees of the Company or any of its subsidiaries exists
or, to the Company&#146;s knowledge, is threatened, which, in either case, would result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Inquiry or Investigation</U>. Except as described in the Disclosure Package and the Final Prospectus, there is no action, suit, proceeding, inquiry, arbitration or investigation before or brought by any court or
governmental agency or body, domestic or foreign, or arbitrator or other person, now pending, or, to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company&#146;s knowledge, threatened, against or affecting the Company or any of its subsidiaries (including rate appeals, recoupment claims or contests or open or unsettled cost reports, or
claims or assertions made in any utilization reviews), which would result in a Material Adverse Effect, or which might materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their
respective obligations under the Transaction Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) &nbsp;&nbsp;&nbsp;&nbsp;<U>Stabilization</U>. The Company and
its affiliates have not taken, directly or indirectly, any action designed to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) &nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property</U>. The Company and its subsidiaries own or possess adequate rights to
use all patents, patent rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks, trade names or other intellectual property (collectively, &#147;<U>Intellectual Property</U>&#148;) described in the Disclosure Package and the Prospectus as being necessary to carry on the business now operated by them,
except where the failure to own or possess such Intellectual Property, singly or in the aggregate, would not result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of any infringement of or
conflict with asserted rights of others with respect to any Intellectual Property and which infringement or conflict, singly or in the aggregate, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) &nbsp;&nbsp;&nbsp;&nbsp;<U>Approvals</U>. No filing with, or authorization, approval, consent, license, order,
registration, qualification or decree of, any court or governmental authority or agency is required for the performance by the Company or the Guarantors of their respective obligations under the Transaction Documents or in connection with the
consummation of the Transactions, except such as have been already obtained or would not materially and adversely affect the consummation of the Transactions or the performance by the Company or the Guarantors of their respective obligations under
the Transaction Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) &nbsp;&nbsp;&nbsp;&nbsp;<U>Licenses</U>. The Company and the Guarantors possess such
permits, licenses, approvals, rights to participate in, or the benefit of valid agreements to participate in, Medicare, Medicaid and other third-party payor programs, consents, accreditations and other authorizations (collectively,
&#147;<U>Governmental Licenses</U>&#148;) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except where the failure to so possess would not, singly or in
the aggregate, result in a Material Adverse Effect; and neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any such Governmental Licenses which, singly or in the
aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Internal Controls</U>. The Company and its subsidiaries maintain a system of internal control over financial reporting (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> under the Exchange
Act) that complies with the requirements of the Exchange Act and has been designed by the Company&#146;s principal executive officer and principal financial officer, or under their supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Such system of internal control over financial reporting was evaluated for effectiveness and was effective as of the date
of the latest audited financial statements included or incorporated by reference in the Disclosure Package or the Final Prospectus and the Company and its subsidiaries are not aware of any material weaknesses in such internal control over financial
reporting. Since the date of the latest audited financial statements included or incorporated by reference in the Disclosure Package and the Final Prospectus, there has been no change in the Company&#146;s internal control over financial reporting
that has materially adversely affected or is reasonably likely to materially adversely affect, the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) &nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Controls</U>. The Company maintains disclosure controls and procedures (as such term
is defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15(e)</FONT> under the Exchange Act) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to ensure that material information
relating to the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures were evaluated for
effectiveness and were effective as of the date of the latest financial statements included or incorporated by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reference in the Disclosure Package or the Final Prospectus and since such evaluation, the Company has made no significant changes in such system of disclosure controls and procedures or in other
systems, processes or otherwise that could materially adversely affect such system of disclosure controls and procedures. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) &nbsp;&nbsp;&nbsp;&nbsp;<U>Real Property</U>. The Company and its subsidiaries have good and marketable title to, or have
valid rights to lease or otherwise use, all real property owned or used by the Company and its subsidiaries and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests,
claims, restrictions or encumbrances of any kind except such as (i)&nbsp;are described in the Disclosure Package and the Final Prospectus, (ii)&nbsp;do not, singly or in the aggregate, materially affect the value of such property and do not
interfere with the use made and proposed to be made of such property by the Company or any of its subsidiaries or (iii)&nbsp;would not, singly or in the aggregate, result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) &nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental</U>. Except as described in the Disclosure Package and the Final Prospectus and
except for such matters as would not, singly or in the aggregate, result in a Material Adverse Effect, (i)&nbsp;neither the Company nor any of its subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation,
or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air,
surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
or petroleum products, asbestos-containing materials or mold (collectively, &#147;<U>Hazardous Materials</U>&#148;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials
(collectively, &#147;<U>Environmental Laws</U>&#148;), (ii)&nbsp;the Company and its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance with their requirements, and
(iii)&nbsp;there are no pending or, to the Company&#146;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings
relating to any Environmental Law against the Company or any of its subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)
&nbsp;&nbsp;&nbsp;&nbsp;<U>ERISA</U>. Except as described in the Disclosure Package and the Final Prospectus, none of the following events has occurred or exists: (i)&nbsp;a failure to fulfill the obligations, if any, under the minimum funding
standards of Section&nbsp;302 of the United States Employee Retirement Income Security Act of 1974, as amended (&#147;<U>ERISA</U>&#148;), and the regulations and published interpretations thereunder with respect to a Plan, determined without regard
to any waiver of such obligations or extension of any amortization period; (ii)&nbsp;an audit or investigation by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other federal or state
governmental agency or any foreign regulatory agency with respect to the employment or compensation of employees by any of the Company or any of its subsidiaries that could have a Material Adverse Effect; or (iii)&nbsp;any breach of any contractual
obligation, or any violation of law or applicable qualification standards, with respect to the employment or compensation of employees by the Company or any of its subsidiaries that could have a Material Adverse Effect. Except as described in the
Disclosure Package and the Final Prospectus, no event or condition giving rise to a liability under Title IV of ERISA that could have a Material Adverse Effect has occurred. For purposes of this paragraph, the term &#147;<U>Plan</U>&#148; means a
plan (within the meaning of Section&nbsp;3(3) of ERISA) subject to Title IV of ERISA with respect to which the Company or any of its subsidiaries may have any liability. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) &nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign Corrupt Practices</U>. None of (x)&nbsp;the Company or any of its subsidiaries, or
(y)&nbsp;to the Company&#146;s knowledge, any director, officer, agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)&nbsp;violated
or is in violation of any provision of the Foreign Corrupt Practices Act of 1977; or (iv)&nbsp;made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) &nbsp;&nbsp;&nbsp;&nbsp;<U>Money Laundering</U>. The operations of the Company and its subsidiaries are and have been
conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#147;<U>Money Laundering Laws</U>&#148;) and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the Company&#146;s knowledge, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) &nbsp;&nbsp;&nbsp;&nbsp;<U>OFAC</U>. None of (x)&nbsp;the Company or any of its subsidiaries, or (y)&nbsp;to the
Company&#146;s knowledge , any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently the subject of any&nbsp;sanctions administered or enforced by the U.S. Department of the Treasury&#146;s Office of
Foreign Assets Control (&#147;<U>Sanctions</U>&#148;); nor is the Company or any of its subsidiaries located, organized or resident in a country, region or territory that is the subject of Sanctions; and the Company will not use the proceeds of the
sale of the Securities, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person, (i)&nbsp;directly or indirectly for the purpose of funding any activities of or business with any person,
or in any country or territory, that, at the time of such funding, is the subject of Sanctions or (ii)&nbsp;in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as
underwriter, advisor, investor or otherwise) of Sanctions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) &nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>. All United States
federal income tax returns of the Company and its subsidiaries required by law to be filed have been filed (except insofar as the failure to file such returns would not, singly or in the aggregate, result in a Material Adverse Effect) and all taxes
shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. The Company and its
subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to applicable foreign, state, local or other law (except insofar as the failure to file such returns would not, singly or in the aggregate, result in
a Material Adverse Effect), and has paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its subsidiaries, except for such taxes, if any, as are being contested in good faith and as to which adequate
reserves have been provided. All material tax liabilities have been adequately provided for in the financial statements of the Company to the extent required under GAAP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) &nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. The Company and its subsidiaries carry or are entitled to the benefits of
insurance in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar business, and all such insurance is, to the Company&#146;s knowledge, in full force and effect. The
Company has no reason to believe that it or any subsidiary will not be able (i)&nbsp;to renew its existing insurance coverage as and when such policies expire or (ii)&nbsp;to obtain comparable coverage from similar institutions as may be necessary
or appropriate to conduct its business as now conducted and at a cost that will not have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Statistical and Market Data</U>. Any statistical and market related data included in the Disclosure Package and the Final Prospectus are based on or derived from sources that the Company believes to be reliable and
accurate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) &nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Company</U>. Neither the Company nor any of its subsidiaries is
required, and upon the consummation of the Transactions, including the application of the net proceeds therefrom as described in the Disclosure Package and the Final Prospectus, none of them will be required, to register as an &#147;investment
company&#148; under the Investment Company Act of 1940, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) &nbsp;&nbsp;&nbsp;&nbsp;<U>Solvency</U>. On and
immediately after the Closing Date, the Company and the Guarantors (after giving effect to the Transactions) will be Solvent. As used in this paragraph, the term &#147;<U>Solvent</U>&#148; means, with respect to a particular date, that on such date
(i)&nbsp;the present fair market value (or present fair saleable value) of the assets of the Company is not less than the total amount required to pay the liabilities of the Company on its total existing debts and liabilities (including contingent
liabilities) as they become absolute and matured; (ii)&nbsp;the Company is able to realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of
business; and (iii)&nbsp;assuming consummation of the Transactions, the Company is not incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cybersecurity</U>. (i)&nbsp;(x) To the
Company&#146;s knowledge, there has been no material security breach or other material compromise of or relating to any of the Company&#146;s or its subsidiaries&#146; information technology and computer systems, networks, hardware, software, data
(including the data of their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (collectively, &#147;<U>IT Systems and Data</U>&#148;) and (y)&nbsp;the Company
and its subsidiaries have not been notified of, and have no knowledge of any event or condition that would reasonably be expected to result in, any material security breach or other material compromise to their IT Systems and Data, (ii)&nbsp;the
Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause (ii),
individually or in the aggregate, have a Material Adverse Effect, and (iii)&nbsp;the Company and its subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Company or by an authorized signatory of a Guarantor, and delivered to the Representative or
counsel for the Underwriters in connection with the offering of the Securities shall be deemed a representation and warranty by the Company or such Guarantor, as applicable, as to matters covered thereby, to each Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2. &nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase and Sale</U>. Subject to the terms and conditions and in reliance upon the representations and
warranties herein set forth, the Company agrees to issue and sell the Securities to the several Underwriters, and each Underwriter agrees, severally and not jointly, to purchase from the Company, the respective principal amount of Securities set
forth opposite such Underwriter&#146;s name in Schedule 1 hereto at a price equal to 98.5% of the principal amount of the Securities, plus accrued interest, if any, from October&nbsp;5, 2020 to the Closing Date. The Company will not be obligated to
deliver any of the Securities except upon payment for all of the Securities to be purchased as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery and Payment</U>. Delivery of and payment for the Securities shall be made not later than 11:00 a.m., New York time, on October&nbsp;5, 2020, or at such time on such later date not more than five Business Days
after the foregoing date as the Representative shall designate, which date and time may be postponed by agreement between the Representative and the Company (such date and time of delivery and payment for the Securities being herein called the
&#147;<U>Closing Date</U>&#148;). Delivery of the Securities shall be made to the Underwriters against payment by the Underwriters of the purchase price thereof to or upon the order of the Company by wire transfer payable in <FONT
STYLE="white-space:nowrap">same-day</FONT> funds to an account specified by the Company. Delivery of the Securities shall be made through the facilities of The Depository Trust Company unless the Representative shall otherwise instruct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4. &nbsp;&nbsp;&nbsp;&nbsp;<U>Offering by the Underwriters</U>. It is understood that the several Underwriters propose to offer the
Securities for sale to the public as set forth in the Disclosure Package and the Final Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">5.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements</U>. The Company and the Guarantors jointly and severally agree with the several Underwriters that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments and Supplements to the Registration Statement, Final Prospectus or Preliminary
Prospectus; Preparation of Final Prospectus; Other Matters</U>. Prior to the termination of the offering of the Securities, the Company will not file any amendment of the Registration Statement or supplement (including the Final Prospectus or any
Preliminary Prospectus) (other than an amendment or supplement resulting from the filing of a report required to be filed by the Company under the Exchange Act or unless otherwise required by applicable law; <U>provided</U>, <U>however</U>, that
from the date hereof to the Closing Date, the Company shall furnish the counsel to the Underwriters with a copy of any Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> that it intends to file with the Commission prior to filing
such report) to the Base Prospectus unless the Company has furnished </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
the Underwriters with a copy for its review prior to filing and will not file any such proposed amendment or supplement to which the Representative reasonably object in a reasonably timely
manner. The Company will cause the Final Prospectus, properly completed, and any supplement thereto to be filed in a form approved by the Representative with the Commission pursuant to the applicable paragraph of Rule&nbsp;424(b) within the time
period prescribed and will provide evidence satisfactory to the Representative of such timely filing. The Company will promptly advise the Representative (i)&nbsp;when the Final Prospectus, and any supplement thereto (if required), shall have been
filed with the Commission pursuant to Rule&nbsp;424(b), (ii)&nbsp;when, prior to termination of the offering of the Securities, any amendment to the Registration Statement shall have been filed or become effective, (iii)&nbsp;prior to the
termination of the offering of Securities of any request by the Commission or its staff for any amendment of the Registration Statement or for any supplement to the Final Prospectus or for any additional information, (iv)&nbsp;of the issuance by the
Commission of any stop order suspending the effectiveness of the Registration Statement or of any notice objecting to its use or the institution or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Act, (v)&nbsp;of
the receipt by the Company of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose and (vi)&nbsp;of the receipt by
the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act. The Company will use its reasonable best efforts to prevent the
issuance of any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement and, upon such issuance, occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop
order or relief from such occurrence or objection, including, if necessary, by filing an amendment to the Registration Statement or a new registration statement and using its reasonable best efforts to have such amendment or new registration
statement declared effective as soon as practicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Package</U>. If, at any
time prior to the filing of the Final Prospectus pursuant to Rule 424(b), any event occurs as a result of which the Disclosure Package would include any untrue statement of a material fact or omit to state any material fact necessary to make the
statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading, or if it shall be necessary to amend the Disclosure Package, file a new registration statement or supplement the
Disclosure Package to comply with the Act or the Exchange Act or the respective rules thereunder, including in connection with use or delivery of the Disclosure Package, the Company will promptly (i)&nbsp;notify the Representative so that any use of
the Disclosure Package may cease until it is amended or supplemented; (ii)&nbsp;amend or supplement the Disclosure Package to correct such statement or omission; and (iii)&nbsp;supply any amendment or supplement to the Representative in such
quantities as they may reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;<U>Prospectus Delivery</U>. If, at any time when a
prospectus relating to the Securities is required to be delivered under the Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), any event occurs as a result of which the Final Prospectus as then
supplemented would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein in the light of the circumstances under which they were made at such time not misleading, or if it shall
be necessary to amend the Registration Statement, file a new registration statement or supplement the Final Prospectus to comply with the Act or the Exchange Act or the respective rules thereunder, including in connection with use or delivery of the
Final Prospectus, the Company will promptly (i)&nbsp;notify the Underwriters of any such event, (ii)&nbsp;prepare and file with the Commission an amendment or supplement or new registration statement which will correct such statement or omission or
effect such compliance, (iii)&nbsp;use its reasonable best efforts to have any amendment to the Registration Statement or new registration statement declared effective as soon as practicable in order to avoid any disruption in use of the Final
Prospectus and (iv)&nbsp;supply any supplemented Final Prospectus to the Underwriters in such quantities as they may reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;<U>Rule 158</U>. As soon as practicable, the Company will make generally available to its security
holders and to the Underwriters an earnings statement or statements of the Company and its subsidiaries which will satisfy the provisions of Section&nbsp;11(a) of the Act and Rule&nbsp;158. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;<U>Copies of Documents</U>. The Company will
furnish to the Representative and counsel for the Underwriters, without charge, signed copies of the Registration Statement (including exhibits thereto) and, so long as delivery of a prospectus by the Underwriters or dealer may be required by the
Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172), as many copies of each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and any supplement thereto as the Underwriters
may reasonably request. The Company will pay the expenses of printing or other production of all documents relating to the offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &nbsp;&nbsp;&nbsp;&nbsp;<U>Blue Sky</U>. The Company will arrange, if necessary, for the qualification of the Securities
for sale under the laws of such jurisdictions as the Representative may designate and will maintain such qualifications in effect so long as required for the distribution of the Securities; <U>provided</U> that in no event shall the Company be
obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any
jurisdiction where it is not now so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectus</U>. The Company
agrees that, unless it has or shall have obtained the prior written consent of the Representative, and each Underwriter agrees with the Company that, unless it has or shall have obtained the prior written consent of the Company, neither party has
made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in Rule 405) required to be filed by the Company
with the Commission or retained by the Company under Rule 433. Any such free writing prospectus consented to by the Representative or the Company is hereinafter referred to as a &#147;<U>Permitted Free Writing Prospectus</U>.&#148; The Company
agrees that (x)&nbsp;it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus and (y)&nbsp;it has complied and will comply, as the case may be, with the requirements of Rules 164
and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &nbsp;&nbsp;&nbsp;&nbsp;<U>Ratings</U>. The Company shall take all reasonable action necessary to enable S&amp;P Global
Ratings, a division of S&amp;P Global, Inc., and Moody&#146;s Investors Service Inc. to provide their respective credit ratings of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement not to Offer or Sell Additional Securities</U>. During the period from the date hereof
through and including the 90th day following the Closing Date, the Company and each of the Guarantors will not, without the prior written consent of Truist Securities, Inc., offer, sell, contract to sell or otherwise dispose of any debt securities
issued or guaranteed by the Company or any of the Guarantors and having a stated maturity of more than one year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
&nbsp;&nbsp;&nbsp;&nbsp;<U>Stabilization</U>. Neither the Company nor the Guarantors will take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price
of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) &nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. The Company and the Guarantors jointly and severally agree
to pay the costs and expenses relating to the following matters: (i)&nbsp;the preparation, printing or reproduction and filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), each Preliminary
Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus, and each amendment or supplement to any of them; (ii)&nbsp;the printing (or reproduction) and delivery (including postage, air freight charges and charges for counting and
packaging and any form of electronic distribution) of such copies of the Registration Statement, each Preliminary Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus, and all amendments or supplements to any of them, as may, in
each case, be reasonably requested for use in connection with the offering and sale of the Securities; (iii)&nbsp;the preparation, printing, authentication, issuance and delivery of certificates for the Securities, including any stamp or transfer
taxes in connection with the original issuance and sale of the Securities; (iv)&nbsp;the printing (or reproduction) and delivery of this Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered
in connection with the offering of the Securities; (v)&nbsp;the registration of the Securities under the Act; (vi)&nbsp;any registration or qualification of the Securities for offer and sale under the securities or blue sky laws of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
the several states (including filing fees and the reasonable fees and expenses of counsel for the Underwriters relating to such registration and qualification); (vii)&nbsp;any filings required to
be made with the Financial Industry Regulatory Authority, Inc. (including filing fees and the reasonable fees and expenses of counsel for the Underwriters relating to such filings); (viii)&nbsp;the transportation and other expenses incurred by or on
behalf of the Company representatives in connection with presentations to prospective purchasers of the Securities; (ix)&nbsp;the fees and expenses of the Company&#146;s accountants and the fees and expenses of counsel (including local and special
counsel) for the Company and the Guarantors; (x)&nbsp;any fees charged by rating agencies for the rating of the Securities; (xi)&nbsp;the fees and expenses of the Trustee (including related fees and expenses of any counsel to the Trustee); and
(xii)&nbsp;all other costs and expenses incident to the performance by the Company and the Guarantors of their respective obligations under the Transaction Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) &nbsp;&nbsp;&nbsp;&nbsp;<U>Use of Proceeds</U>. The Company will apply the net proceeds of the Securities as described in
the Disclosure Package and the Final Prospectus under the heading &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">6. &nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
to the Obligations of the Underwriter</U>. The obligations of the Underwriters to purchase the Securities shall be subject to the accuracy of the representations and warranties on the part of the Company and the Guarantors contained herein as of the
Execution Time and as of the Closing Date, to the accuracy of the statements of the Company and the Guarantors made in any certificates pursuant to the provisions hereof, to the performance by the Company and the Guarantors of their respective
obligations hereunder and to the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Filings under the Act</U>.
The Final Prospectus, and any supplement thereto, shall have been filed in the manner and within the time period required by Rule&nbsp;424(b) and any other material required to be filed by the Company pursuant to Rule 433(d) under the Act, shall
have been filed with the Commission within the applicable time periods prescribed for such filings by Rule 433; and no stop order suspending the effectiveness of the Registration Statement or any notice objecting to its use shall have been issued
and no proceedings for that purpose or pursuant to Section&nbsp;8A of the Act shall have been instituted or threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel for the Company; Opinion of General Counsel of the Company</U>. The
Representative shall have received an opinion, dated the Closing Date, of: (a)&nbsp;Maynard Cooper&nbsp;&amp; Gale, P.C., counsel for the Company, (b)&nbsp;Patrick Darby, Executive Vice President, General Counsel and Corporate Secretary of the
Company, (c)&nbsp;Hawley Troxell Ennis&nbsp;&amp; Hawley LLP, covering certain legal matters relating to Idaho law, (d)&nbsp;Bradley Arant Boult Cummings LLP, covering certain legal matters relating to Massachusetts, Mississippi, South Carolina and
Texas law, and (e)&nbsp;Snell&nbsp;&amp; Wilmer L.L.P., covering certain legal matters relating to New Mexico law, in each case, in the forms agreed upon by the Representative and such persons on the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel for the Representative</U>. The Representative shall have received from
Cahill Gordon&nbsp;&amp; Reindel <SMALL>LLP</SMALL>, counsel for the Underwriters, such opinion or opinions, dated the Closing Date and addressed to the Underwriters, with respect to the issuance and sale of the Securities, the Registration
Statement, the Disclosure Package, the Final Prospectus (together with any supplement thereto) and other related matters as the Representative may reasonably require, and the Company shall have furnished to such counsel such documents as they
request for the purpose of enabling them to pass upon such matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&#146;
Certificate</U>. The Company shall have furnished to the Representative a certificate of the Company, signed by a President or Vice President of the Company and the principal financial or accounting officer of the Company, dated the Closing Date, to
the effect that the signers of such certificate have carefully examined the Registration Statement, the Disclosure Package, the Final Prospectus and any supplements or amendments thereto, and this Agreement and that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of the Company and the Guarantors in this Agreement are true
and correct on and as of the Closing Date with the same effect as if made on the Closing Date and the Company and each of the Guarantors has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied
at or prior to the Closing Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) &nbsp;&nbsp;&nbsp;&nbsp;no stop order suspending the effectiveness of
the Registration Statement or any notice objecting to its use has been issued and no proceedings for that purpose or pursuant to Section&nbsp;8A of the Act have been instituted or, to the Company&#146;s and the Guarantors&#146; knowledge,
threatened; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;since the date of the most recent financial statements included in the
Disclosure Package and the Final Prospectus (exclusive of any supplement thereto), there has been no Material Adverse Effect, except as set forth in or contemplated in the Disclosure Package and the Final Prospectus (exclusive of any supplement
thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &nbsp;&nbsp;&nbsp;&nbsp;<U>Comfort Letter</U>. At the time of execution of this Agreement, the
Representative shall have received from PricewaterhouseCoopers LLP, a letter dated such date, which in form and substance satisfactory to the Representative and PricewaterhouseCoopers LLP, containing statements and information of the type ordinarily
included in accountants&#146; &#147;comfort letters&#148; to Underwriters with respect to the financial statements and certain financial information contained in the Disclosure Package. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &nbsp;&nbsp;&nbsp;&nbsp;<U>Bring-Down Comfort Letter</U>. At the Closing Date, the Representative shall have received from
PricewaterhouseCoopers LLP, a letter dated such date, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e)&nbsp;of this Section&nbsp;6, except that the specified dated referred in such letter to
shall be a date not more than three Business Days prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &nbsp;&nbsp;&nbsp;&nbsp;<U>No Material
Adverse Change</U>. Subsequent to the date of this Agreement or, if earlier, the dates as of which information is given in the Registration Statement (exclusive of any amendment thereof), the Disclosure Package (exclusive of any amendment or
supplement thereto) and the Final Prospectus (exclusive of any amendment or supplement thereto), there shall not have been&nbsp;any change, or any development involving a prospective change, in or affecting the condition (financial or otherwise),
earnings, business or properties of the Company and its subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth in or contemplated in the Disclosure Package (exclusive of any
amendment or supplement thereto) and the Final Prospectus (exclusive of any amendment or supplement thereto) the effect of which, is, in the judgment of the Representative, so material and adverse as to make it impractical or inadvisable to proceed
with the offering, sale or delivery of the Securities as contemplated by the Registration Statement (exclusive of any amendment thereof), the Disclosure Package (exclusive of any amendment or supplement thereto) and the Final Prospectus (exclusive
of any amendment or supplement thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &nbsp;&nbsp;&nbsp;&nbsp;<U>No Ratings Agency Change</U>. Subsequent to the
Execution Time, (i)&nbsp;there shall not have been any decrease in the rating of any of the Company&#146;s debt securities by any &#147;nationally recognized statistical rating organization&#148; (as such term is defined for purposes of
Section&nbsp;3(a)(62) of the Exchange Act) or any notice given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction of the possible change, and (ii)&nbsp;no such
organization shall have publicly announced that it has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any of the Company&#146;s debt securities (other than an announcement with positive
implications of possible upgrading). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;<U>CFO Certificate</U>. At the time of execution of this
Agreement, the Representative shall have received from the Chief Financial Officer of the Company, a certificate dated the date hereof addressed to the Representative, in form and substance satisfactory to the Representative. On the Closing Date,
the Representative shall have received from the Chief Financial Officer of the Company, a certificate dated such date in form and substance satisfactory to the Representative, to the effect that he reaffirms the statements made in the certificate
furnished by him pursuant to the previous sentence of this subsection (i). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) &nbsp;&nbsp;&nbsp;&nbsp;<U>Other Documents</U>. Prior to the Closing
Date, the Company shall have furnished to the Representative such further information, certificates and documents as the Representative may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If any of the conditions specified in this Section&nbsp;6 shall not have been fulfilled when and as provided in this Agreement, this Agreement
and all obligations of the Underwriters, the Company and the Guarantors, except as provided in Section&nbsp;7 and except that Sections 1, 5(k), 8 and 11 to 22 shall survive any such termination and remain in full force and effect, hereunder may be
canceled at, or at any time prior to, the Closing Date by the Representative. Notice of such cancellation shall be given to the Company in writing or by telephone or facsimile confirmed in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">7. &nbsp;&nbsp;&nbsp;&nbsp;<U>Reimbursement of Underwriters&#146; Expenses</U>. If the sale of the Securities provided for herein is not
consummated (i)&nbsp;because a condition to the obligations of the Underwriters set forth in Section&nbsp;6 (excluding Section (c)) hereof is not satisfied, (ii)&nbsp;because of any termination pursuant to Section&nbsp;9 hereof, or
(iii)&nbsp;because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof other than by reason of a default by any of the Underwriters, then, in each case, the Company and
the Guarantors, jointly and severally, agree to reimburse the Underwriters on demand through Truist Securities, Inc. for all expenses (including reasonable fees and disbursements of counsel) that shall have been reasonably incurred by the
Underwriters in connection with the proposed purchase and sale of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">8. &nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification and
Contribution</U>. (a)<I>&nbsp;Indemnification of the Underwriters</I>. The Company and each of the Guarantors, jointly and severally, agree to indemnify and hold harmless each Underwriter, its affiliates, the directors, officers, employees and
agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Act or the Exchange Act, from and against any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may
become subject under the Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon
any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Securities as originally filed or in any amendment thereof, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or arise out of or are based upon any untrue statement or alleged untrue statement of a material fact
contained in the Base Prospectus, any Preliminary Prospectus or any other preliminary prospectus supplement relating to the Securities, the Final Prospectus, any Issuer Free Writing Prospectus, or in any amendment thereof or supplement thereto, or
arise out of or are based upon the omission or alleged omission to state therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and agrees to reimburse each such
indemnified party, as incurred, for any legal or other expenses (including the fees and disbursements of counsel chosen by Truist Securities, Inc.) reasonably incurred by them in connection with investigating or defending any such loss, claim,
damage, liability or action; <U>provided</U>, <U>however</U>, that the Company and the Guarantors will not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of or is based upon any such untrue
statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of the Underwriters specifically for inclusion therein, which
information consists solely of the information specified in paragraph (b)&nbsp;of this Section&nbsp;8. This indemnity agreement will be in addition to any liability which the Company or the Guarantors may otherwise have. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of the Company</I>. Each Underwriter agrees, severally and not jointly, to
indemnify and hold harmless the Company, each of its directors, each of its officers who signs the Registration Statement, and each person who controls the Company within the meaning of either the Act or the Exchange Act, to the same extent as the
foregoing indemnity from the Company and the Guarantors to the Underwriters, but only with reference to written information relating to the Underwriters furnished to the Company by or on behalf of the Underwriters specifically for inclusion in the
documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability which the Underwriters may otherwise have. The Company acknowledges and agrees that the only written information furnished by the
Underwriters consists of the paragraphs in the Disclosure Package and the Final Prospectus under the heading &#147;Underwriting (Conflicts of Interest)&#148; related to short sales, market making, stabilization, penalty bids, and purchases to cover
positions created by short sales. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &nbsp;&nbsp;&nbsp;&nbsp;<I>Notice and Procedures</I>. Promptly after
receipt by an indemnified party under this Section&nbsp;8&nbsp;of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;8, notify the
indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party (i)&nbsp;will not relieve the indemnifying party from liability under paragraph&nbsp;(a)&nbsp;or&nbsp;(b)&nbsp;above unless and to the
extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and&nbsp;(ii)&nbsp;will not, in any event, relieve the indemnifying party from any obligations
to any indemnified party other than the indemnification obligation provided in paragraph&nbsp;(a)&nbsp;or (b)&nbsp;above. The indemnifying party shall be entitled to appoint counsel of the indemnifying party&#146;s choice at the indemnifying
party&#146;s expense to represent the indemnified party in any action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the
indemnified party or parties except as set forth below); <U>provided</U>, <U>however</U>, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party&#146;s election to appoint counsel to
represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel) (which counsel and local counsel will, in connection with any indemnification pursuant to Section&nbsp;8(a)
hereof, be chosen by Truist Securities, Inc.), and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i)&nbsp;the use of counsel chosen by the indemnifying party to represent the indemnified party
would present such counsel with a conflict of interest, (ii)&nbsp;the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably
concluded that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party, (iii)&nbsp;the indemnifying party shall not have employed counsel
reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action or (iv)&nbsp;the indemnifying party shall authorize the indemnified party to employ separate
counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any pending or threatened
claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or
consent (x)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding, and (y)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure
to act by or on behalf of any indemnified party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution</I>. In the event that the
indemnity provided in paragraph&nbsp;(a) or (b)&nbsp;of this Section&nbsp;8&nbsp;is unavailable to or insufficient to hold harmless an indemnified party for any reason, the Company and the Guarantors jointly and severally agree and the Underwriters
severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending the same) (collectively &#147;<U>Losses</U>&#148;) to which
the Company, the Guarantors and the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the Guarantors on the one hand and by the Underwriters on the other from the offering
of the Securities. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the Company, the Guarantors and the Underwriters shall contribute in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company and the Guarantors on the one hand and of the Underwriters on the other in connection with the statements or omissions which resulted in such Losses as well as any other relevant equitable
considerations. Benefits received by the Company and the Guarantors shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by the Company, and benefits received by the Underwriters shall be
deemed to be equal to the total underwriting discounts and commissions, in each case as set forth on the cover page of the Final Prospectus. Relative fault shall be determined by reference to, among other things, whether any untrue or any alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information provided by the Company and the Guarantors on the one hand or the Underwriters on the other, the intent of the parties and their
relative knowledge, access to information and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
opportunity to correct or prevent such untrue statement or omission. The Company, the Guarantors and the Underwriters agree that it would not be just and equitable if contribution pursuant to
this Section&nbsp;8 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph&nbsp;(d), no person
guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;8, each person
who controls an Underwriter within the meaning of either the Act or the Exchange Act and each affiliate, director, officer, employee and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who
controls the Company within the meaning of either the Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company,
subject in each case to the applicable terms and conditions of this paragraph (d). In no case shall the Underwriters be responsible for any amount in excess of the underwriting discount or commission applicable to the Securities purchased by the
Underwriters hereunder. Each Underwriter&#146;s respective obligation to contribute pursuant to this Section&nbsp;8 is several in proportion to its respective purchase obligations hereunder and not joint. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">9. &nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement may be terminated in the absolute discretion of the Representative, by notice
to the Company, if after the execution and delivery of this Agreement and prior to the delivery of and payment for the Securities, (i)&nbsp;trading generally shall have been suspended or materially limited on the New York Stock Exchange or the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (ii)&nbsp;trading of any securities issued by the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; (iv)&nbsp;a material disruption in commercial
banking or securities settlement or clearance services in the United States shall have occurred; or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, that,
in the judgment of the Representative, makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the Closing Date on the terms and in the manner contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">10. &nbsp;&nbsp;&nbsp;&nbsp;<U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter defaults on its obligation to
purchase the Securities that it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the
Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Securities, then the
Company shall be entitled to a further period of 36 hours within which to procure other persons reasonably satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms. If other
persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full business days
in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to
promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#147;<U>Underwriter</U>&#148; includes, for all purposes of this Agreement unless the
context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;10, purchases Securities&nbsp;that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a defaulting
Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not
exceed <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase
the principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s pro&nbsp;rata share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities
of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, after giving effect to any arrangements for the purchase of the Securities of a defaulting
Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
(a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased exceeds <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate principal amount of all the
Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement shall terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any
termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company or the Guarantors, except that the Company and the Guarantors will continue to be liable for the payment of expenses as set forth in
Section&nbsp;7 hereof and except that the provisions of Section&nbsp;8 hereof shall not terminate and shall remain in effect; <U>provided</U>, <U>however</U>, that the Company shall not be liable for the payment of expenses incurred by any
defaulting Underwriter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing contained herein shall relieve a defaulting Underwriter
of any liability it may have to the Company or any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">11. &nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Indemnities to Survive</U>. The respective agreements, representations, warranties,
indemnities and other statements of the Company, the Guarantors, the Company&#146;s officers and of the Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of the Underwriters or the Company, the Guarantors or any of the affiliates, officers, directors, employees, agents or controlling persons referred to in Section&nbsp;8 hereof, and will survive delivery of and payment for the Securities. The
provisions of Sections&nbsp;5(k), 7 and 8 hereof shall survive the termination or cancellation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">12.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications hereunder shall be in writing and effective only on receipt, and, if sent to the Underwriter, will be mailed or transmitted by any standard form of telecommunication, to
Truist Securities, Inc. at 3333 Peachtree Road, 10th Floor, Atlanta, GA 30326, Attention: High Yield Syndicate, Facsimile: (404) <FONT STYLE="white-space:nowrap">926-5248;</FONT> or, if sent to the Company, will be mailed or transmitted by any
standard form of telecommunication to the Company at 9001 Liberty Parkway, Birmingham, AL 35242, Facsimile: <FONT STYLE="white-space:nowrap">(205)&nbsp;262-8692,</FONT> attention of Patrick Darby, Executive Vice President, General Counsel and
Corporate Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">13. &nbsp;&nbsp;&nbsp;&nbsp;<U>Successors</U>. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the affiliates, officers, directors, employees, agents and controlling persons referred to in Section&nbsp;8 hereof, and no other person will have any right or obligation hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">14. &nbsp;&nbsp;&nbsp;&nbsp;<U>No Fiduciary Duty</U>. The Company and the Guarantors hereby acknowledge that (a)&nbsp;the purchase and sale
of the Securities pursuant to this Agreement is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company and the Guarantors, on the one hand, and the Underwriters and any affiliate through which they
may be acting, on the other, (b)&nbsp;the Underwriters are acting as principals and not as agents or fiduciaries of the Company and the Guarantors and (c)&nbsp;the Company&#146;s and the Guarantors&#146; engagement of the Underwriters in connection
with the offering and the process leading up to the offering is as independent contractors and not in any other capacity. Furthermore, the Company and each Guarantor agrees that it is solely responsible for making its own judgments in connection
with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company or any Guarantor on related or other matters). The Company and each Guarantor agrees that it will not claim that the Underwriters
have rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company or to any Guarantor, in connection with such transaction or the process leading thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">15. &nbsp;&nbsp;&nbsp;&nbsp;<U>Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT
STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include
the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">16. &nbsp;&nbsp;&nbsp;&nbsp;<U>Integration</U>. This Agreement supersedes all prior agreements and understandings (whether written or oral)
between the Company and the Guarantors, on the one hand, and the Underwriters, on the other hand, or any of them, with respect to the subject matter hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">17. &nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law</U>. This Agreement and any claim,
controversy or dispute arising under or relating to this Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed within the State of New&nbsp;York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">18. &nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Jury Trial</U>. The Company and each Guarantor hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">19. &nbsp;&nbsp;&nbsp;&nbsp;<U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special
Resolution Regime, the transfer of this Agreement, and any interest and obligation in or under this Agreement, from such Underwriter will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if
this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes
subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under
the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For
purposes of this Section&nbsp;19, a &#147;<U>BHC Act Affiliate</U>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#147;<U>Covered Entity</U>&#148; means
any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with,
12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#147;<U>Default Right</U>&#148; has the meaning assigned to that term in, and shall be
interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;<U>U.S. Special Resolution Regime</U>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and
(ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Agreement may be signed in one or more counterparts, each of which shall constitute an
original and all of which together shall constitute one and the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">21. &nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The section
headings used herein are for convenience only and shall not affect the construction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">22.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. The terms that follow, when used in this Agreement, shall have the meanings indicated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Act</U>&#148; shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission
promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Prospectus</U>&#148; shall mean the base prospectus referred to in Section&nbsp;1(a)
above contained in the Registration Statement at the Execution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; shall mean any
day&nbsp;other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorized or obligated by law to remain closed in New York City, New York. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commission</U>&#148; shall mean the Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Package</U>&#148; shall mean (i)&nbsp;the Base
Prospectus, (ii)&nbsp;the Preliminary Prospectus used most recently prior to the Execution Time, (iii)&nbsp;any Free Writing Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as part of the Disclosure Package,
and (iv)&nbsp;each Free Writing Prospectus listed on Annex A hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Date</U>&#148; shall mean each
date and time that the Registration Statement, and any post-effective amendment or amendments thereto became or is deemed to become effective. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of
the Commission promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Execution Time</U>&#148; shall mean 2:35 p.m. (EDT) on September&nbsp;30,
2020. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Prospectus</U>&#148; shall mean the prospectus supplement relating to the Securities that was first
filed pursuant to Rule 424(b) after the Execution Time, together with the Base Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Free Writing
Prospectus</U>&#148; shall mean a free writing prospectus, as defined in Rule 405. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issuer Free Writing
Prospectus</U>&#148; shall mean an issuer free writing prospectus, as defined in Rule&nbsp;433. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preliminary
Prospectus</U>&#148; shall mean any preliminary prospectus supplement to the Base Prospectus referred to in Section&nbsp;1(a) above which is used prior to the Execution Time, together with the Base Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Statement</U>&#148; shall mean the registration statement referred to in Section&nbsp;1(a) above,
including exhibits and financial statements and any prospectus supplement relating to the Securities that is filed with the Commission pursuant to Rule 424(b) and deemed part of such registration statement pursuant to Rule 430B, as amended on each
Effective Date and, in the event any post-effective amendment thereto becomes effective prior to the Closing Date, shall also mean such registration statement as so amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Rule 158</U>,&#148; &#147;<U>Rule 163</U>,&#148; &#147;<U>Rule 164</U>,&#148; &#147;<U>Rule 172</U>,&#148;
&#147;<U>Rule 405</U>,&#148; &#147;<U>Rule</U><U></U><U>&nbsp;415</U>,&#148; &#147;<U>Rule</U><U></U><U>&nbsp;424</U>,&#148; &#147;<U>Rule 430B</U>,&#148; and &#147;<U>Rule 433</U>&#148; refer to such rules under the Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trust Indenture Act</U>&#148; shall mean the Trust Indenture Act of 1939, as amended, and the rules and regulations of
the Commission promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Well-Known Seasoned Issuer</U>&#148; shall mean a well-known seasoned
issuer, as defined in Rule 405. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement among the Company, the Guarantors and the several Underwriters. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Douglas E. Coltharp</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Douglas E. Coltharp</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="74%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>GUARANTORS</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Advanced Homecare Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Advanced Homecare Management, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">AHM Texas LP, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Camellia Medical Systems, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">CareSouth Health System, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">DOSIK, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EHHI Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health C Corp Sub Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Central Arkansas Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Home Health Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Home Health Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Jonesboro Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of City View, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Columbia, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Concord, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Dothan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Florence, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Manati, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Panama City, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of San Antonio, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of San Juan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Texarkana, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of The Woodlands, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Tyler Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Yuma Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA HEALTHCARE, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA HOMECARE, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Guardian Home Care, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HealthSouth Rehabilitation Hospital of Austin, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Home Health Care of Bogalusa, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Home Health Care Systems, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Idaho Homecare Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Reliant Blocker Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">WellCare, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Wellmark Healthcare Services of El Paso, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">West Mississippi Home Health Services, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Abba&nbsp;Home&nbsp;Health,&nbsp;L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">AHM Action Home Health, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Best Home Care LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">DRC Health Systems, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Continental Rehabilitation Hospital of Arizona, Inc., its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Tustin, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Western Neuro Care, Inc., its Managing General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass of Fort Worth, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass of West Texas, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Hallmark Homecare, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Preferred Home Health, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Texas Senior Care, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">A&amp;B&nbsp;Home&nbsp;Health&nbsp;Solutions,&nbsp;LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AHM Texas GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Apex Hospice LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Home Health of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Home Health of East Tennessee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Home Health of the Gulf Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of Central Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of East Louisiana, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of Louisiana, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of North Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of Northeast Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of Northeast Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of South Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of Southwest Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Camellia Hospice of the Gulf Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareServices of the Treasure Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Columbus, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Dothan, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Gainesville, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Greensboro, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Lexington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of North Florida, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Panama City, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Richmond, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of South Carolina, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Tallahassee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of the Bay Area, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Valley, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Washington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Western Carolina, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings of Winchester, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth HHA Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CareSouth Hospice, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Continental Home Care, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Continental Medical Systems, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CS Health&nbsp;&amp; Wellness, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Day-By-Day</FONT></FONT> Staff Relief, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Acquisition Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Acquisition Holdings Subsidiary, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Alabama Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Arizona Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Arkansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Boise Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Bryan Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health California Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Colorado Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Deaconess Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Fairlawn Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health GKBJH Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Gulfport Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Birmingham, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Central Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Florida, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Kentucky, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass&nbsp;Health&nbsp;Home&nbsp;Health&nbsp;of&nbsp;New&nbsp;England,&nbsp;LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Home Health of Ohio, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Hospice of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Hospice of Pennsylvania, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Hospice of the Midwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Hospice of the Southwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Iowa Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Johnson City Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Joint Ventures Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Kansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Kentucky Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Littleton Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Lubbock Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Martin County Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Maryland Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Massachusetts Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Midland Odessa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Myrtle Beach Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Nevada Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health New Mexico Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Ohio Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Owned Hospitals Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Pennsylvania Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Properties, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Abilene, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Arlington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Austin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bluffton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Braintree, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Charleston, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cypress, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Dallas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of East Valley, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Erie, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Franklin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Gadsden, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Harmarville, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Henderson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Humble, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Katy, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Kingsport, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Lakeview, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Largo, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Littleton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Miami, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass&nbsp;Health&nbsp;Rehabilitation&nbsp;Hospital&nbsp;of&nbsp;Middletown,&nbsp;LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Modesto, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Murrieta, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Newnan, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Ocala, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Pearland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Petersburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Reading, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Richardson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Round Rock, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sarasota, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Shelby County, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sugar Land, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sunrise, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Toms River, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Utah, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Vineland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of York, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital The Vintage, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Hospital Vision Park, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Rehabilitation Institute of Tucson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Savannah Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Sea Pines Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Sewickley Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health South Carolina Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health South Dakota Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Support Companies, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Texas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Tucson Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Tulsa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Utah Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Walton Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health West Tennessee Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health West Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Westerville Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Health Winston-Salem Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of Austin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of Colorado, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of DFW, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of East Texas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of the Mid Atlantic, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of the Midwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of the Southeast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Encompass Home Health of the West, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="45%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="74%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Encompass&nbsp;Hospice&nbsp;of&nbsp;the&nbsp;West,&nbsp;LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">EXCELLA ASSOCIATES, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">EXCELLA HOME HEALTH AGENCY, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">HealthCare Innovations of Oklahoma, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">HEALTHCARE INNOVATIONS OF WESTERN OKLAHOMA, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">HealthCare Innovations-Travertine Health Services, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Hospice Care of Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Orion Homecare, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Print Promotions Group, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Rebound, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Rehabilitation Hospital Corporation of America, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Rehabilitation Hospital of North Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">Saad Healthcare of St. Clair County LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5">TH of San Antonio LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;/s/ Edmund M.
Fay&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Edmund&nbsp;M.&nbsp;Fay&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted&nbsp;and&nbsp;agreed&nbsp;to&nbsp;as&nbsp;of&nbsp;the&nbsp;date</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">first written above</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Truist Securities, Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as R</I><I>epresentative and Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ron Caldwell</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ron Caldwell</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director, Leveraged Finance</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Barclays&nbsp;Capital&nbsp;Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Skrobe</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">John Skrobe</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BofA&nbsp;Securities,&nbsp;Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James C. Brett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">James C. Brett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Citigroup&nbsp;Global&nbsp;Markets&nbsp;Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Akshay&nbsp;Kolkarni&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Akshay Kolkarni</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman&nbsp;Sachs&nbsp;&amp; Co.&nbsp;LLC,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>as an Underwriter</I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Shakhi Majumdar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shakhi Majumdar</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President &amp; Associate General Counsel</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P.&nbsp;Morgan&nbsp;Securities&nbsp;LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andreas Pierroutsakos</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Andreas Pierroutsakos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Morgan&nbsp;Stanley&nbsp;&amp; Co.&nbsp;LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Molly Breen</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Molly Breen</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">RBC&nbsp;Capital&nbsp;Markets,&nbsp;LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles D. Smith</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Charles D. Smith</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Co-Head,</FONT> U.S. Leveraged Finance</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Regions&nbsp;Securities&nbsp;LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas Bove</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Thomas Bove</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Wells&nbsp;Fargo&nbsp;Securities,&nbsp;LLC,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>as an Underwriter</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Charles&nbsp;Stoll&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Charles Stoll</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Encompass Underwriting Agreement] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal&nbsp;Amount<br>of&nbsp;Securities</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regions Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27,200,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,600,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule 2 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A&amp;B Home Health Solutions, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Abba Home Health, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advanced Homecare Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advanced Homecare Management, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Action Home Health, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Texas GP, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Texas LP, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apex Hospice LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Best Home Care LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of East Tennessee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of the Gulf Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Central Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of East Louisiana, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Louisiana, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of North Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Northeast Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Northeast Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of South Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Southwest Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of the Gulf Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Medical Systems, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareServices of the Treasure Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth Health System, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Columbus, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Dothan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Gainesville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Greensboro, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Lexington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of North Florida, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Panama City, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Richmond, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of South Carolina, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of the Bay Area, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Washington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Western Carolina, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Winchester, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth Hospice, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Home Care, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Rehabilitation Hospital of Arizona, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CS Health&nbsp;&amp; Wellness, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or</B><br><B>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Day-By-Day</FONT></FONT> Staff
Relief, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DOSIK, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DRC Health Systems, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EHHI Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health C Corp Sub Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Central Arkansas Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Birmingham, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Central Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Florida, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Ohio, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of Pennsylvania, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of the Midwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of the Southwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Jonesboro Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Abilene, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Arlington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Charleston, LLC*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of City View, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Columbia, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Concord, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cypress, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dallas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dothan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Humble, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Katy, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Manati, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Murrieta, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This entity shall cease to be a Guarantor effective October&nbsp;1, 2020 at 12:01 a.m. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Panama City, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Pearland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Richardson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Round Rock, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Antonio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Juan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sugar Land, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Texarkana, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of the
<FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of The Woodlands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tustin, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital The Vintage, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital Vision Park, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tyler Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Yuma Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of Colorado, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of DFW, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of East Texas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Mid Atlantic, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Midwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Southeast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the West, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Hospice of the West, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass of Fort Worth, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass of West Texas, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA ASSOCIATES, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HEALTHCARE, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HOME HEALTH AGENCY, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HOMECARE, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guardian Home Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hallmark Homecare, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthCare Innovations of Oklahoma, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HEALTHCARE INNOVATIONS OF WESTERN OKLAHOMA, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthCare Innovations-Travertine Health Services, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Austin, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Home Health Care of Bogalusa, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Home Health Care Systems, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospice Care of Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Idaho Homecare Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Orion Homecare, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred Home Health, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rebound, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital Corporation of America, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of North Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reliant Blocker Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Saad Healthcare of St. Clair County LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Texas Senior Care, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TH of San Antonio LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WellCare, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">New Mexico</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wellmark Healthcare Services of El Paso, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">West Mississippi Home Health Services, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Western Neuro Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;Term sheet containing the terms of the Securities in the form of Annex B. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING TERM SHEET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The free writing prospectus filed on September&nbsp;30, 2020 by the Company with the Commission pursuant to Rule 433. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d12659dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TENTH SUPPLEMENTAL INDENTURE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ENCOMPASS HEALTH CORPORATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4.625% SENIOR NOTES DUE 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WELLS FARGO BANK, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NATIONAL
ASSOCIATION, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Trustee </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of October&nbsp;5, 2020 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE I</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">Establishment of New Series</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Establishment of New Series</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE II</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">Definitions</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE III</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">The Securities</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Form</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE IV</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">Amendment Of Base Indenture</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article I of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.02.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article III of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.03.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article IV of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.04.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article V of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.05.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article VI of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.06.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendments of Article VII of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.07.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article XI of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.08.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article XII of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.09.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article XIII of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4.10.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amendment of Article XIV of Base Indenture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE V</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">Subsidiary Guarantees</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guarantees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.02.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Limitation on Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.03.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Successors and Assigns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.04.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">No Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.05.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Modification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.06.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Release of Subsidiary Guarantor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5.07.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contribution</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">ARTICLE VI</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="6" ALIGN="center">Miscellaneous</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0em; text-indent:0em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.01.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Integral Part</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.02.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adoption, Ratification and Confirmation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.03.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.04.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.05.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.06.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee Makes No Representation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.07.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Damages Limitation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6.08.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S.A. PATRIOT Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT A:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Form of Security</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXHIBIT B:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Form of Guaranty Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TENTH SUPPLEMENTAL INDENTURE dated as of October&nbsp;5, 2020 (this &#147;<U>Supplemental
Indenture</U>&#148;), between ENCOMPASS HEALTH CORPORATION, a Delaware corporation (formerly known as HealthSouth Corporation, the &#147;<U>Company</U>&#148;), the SUBSIDIARY GUARANTORS (as defined herein) party hereto and WELLS FARGO BANK, NATIONAL
ASSOCIATION, as trustee (the &#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company has heretofore entered into a senior indenture, dated as of December&nbsp;1, 2009 (the &#147;<U>Base Indenture</U>&#148;),
with the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Base Indenture, as supplemented by this Supplemental Indenture, is herein called the
&#147;<U>Indenture</U>&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to Section&nbsp;3.01 of the Indenture, the form and terms of a new series of Securities
may at any time be established by a supplemental indenture executed by the Company and the Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company proposes to
create under the Indenture a new series of Securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS additional Securities of this series and other series hereafter
established, except as may be limited in the Indenture as at the time supplemented and modified, may be issued from time to time pursuant to the Indenture as at the time supplemented and modified; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS all conditions necessary to authorize the execution and delivery of this Supplemental Indenture and to make it a valid and binding
obligation of the Company and the Subsidiary Guarantors have been done or performed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the agreements
and obligations set forth herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESTABLISHMENT OF NEW SERIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Establishment of New Series</U>. (a)&nbsp;There is hereby established a new series of Securities to be
issued under the Indenture, to be designated as the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Securities</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;On the Issue Date, the Trustee shall authenticate and deliver $400,000,000.00 of the Securities and, at any time
and from time to time thereafter, the Trustee shall authenticate and deliver Additional Securities for original issue in accordance with Section&nbsp;3.14 of the Indenture in an aggregate principal amount specified in the applicable resolution of
the Board of Directors and Officers&#146; Certificate. Further, from time to time after the original issue date, Securities shall be authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of other Securities as
set forth in the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Securities shall be issued initially in the form of one or more Global
Securities in substantially the form set out in Exhibit A hereto. The Depositary with respect to the Securities shall be DTC. The Company initially appoints the Trustee to act as the Registrar and Paying Agent and to act as custodian with respect to
the Global Securities. The Company has entered into a letter of representations with the Depositary in the form provided by the Depositary and the Trustee and each agent are hereby authorized to act in accordance with such letter and applicable
Depositary procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each Security shall be dated the date of authentication thereof and shall bear interest
as provided in the form of Security in Exhibit A hereto. The date on which principal is payable on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The record dates for the Securities and the manner of payment of
principal and interest on the Securities shall be as provided in the form of Security in Exhibit A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;If
and to the extent that the provisions of the Base Indenture are duplicative of, or in contradiction with, the provisions of this Supplemental Indenture, the provisions of this Supplemental Indenture shall govern, but solely with respect to the
Securities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
2.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. For purposes of the Indenture, but only with respect to the Securities, and the Securities, the following terms have the meanings indicated below. All capitalized terms used herein and not otherwise
defined below shall have the meanings ascribed thereto in the Base Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Assets</U>&#148; means (1)&nbsp;any
property or assets used in a Related Business; (2)&nbsp;the Capital Stock of a Person that becomes a Restricted Subsidiary as a result of the acquisition of such Capital Stock by the Company or another Restricted Subsidiary; or (3)&nbsp;Capital
Stock constituting a minority interest in any Person that at such time is a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that any such Restricted Subsidiary described in clause (2)&nbsp;or (3) above is primarily engaged in a Related
Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Additional Securities</U>&#148; means Securities issued under the terms of this Indenture subsequent to the Issue
Date, and in compliance with Sections 3.14 and 6.03, it being understood that any Securities issued in exchange for or replacement of any Security issued on the Issue Date shall not be an Additional Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjusted Treasury Rate</U>&#148; means, with respect to any redemption date, (1)&nbsp;the yield, under the heading which represents
the average for the immediately preceding week, appearing in the most recently published statistical release designated &#147;H.15(519)&#148; or any successor publication that is published weekly by the Board of Governors of the Federal Reserve
System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption &#147;Treasury Constant Maturities,&#148; for the maturity corresponding to the Comparable Treasury Issue (if no
maturity is within three months before or after April&nbsp;1, 2026, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue shall be determined and the Adjusted Treasury Rate shall be interpolated or
extrapolated from such yields on a straight line basis, rounding to the nearest month) or (2)&nbsp;if such release (or any successor release) is not published during the week preceding the calculation date or does not contain such yields, the rate
per year equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date, in each case calculated on the third
Business Day immediately preceding the redemption date, and in each case of (1)&nbsp;and (2), plus 0.50%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; of
any specified Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, &#147;control&#148; when used with respect
to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms &#147;controlling&#148; and
&#147;controlled&#148; have meanings correlative to the foregoing. No Person (other than the Company or any Subsidiary of the Company) in whom a Receivables Entity makes an Investment in connection with a Qualified Receivables Transaction will be
deemed to be an Affiliate of the Company or any of its Subsidiaries solely by reason of such Investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable
Premium</U>&#148; means, with respect to a Security at any redemption date, the greater of (1) 1.00% of the principal amount of such Security and (2)&nbsp;the excess of (A)&nbsp;the present value at such redemption date of (i)&nbsp;the redemption
price of such Security on April&nbsp;1, 2026 (such redemption price being set forth in paragraph 5 of such Security, exclusive of any accrued interest), plus (ii)&nbsp;all required remaining scheduled interest payments due on such Security through
April&nbsp;1, 2026 (but excluding accrued and unpaid interest to the redemption date), computed using a discount rate equal to the Adjusted Treasury Rate, over (B)&nbsp;the principal amount of such Security on such redemption date. The Company will
provide written notice to the Trustee of the Applicable Premium promptly after calculation and the Trustee will not be responsible for such calculation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Disposition</U>&#148; means any sale, lease, transfer or other disposition
(or series of related sales, leases, transfers or dispositions) by the Company or any Restricted Subsidiary, including any disposition by means of a merger, consolidation or similar transaction (each referred to for the purposes of this definition
as a &#147;<U>disposition</U>&#148;), of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any shares of Capital Stock of a Restricted Subsidiary (other than
directors&#146; qualifying shares or shares required by applicable law to be held by a Person other than the Company or a Restricted Subsidiary); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;all or substantially all the assets of any division or line of business of the Company or any Restricted
Subsidiary; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;any other assets of the Company or any Restricted Subsidiary outside of the ordinary course of
business of the Company or such Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">other than, in the case of clauses (1), (2) and (3)&nbsp;above, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;a disposition by a Restricted Subsidiary to the Company or by the Company or a Restricted Subsidiary
to a Restricted Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;for purposes of Section&nbsp;6.06 only, a disposition that
constitutes a Restricted Payment (or would constitute a Restricted Payment but for the exclusions from the definition thereof) that is not prohibited by Section&nbsp;6.04 or that constitutes a Permitted Investment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;a disposition of all or substantially all the assets of the Company in accordance with
Section&nbsp;5.01; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;a disposition of Capital Stock or other assets with a Fair Market Value of
less than or equal to $10,000,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;sales of damaged,
<FONT STYLE="white-space:nowrap">worn-out</FONT> or obsolete equipment or assets in the ordinary course of business that, in the Company&#146;s reasonable judgment, are no longer either used or useful in the business of the Company or its
Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F)&nbsp;&nbsp;&nbsp;&nbsp;the sale or discount, in each case without recourse, of accounts receivable
arising in the ordinary course of business, but only in connection with the compromise or collection thereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G)&nbsp;&nbsp;&nbsp;&nbsp;sales of accounts receivable and related assets of the type specified in the definition of
&#147;<U>Qualified Receivables Transaction</U>&#148; to a Receivables Entity; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H)&nbsp;&nbsp;&nbsp;&nbsp;transfers of
accounts receivable and related assets of the type specified in the definition of &#147;<U>Qualified Receivables Transaction</U>&#148; (or a fractional undivided interest therein) by a Receivables Entity in a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I)&nbsp;&nbsp;&nbsp;&nbsp;leases or subleases to third Persons in the ordinary course of business that do not interfere in any
material respect with the business of the Company or any of its Restricted Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J)&nbsp;&nbsp;&nbsp;&nbsp;a
disposition of cash or Temporary Cash Investments; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K)&nbsp;&nbsp;&nbsp;&nbsp;the creation of a Lien (but not the sale
or other disposition of the property subject to such Lien). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Attributable Debt</U>&#148; in respect of a Sale/Leaseback
Transaction means, as at the time of determination, the present value (discounted at the interest rate implicit in the lease, compounded annually) of the total obligations of the lessee for rental payments during the remaining term of the lease
included in such Sale/Leaseback Transaction (including any period for which such lease has been extended); <U>provided</U>, <U>however</U>, that if such Sale/Leaseback Transaction results in a Finance Lease Obligation, the amount of Indebtedness
represented thereby shall be determined in accordance with the definition of &#147;Finance Lease Obligation.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Average Life</U>&#148; means, as of the date of determination, with respect to any
Indebtedness, the quotient obtained by dividing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the sum of the products of the numbers of years from the date
of determination to the dates of each successive scheduled principal payment of or redemption or similar payment with respect to such Indebtedness multiplied by the amount of such payment by </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the sum of all such payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means each day which is not a Saturday, a Sunday or a day on which the Trustee is authorized or required by
law to close or banking institutions are not required to be open in the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Capital Markets
Indebtedness</U>&#148; means any Indebtedness: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;in the form of, or represented by, bonds (other than surety
bonds, indemnity bonds, performance bonds or bonds of a similar nature) or other securities or any Guarantee thereof; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;that is, or may be, quoted, listed or purchased and sold on any stock exchange, automated trading system or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> or other securities market (including, without prejudice to the generality of the foregoing, the market for securities eligible for resale pursuant to Rule
144A under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Captive Insurance Subsidiary</U>&#148; means HCS, Ltd., a Cayman Islands entity, and any
successor to it, and any other Subsidiary formed for the purpose of facilitating self-insurance programs of the Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Change of Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the Company becomes aware that any &#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the
Exchange Act) is or has become the &#147;beneficial owner&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act, except that for purposes of this clause
(1)&nbsp;such person shall be deemed to have &#147;beneficial ownership&#148; of all shares that any such person has the right to acquire, whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of
more than 50% of the total voting power of the Voting Stock of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;at any time during any period of
up to 24 consecutive months, commencing on the Issue Date, individuals who at the beginning of such period constituted the Board of Directors (together with any new directors whose election by such Board of Directors or whose nomination for election
by the shareholders of the Company was approved by a vote of a majority of the directors of the Company then still in office who were either directors at the beginning of such period or whose election or nomination for election was previously so
approved) cease for any reason to constitute a majority of the Board of Directors then in office; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the Company
is liquidated or dissolved or adopts a plan of liquidation or dissolution; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the merger or consolidation of
the Company with or into another Person or the merger of another Person with or into the Company, or the sale of all or substantially all the assets of the Company (determined on a consolidated basis) to another Person, other than a transaction
following which (i)&nbsp;in the case of a merger or consolidation transaction, holders of securities that represented 100% of the Voting Stock of the Company immediately prior to such transaction (or other securities into which such securities are
converted as part of such merger or consolidation transaction) own directly or indirectly at least a majority of the voting power of the Voting Stock of the surviving Person in such merger or consolidation transaction immediately after such
transaction and (ii)&nbsp;in the case of a sale of assets transaction, each transferee becomes an obligor in respect of the Securities and a Subsidiary of the transferor of such assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and any
applicable Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Issue</U>&#148; means the United States Treasury
security selected by the Quotation Agent as having a maturity comparable to the remaining term of the Securities from the redemption date to April&nbsp;1, 2026, that would be utilized, at the time of selection and in accordance with customary
financial practice, in pricing new issues of corporate debt securities of a maturity most nearly equal to April&nbsp;1, 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Comparable Treasury Price</U>&#148; means, with respect to any redemption date, if clause (2)&nbsp;of the Adjusted Treasury Rate is
applicable, the average of two, or if not possible, such lesser number as is obtained by the Company, Reference Treasury Dealer Quotations for such redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Amortization Expense</U>&#148; means, for any Person for any period, the amortization expense of such Person and its
Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP, excluding amortization expense attributable to a prepaid item
that was paid in cash in a prior period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Coverage Ratio</U>&#148; as of any date of determination means the ratio
of (a)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters ending at least 45 days prior to the date of such determination to (b)&nbsp;Consolidated Interest Expense for such four fiscal quarters;
<U>provided</U>, <U>however</U>, that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;if the Company or any Restricted Subsidiary has Incurred any
Indebtedness since the beginning of such period that remains outstanding or if the transaction giving rise to the need to calculate the Consolidated Coverage Ratio is an Incurrence of Indebtedness, or both, EBITDA and Consolidated Interest Expense
for such period shall be calculated after giving effect on a pro forma basis to such Indebtedness (and the application of the proceeds thereof) as if such Indebtedness had been Incurred on the first day of such period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;if the Company or any Restricted Subsidiary has repaid, repurchased, defeased or otherwise discharged any
Indebtedness since the beginning of such period or if any Indebtedness is to be repaid, repurchased, defeased or otherwise discharged (in each case other than Indebtedness Incurred under any revolving credit facility unless such Indebtedness has
been permanently repaid and has not been replaced) on the date of the transaction giving rise to the need to calculate the Consolidated Coverage Ratio, EBITDA and Consolidated Interest Expense for such period shall be calculated on a pro forma basis
as if such discharge had occurred on the first day of such period and as if the Company or such Restricted Subsidiary had not earned the interest income actually earned during such period in respect of cash or Temporary Cash Investments used to
repay, repurchase, defease or otherwise discharge such Indebtedness; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;if since the beginning of such period the
Company or any Restricted Subsidiary shall have made any Asset Disposition, EBITDA for such period shall be reduced by an amount equal to EBITDA (if positive) directly attributable to the assets which are the subject of such Asset Disposition for
such period, or increased by an amount equal to EBITDA (if negative), directly attributable thereto for such period and Consolidated Interest Expense for such period shall be reduced by an amount equal to the Consolidated Interest Expense directly
attributable to any Indebtedness of the Company or any Restricted Subsidiary repaid, repurchased, defeased or otherwise discharged with respect to the Company and its continuing Restricted Subsidiaries in connection with such Asset Disposition for
such period (or, if the Capital Stock of any Restricted Subsidiary is sold, the Consolidated Interest Expense for such period directly attributable to the Indebtedness of such Restricted Subsidiary to the extent the Company and its continuing
Restricted Subsidiaries are no longer liable for such Indebtedness after such sale); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;if since the beginning of
such period the Company or any Restricted Subsidiary (by merger or otherwise) shall have made an Investment in any Restricted Subsidiary (or any Person that becomes a Restricted Subsidiary) or an acquisition of assets, including any acquisition of
assets occurring in connection with a transaction requiring a calculation to be made hereunder, that constitutes a hospital or other health care-related business or all or substantially all of an operating unit of a business, EBITDA and Consolidated
Interest Expense for such period shall be calculated after giving pro forma effect thereto (including the Incurrence of any Indebtedness) as if such Investment or acquisition had occurred on the first day of such period; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;if since the beginning of such period any Person (that
subsequently became a Restricted Subsidiary or was merged with or into the Company or any Restricted Subsidiary since the beginning of such period) shall have made any Asset Disposition, any Investment or acquisition of assets that would have
required an adjustment pursuant to clause (3)&nbsp;or (4) above if made by the Company or a Restricted Subsidiary during such period, EBITDA and Consolidated Interest Expense for such period shall be calculated after giving pro forma effect thereto
as if such Asset Disposition, Investment or acquisition had occurred on the first day of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this definition,
whenever pro forma effect is to be given to an acquisition of assets, the amount of income or earnings relating thereto and the amount of Consolidated Interest Expense associated with any Indebtedness Incurred in connection therewith, the pro forma
calculations shall be determined in good faith by a responsible financial or accounting Officer of the Company (and shall include any applicable Pro Forma Cost Savings). If any Indebtedness bears a floating rate of interest and is being given pro
forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the date of determination had been the applicable rate for the entire period (taking into account any Interest Rate Agreement applicable to such
Indebtedness). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Indebtedness is incurred under a revolving credit facility and is being given pro forma effect, the interest on
such Indebtedness shall be calculated based on the average daily balance of such Indebtedness for the four fiscal quarters subject to the pro forma calculation to the extent that such Indebtedness was incurred solely for working capital purposes.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Depreciation Expense</U>&#148; means, for any Person for any period, the depreciation expense of such Person and
its Restricted Subsidiaries for such period (to the extent included in the computation of Consolidated Net Income of such Person), determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Income Tax Expense</U>&#148; means, for any Person for any period, the provision for taxes based on income and profits
of such Person and its Restricted Subsidiaries to the extent such provision for income taxes was deducted in computing Consolidated Net Income of such Person for such period, determined on a consolidated basis in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Interest Expense</U>&#148; means, for any period, the total interest expense of the Company and its consolidated
Restricted Subsidiaries, net of interest income of the Company and its consolidated Restricted Subsidiaries (other than interest income of any Captive Insurance Subsidiary that is a Restricted Subsidiary), <U>plus</U>, to the extent not included in
the calculation of total interest expense, and to the extent incurred by the Company or its Restricted Subsidiaries, without duplication: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;interest expense attributable to Finance Lease Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;amortization of debt discount; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;capitalized interest; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">(4)&nbsp;&nbsp;&nbsp;&nbsp;non-cash</FONT> interest expense; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;commissions, discounts and other fees and charges owed with respect to letters of credit and bankers&#146;
acceptance financing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;net payments made or received pursuant to Hedging Obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;dividends accrued in respect of all Disqualified Stock of the Company and all Preferred Stock of any Restricted
Subsidiary, in each case held by Persons other than the Company or a Wholly Owned Subsidiary (other than dividends payable solely in Capital Stock (other than Disqualified Stock) of the Company); <U>provided</U>, <U>however</U>, that such dividends
shall be multiplied by a fraction the numerator of which is one and the denominator of which is one minus the effective combined tax rate of the issuer of such Preferred Stock (expressed as a decimal) for such period (as estimated by the chief
financial officer of the Company in good faith); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;interest accruing on any Indebtedness of any other Person to the
extent such Indebtedness is Guaranteed by (or secured by the assets of) the Company or any Restricted Subsidiary; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;the cash contributions to any employee stock ownership plan or similar trust to the extent such contributions are
used by such plan or trust to pay interest or fees to any Person (other than the Company) in connection with Indebtedness Incurred by such plan or trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Net Income</U>&#148; means, for any period, the net income of the Company and its consolidated Subsidiaries;
<U>provided</U>, <U>however</U>, that there shall not be included in such Consolidated Net Income: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any net
income of any Person (other than the Company) if such Person is not a Restricted Subsidiary, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;subject to the exclusion contained in clause (4)&nbsp;below, the Company&#146;s equity in the net
income of any such Person for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash actually distributed by such Person during such period to the Company or a Restricted Subsidiary as a dividend or other
distribution (subject, in the case of a dividend or other distribution paid to a Restricted Subsidiary, to the limitations contained in clause (3)&nbsp;below); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the Company&#146;s equity in a net loss of any such Person for such period shall be included in
determining such Consolidated Net Income to the extent such loss has been funded with cash from the Company or a Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any net income (or loss) of any Person acquired by the Company or a Subsidiary in a pooling of interests
transaction (or any transaction accounted for in a manner similar to a pooling of interests) for any period prior to the date of such acquisition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;any net income of any Restricted Subsidiary if such Restricted Subsidiary is subject to restrictions, directly or
indirectly, on the payment of dividends or the making of distributions by such Restricted Subsidiary, directly or indirectly, to the Company, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;subject to the exclusion contained in clause (4)&nbsp;below, the Company&#146;s equity in the net
income of any such Restricted Subsidiary for such period shall be included in such Consolidated Net Income up to the aggregate amount of cash that could have been distributed by such Restricted Subsidiary during such period to the Company or another
Restricted Subsidiary as a dividend or other distribution (subject, in the case of a dividend or other distribution paid to another Restricted Subsidiary, to the limitation contained in this clause); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the Company&#146;s equity in a net loss of any such Restricted Subsidiary for such period shall be
included in determining such Consolidated Net Income; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;any gain (or loss) realized upon the sale or other
disposition of any assets of the Company, its consolidated Subsidiaries or any other Person (including pursuant to any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sale-and-leaseback</FONT></FONT> arrangement) which is not sold
or otherwise disposed of in the ordinary course of business and any gain (or loss) realized upon the sale or other disposition of any Capital Stock of any Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;any net income or net losses from discontinued operations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;extraordinary gains or losses; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;the cumulative effect of a change in accounting principles, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case, for such period. Notwithstanding the foregoing, for the purposes of Section&nbsp;6.04 only, there shall be excluded from Consolidated Net Income
any repurchases, repayments or redemptions of Investments, proceeds realized on the sale of Investments or return of capital to the Company or a Restricted Subsidiary to the extent such repurchases, repayments, redemptions, proceeds or returns
increase the amount of Restricted Payments permitted under clause (a)(3)(D) or (a)(3)(E) of Section&nbsp;6.04. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Secured Debt Ratio</U>&#148; as of any date of determination, means
the ratio of (a)&nbsp;Indebtedness of the Company and its Restricted Subsidiaries, determined on a consolidated basis, secured by Liens, to (b)&nbsp;the aggregate amount of EBITDA for the period of the most recent four consecutive fiscal quarters
ending at least 45 days prior to the date of such determination, in each case with such pro forma adjustments to consolidated total Indebtedness and EBITDA as are appropriate and consistent with the pro forma adjustment provisions set forth in the
definition of &#147;Consolidated Coverage Ratio.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Tangible Assets</U>&#148; as of any date means the total
assets of the Company and its Restricted Subsidiaries (excluding any assets that would be classified as &#147;intangible assets&#148; under GAAP) on a consolidated basis at such date, as determined in accordance with GAAP, less (i)&nbsp;all <FONT
STYLE="white-space:nowrap">write-ups</FONT> subsequent to the Issue Date in the book value of any asset owned by the Company or any of its Restricted Subsidiaries and (ii)&nbsp;Investments in and assets of Unrestricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consolidated Total Indebtedness</U>&#148; of any Person as of any date means (a)&nbsp;all Indebtedness (including Finance Lease
Obligations but excluding (i)&nbsp;Hedging Obligations and (ii)&nbsp;to the extent they constitute Indebtedness, contingent reimbursement obligations in respect of undrawn amounts of letters of credit) minus (b)&nbsp;the aggregate amount of cash and
cash equivalents of such Person and its Subsidiaries (other than Restricted Cash and Cash Equivalents) as of such date in an amount not to exceed $100,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Corporate Trust Office</U>&#148; shall be the office of the Trustee at which this Indenture shall be principally administered, which
at the Issue Date is 150 East 42nd Street, 40th Floor, New York, New York 10017, Attn: Corporate, Trust Services, and with respect to Paying Agent and Registrar services such office shall also mean the office or agency of the Trustee located at 600
South Fourth Street, 7th Floor, Minneapolis, MN 55415, Attn: Corporate Trust Operations, or such other address as to which the Trustee may give notice to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Credit Agreement</U>&#148; means the Fifth Amended and Restated Credit Agreement dated as of November&nbsp;25,&nbsp;2019, by and
among the Company, as borrower, Barclays Bank PLC, as administrative agent, and the other lenders and agents party thereto from time to time, together with the related documents thereto (including the term loans and revolving loans thereunder, any
guarantees and security documents), as amended by a First Amendment to Fifth Amended and Restated Credit Agreement dated as of April&nbsp;24, 2020, and as further amended, extended, renewed, restated, supplemented or otherwise modified (in whole or
in part, and without limitation as to amount, terms, conditions, covenants and other provisions) from time to time, and any agreement (and related document) governing Indebtedness incurred to Refinance, in whole or in part, the borrowings and
commitments then outstanding or permitted to be outstanding under such Credit Agreement or a successor Credit Agreement, whether by the same or any other lender or group of lenders (including by means of sales of debt securities to institutional
investors). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Currency Agreement</U>&#148; means any foreign exchange contract, currency swap agreement or other similar agreement
with respect to currency values. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>DTC</U>&#148; means The Depository Trust Company, a New York corporation, or any successor
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Designated Noncash Consideration</U>&#148; means noncash consideration received by the Company or one of its Restricted
Subsidiaries in connection with an Asset Disposition that is designated by the Company as Designated Noncash Consideration, less the amount of cash or cash equivalents received in connection with a subsequent sale of such Designated Noncash
Consideration, which cash and cash equivalents shall be considered Net Available Cash received as of such date and shall be applied pursuant to Section&nbsp;6.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disqualified Stock</U>&#148; means, with respect to any Person, any Capital Stock that by its terms (or by the terms of any security
into which it is convertible or for which it is exchangeable at the option of the holder) or upon the happening of any event: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;matures or is mandatorily redeemable (other than redeemable only for Capital Stock of such Person which is not
itself Disqualified Stock) pursuant to a sinking fund obligation or otherwise; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;is convertible or exchangeable at the option of the holder for
Indebtedness or Disqualified Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;is mandatorily redeemable or must be purchased upon the occurrence of
certain events or otherwise, in whole or in part; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case on or prior to the date that is 91 days after the Stated Maturity of the Securities;
<U>provided</U>, <U>however</U>, that any Capital Stock that would not constitute Disqualified Stock but for provisions thereof giving holders thereof the right to require such Person to purchase or redeem such Capital Stock upon the occurrence of
an &#147;asset sale&#148; or &#147;change of control&#148; occurring prior to the date that is 91 days after the Stated Maturity of the Securities shall not constitute Disqualified Stock if the &#147;asset sale&#148; or &#147;change of control&#148;
provisions applicable to such Capital Stock are not more favorable to the holders of such Capital Stock than the terms applicable to the Securities under Sections 6.06 and 6.08. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Disqualified Stock that does not have a fixed redemption, repayment or repurchase price shall be calculated in accordance
with the terms of such Disqualified Stock as if such Disqualified Stock were redeemed, repaid or repurchased on any date on which the amount of such Disqualified Stock is to be determined pursuant to this Indenture; <U>provided</U>, <U>however</U>,
that if such Disqualified Stock could not be required to be redeemed, repaid or repurchased at the time of such determination, the redemption, repayment or repurchase price shall be the book value of such Disqualified Stock as reflected in the most
recent financial statements of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>EBITDA</U>&#148; of any Person for any period means Consolidated Net Income of such
Person for such period plus, without duplication, the sum for such Person of the following to the extent deducted in calculating Consolidated Net Income for such period: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Income Tax Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Depreciation Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Amortization Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;Consolidated Interest Expense, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;all other <FONT STYLE="white-space:nowrap">non-cash</FONT> items or
<FONT STYLE="white-space:nowrap">non-recurring</FONT> <FONT STYLE="white-space:nowrap">non-cash</FONT> items reducing Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP (including <FONT
STYLE="white-space:nowrap">non-cash</FONT> charges incurred as a result of the application of FASB Accounting Standard Codification 718, Compensation&#151;Stock Compensation); <U>provided</U> that cash expenditures made in respect of items to which
the charges referred to in this clause (5)&nbsp;relate in an aggregate amount in excess of $10,000,000 for any period of four consecutive fiscal quarters shall be deducted in determining EBITDA for the period during which such expenditures are made,
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;any restructuring charges in respect of legal fees associated with the government, class-action and
shareholder derivative litigation described in the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2009, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;fees, costs and expenses related to the offering of the Securities and the other Refinancing Transactions, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;any losses from discontinued operations and closed locations, and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;costs and expenses related to the settlement of the Shareholder Litigation, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in each case determined on a consolidated basis in accordance with GAAP, less all unusual noncash items or
nonrecurring noncash items to the extent increasing Consolidated Net Income of such Person and its Subsidiaries, determined on a consolidated basis in accordance with GAAP, in each case for such period. Notwithstanding the foregoing, the provision
for taxes based on the income or profits of, and the depreciation and amortization and noncash charges of, a Restricted Subsidiary shall be added to Consolidated Net Income to compute EBITDA only to the extent (and in the same proportion, including
by reason of minority interests) that the net income or loss of such Restricted Subsidiary was included in calculating Consolidated Net Income and only if a corresponding amount would be permitted at the date of determination to be dividended to the
Company by such Restricted Subsidiary without prior approval (that has not been obtained), pursuant to the terms of its charter and all agreements, instruments, judgments, decrees, orders, statutes, rules and governmental regulations applicable to
such Restricted Subsidiary or its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Equity Offering</U>&#148; means any public or private sale of Capital Stock
(other than Disqualified Stock) of the Company, other than public offerings with respect to the Company&#146;s common stock registered on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act and other than issuances to any
Subsidiary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fair Market Value</U>&#148; means, with respect to any asset or property, the price that could be
negotiated in an <FONT STYLE="white-space:nowrap">arm&#146;s-length,</FONT> free market transaction, for cash, between a willing and able buyer and an unaffiliated willing seller, neither of whom is under undue pressure or compulsion to complete the
transaction, as such price is determined in good faith by (1)&nbsp;the Chief Financial Officer, the Treasurer or the Chief Accounting Officer of the Company (unless otherwise provided in this Indenture) for transactions valued at, or below,
$10,000,000, or (2)&nbsp;the Board of Directors of the Company (unless otherwise provided in this Indenture) for transactions valued in excess of $10,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finance Lease Obligation</U>&#148; means an obligation that is required to be classified and accounted for as a finance lease for
financial reporting purposes in accordance with GAAP, and the amount of Indebtedness represented by such obligation shall be the capitalized amount of such obligation determined in accordance with GAAP; and the Stated Maturity thereof shall be the
date of the last payment of rent or any other amount due under such lease prior to the first date upon which such lease may be terminated by the lessee without payment of a penalty. For purposes of Section&nbsp;6.09, a Finance Lease Obligation shall
be deemed to be secured by a Lien on the property being leased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guarantee</U>&#148; means any obligation, contingent or
otherwise, of any Person directly or indirectly guaranteeing any Indebtedness of any Person and any obligation, direct or indirect, contingent or otherwise, of such Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness of such Person
(whether arising by virtue of partnership arrangements, or by agreements to keep-well, to purchase assets, goods, securities or services, to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">take-or-pay</FONT></FONT> or to maintain
financial statement conditions or otherwise); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;entered into for the purpose of assuring in any other manner
the obligee of such Indebtedness of the payment thereof or to protect such obligee against loss in respect thereof (in whole or in part); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that the term &#147;<U>Guarantee</U>&#148; shall not include endorsements for collection or deposit in the ordinary course of
business. The term &#147;<U>Guarantee</U>&#148; used as a verb has a corresponding meaning. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Guaranty Agreement</U>&#148; means
an agreement, in substantially the form of Exhibit B hereto or another form satisfactory to the Trustee, pursuant to which a Subsidiary Guarantor guarantees the Company&#146;s obligations with respect to the Securities on the terms provided for in
this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hedging Obligations</U>&#148; of any Person means the obligations of such Person pursuant to any Interest Rate
Agreement or Currency Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incur</U>&#148; means issue, assume, Guarantee, incur or otherwise become liable for;
<U>provided</U>, <U>however</U>, that any Indebtedness of a Person existing at the time such Person becomes a Restricted Subsidiary (whether by merger, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the
time it becomes a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Restricted Subsidiary. The term &#147;<U>Incurrence</U>&#148; when used as a noun shall have a correlative
meaning. Solely for purposes of determining compliance with Section&nbsp;6.03: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;amortization of debt discount
or the accretion of principal with respect to a noninterest bearing or other discount security; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the payment of
regularly scheduled interest in the form of additional Indebtedness of the same instrument or the payment of regularly scheduled dividends on Capital Stock in the form of additional Capital Stock of the same class and with the same terms; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &nbsp;&nbsp;&nbsp;&nbsp;the obligation to pay a premium in respect of Indebtedness arising in connection with the issuance of a notice of
redemption or making of a mandatory offer to purchase such Indebtedness </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">will not be deemed to be the Incurrence of Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any Person on any date of determination (without duplication): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the principal in respect of (A)&nbsp;indebtedness of such Person for money borrowed and (B)&nbsp;indebtedness
evidenced by notes, debentures, bonds or other similar instruments for the payment of which such Person is responsible or liable, including, in each case, any premium on such indebtedness to the extent such premium has become due and payable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;all Finance Lease Obligations of such Person and all Attributable Debt in respect of Sale/Leaseback Transactions
entered into by such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;all obligations of such Person issued or assumed as the deferred purchase price
of property, all conditional sale obligations of such Person and all obligations of such Person under any title retention agreement (but excluding any accounts payable or other liability to trade creditors arising in the ordinary course of
business); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;all obligations of such Person for the reimbursement of any obligor on any letter of credit,
bankers&#146; acceptance or similar credit transaction (other than obligations with respect to letters of credit securing obligations (other than obligations described in clauses (1)&nbsp;through (3) above) entered into in the ordinary course of
business of such Person to the extent such letters of credit are not drawn upon or, if and to the extent drawn upon, such drawing is reimbursed no later than the tenth Business Day following payment on the letter of credit); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any
Disqualified Stock of such Person or, with respect to any Preferred Stock of any Subsidiary of such Person, the principal amount of such Preferred Stock to be determined in accordance with this Indenture (but excluding, in each case, any accrued
dividends); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;all obligations of the type referred to in clauses (1)&nbsp;through (5) of other Persons and all
dividends of other Persons for the payment of which, in either case, such Person is responsible or liable, directly or indirectly, as obligor, guarantor or otherwise, including by means of any Guarantee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;all obligations of the type referred to in clauses (1)&nbsp;through (6) of other Persons secured by any Lien on any
property or asset of such Person (whether or not such obligation is assumed by such Person), the amount of such obligation being deemed to be the lesser of the Fair Market Value of such property or assets and the amount of the obligation so secured;
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;to the extent not otherwise included in this definition, Hedging Obligations of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, in connection with the purchase by the Company or any Restricted Subsidiary of any business, the term
&#147;Indebtedness&#148; will exclude indemnification, purchase price adjustment, holdback and contingency payment obligations to which the seller may become entitled to the extent such payment is determined by a final closing balance sheet or such
payment depends on the performance of such business after the closing; <U>provided</U>, <U>however</U>, that, at the time of closing, the amount of any such payment is not determinable and, to the extent such payment thereafter becomes fixed and
determined, the amount is paid within 60 days thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of Indebtedness of any Person at any date shall be the outstanding balance at
such date of all obligations as described above; <U>provided</U>, <U>however</U>, that in the case of Indebtedness sold at a discount, the amount of such Indebtedness at any time will be the accreted value thereof at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Qualified Party</U>&#148; means an investment banking firm, accounting firm or appraisal firm of national standing;
<U>provided</U>, <U>however</U>, that such firm is not an Affiliate of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Payment Date</U>&#148; means each
date specified in the Security as a fixed date on which an installment of interest is due and payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interest Rate
Agreement</U>&#148; means any interest rate swap agreement, interest rate cap agreement or other financial agreement or arrangement with respect to exposure to interest rates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment</U>&#148; in any Person means any direct or indirect advance, loan (other than advances to customers in the ordinary
course of business that are recorded as accounts receivable on the balance sheet of the lender) or other extensions of credit (including by way of Guarantee or similar arrangement) or capital contribution to (by means of any transfer of cash or
other property to others or any payment for property or services for the account or use of others), or any purchase or acquisition of Capital Stock, Indebtedness or other similar instruments issued by such Person. If the Company or any Restricted
Subsidiary issues, sells or otherwise disposes of any Capital Stock of a Person that is a Restricted Subsidiary such that, after giving effect thereto, such Person is no longer a Restricted Subsidiary, any Investment by the Company or any Restricted
Subsidiary in such Person remaining after giving effect thereto will be deemed to be a new Investment at such time. The acquisition by the Company or any Restricted Subsidiary of a Person that holds an Investment in a third Person shall be deemed to
be an Investment by the Company or such Restricted Subsidiary in such third Person at such time. Except as otherwise provided for herein, the amount of an Investment shall be its Fair Market Value at the time the Investment is made and without
giving effect to subsequent changes in value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the definition of &#147;<U>Unrestricted Subsidiary</U>&#148;, the
definition of &#147;<U>Restricted Payment</U>&#148; and Section&nbsp;6.04: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Investment</U>&#148; shall
include the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of any Subsidiary of the Company at the time that such Subsidiary is designated an Unrestricted Subsidiary;
<U>provided</U>, <U>however</U>, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to have a permanent &#147;Investment&#148; in an Unrestricted Subsidiary equal to an amount (if
positive) equal to (A)&nbsp;the Company&#146;s &#147;Investment&#148; in such Subsidiary at the time of such redesignation less (B)&nbsp;the portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of
the net assets of such Subsidiary at the time of such redesignation; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any property transferred to or from
an Unrestricted Subsidiary shall be valued at its Fair Market Value at the time of such transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Issue Date</U>&#148; means
October&nbsp;5, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leverage Ratio</U>&#148; means, at any date, the ratio of (a)&nbsp;Consolidated Total Indebtedness of the
Company and its Restricted Subsidiaries on such date to (b)&nbsp;EBITDA of the Company and its Restricted Subsidiaries for the period of four consecutive fiscal quarters ending at least 45 days prior to such date, in each case with such pro forma
adjustments as are appropriate and consistent with the pro forma adjustment provisions set forth in the definition of &#147;Consolidated Coverage Ratio.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lien</U>&#148; means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind (including any conditional sale
or other title retention agreement or lease in the nature thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Moody&#146;s</U>&#148; means Moody&#146;s Investors Service, Inc., and any
successor to its rating agency business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Available Cash</U>&#148; from an Asset Disposition means cash payments received
therefrom (including any cash payments received by way of deferred payment of principal pursuant to a note or installment receivable or otherwise and proceeds from the sale or other disposition of any securities received as consideration, but only
as and when received, but excluding any other consideration received in the form of assumption by the acquiring Person of Indebtedness or other obligations relating to such properties or assets or received in any other
<FONT STYLE="white-space:nowrap">non-cash</FONT> form), in each case net of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;all legal, title and recording
tax expenses, commissions and other fees and expenses incurred (including legal, accounting and investment banking fees and commissions), and all federal, state, provincial, foreign and local taxes required to be accrued as a liability under GAAP,
as a consequence of such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;all payments made on any Indebtedness which is secured by any
assets subject to such Asset Disposition, in accordance with the terms of any Lien upon or other security agreement of any kind with respect to such assets, or which must by its terms, or in order to obtain a necessary consent to such Asset
Disposition, or by applicable law, be repaid out of the proceeds from such Asset Disposition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;all
distributions and other payments required to be made to minority interest holders in Restricted Subsidiaries as a result of such Asset Disposition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the deduction of appropriate amounts provided by the seller as a reserve, in accordance with GAAP, against any
liabilities associated with the property or other assets disposed in such Asset Disposition and retained by the Company or any Restricted Subsidiary after such Asset Disposition; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;any portion of the purchase price from an Asset Disposition placed in escrow, whether as a reserve for adjustment
of the purchase price, for satisfaction of indemnities in respect of such Asset Disposition or otherwise in connection with that Asset Disposition; <U>provided</U>, <U>however</U>, that upon the termination of that escrow, Net Available Cash shall
be increased by any portion of funds in the escrow that are released to the Company or any Restricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Cash
Proceeds</U>&#148;, with respect to any issuance or sale of Capital Stock or Indebtedness, means the cash proceeds of such issuance or sale net of attorneys&#146; fees, accountants&#146; fees, underwriters&#146; or placement agents&#146; fees,
discounts or commissions and brokerage, consultant and other fees actually incurred in connection with such issuance or sale and net of taxes paid or payable as a result thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Obligations</U>&#148; means, with respect to any Indebtedness, all obligations for principal, premium, interest, penalties, fees,
indemnifications, reimbursements, and other amounts payable pursuant to the documentation governing such Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer</U>&#148; means the Chairman of the Board of Directors, the Chief Executive Officer, the President, the Chief Financial
Officer, the Chief Accounting Officer, any Vice President, the Treasurer or the Secretary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Officer&#146;s
Certificate</U>&#148; means a certificate signed by an Officer and delivered to the Trustee and &#147;<U>Officers&#146; Certificate</U>&#148; means a certificate signed by two Officers and delivered to the Trustee. Each such certificate shall
include the statements provided for in Section&nbsp;16.01 if and to the extent required by the provisions of such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Opinion of Counsel</U>&#148; means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Company
or may be other counsel who is reasonably acceptable to the Trustee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Investment</U>&#148; means an Investment by the Company or any Restricted
Subsidiary in: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the Company, a Restricted Subsidiary or a Person that shall, upon the making of such
Investment, become a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the primary business of such Restricted Subsidiary is a Related Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;another Person if, as a result of such Investment, such other Person is merged or consolidated with or into, or
transfers or conveys all or substantially all its assets to, the Company or a Restricted Subsidiary; <U>provided</U>, <U>however</U>, that such Person&#146;s primary business is a Related Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;cash and Temporary Cash Investments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;receivables owing to the Company or any Restricted Subsidiary if created or acquired in the ordinary course of
business and payable or dischargeable in accordance with customary trade terms; <U>provided</U>, <U>however</U>, that such trade terms may include such concessionary trade terms as the Company or any such Restricted Subsidiary deems reasonable under
the circumstances; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;payroll, travel and similar advances to cover matters that are expected at the time of such
advances ultimately to be treated as expenses for accounting purposes and that are made in the ordinary course of business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;loans or advances to officers, directors and employees made in the ordinary course of business of the Company or
such Restricted Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;stock, obligations or securities received in settlement of debts created in the
ordinary course of business and owing to the Company or any Restricted Subsidiary or in satisfaction of judgments; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;any Person to the extent such Investment represents the <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of
the consideration received for (A)&nbsp;an Asset Disposition as permitted pursuant to Section&nbsp;6.06 or (B)&nbsp;a disposition of assets not constituting an Asset Disposition; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;any Person where such Investment was acquired by the Company or any of its Restricted Subsidiaries (A)&nbsp;in
exchange for any other Investment or accounts receivable held by the Company or any such Restricted Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or
accounts receivable or (B)&nbsp;as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&nbsp;&nbsp;&nbsp;&nbsp;any Person to the extent such Investments consist of prepaid expenses, negotiable instruments held for collection
and lease, utility and workers&#146; compensation, performance and other similar deposits made in the ordinary course of business by the Company or any Restricted Subsidiary; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&nbsp;&nbsp;&nbsp;&nbsp;any Person to the extent such Investments consist of Hedging Obligations otherwise permitted under
Section&nbsp;6.03; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&nbsp;&nbsp;&nbsp;&nbsp;any Person to the extent such Investment exists on the Issue Date, and any extension,
modification or renewal of any such Investments existing on the Issue Date, but only to the extent not involving additional advances, contributions or other Investments of cash or other assets or other increases thereof (other than as a result of
the accrual or accretion of interest or original issue discount or the issuance of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-in-kind</FONT></FONT> securities, in each case, pursuant to the terms of such Investment as in
effect on the Issue Date); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&nbsp;&nbsp;&nbsp;&nbsp;Investments made by the Captive Insurance Subsidiary in the ordinary course of
business and in accordance with applicable law; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&nbsp;&nbsp;&nbsp;&nbsp;a Receivables Entity, or any Investment by a Receivables
Entity in any other Person in connection with a Qualified Receivables Transaction, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Receivables Transaction or any related
Indebtedness; <U>provided</U>, <U>however</U>, that any Investment in a Receivables Entity is in the form of a purchase money note, contribution of additional receivables or an equity interest; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15)&nbsp;&nbsp;&nbsp;&nbsp;Persons to the extent such Investments, when taken together with
all other Investments made pursuant to this clause (15)&nbsp;and outstanding on the date such Investment is made, do not exceed 10% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end
of the most recent fiscal quarter ending at least 45 days prior thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means, with respect to any
Person: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;pledges or deposits by such Person under worker&#146;s compensation laws, unemployment insurance laws
or similar legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person
or deposits of cash or United States government bonds to secure surety or appeal bonds to which such Person is a party, performance bonds or obligations of a like nature or deposits as security for contested taxes or import duties or for the payment
of rent, in each case Incurred in the ordinary course of business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;Liens imposed by law, such as
carriers&#146;, warehousemen&#146;s and mechanics&#146; Liens, in each case for sums not yet due or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which
such Person shall then be proceeding with an appeal or other proceedings for review and Liens arising solely by virtue of any statutory or common law provision relating to banker&#146;s Liens, rights of
<FONT STYLE="white-space:nowrap">set-off</FONT> or similar rights and remedies as to deposit accounts or other funds maintained with a creditor depository institution; <U>provided</U>, <U>however</U>, that (A)&nbsp;such deposit account is not a
dedicated cash collateral account and is not subject to restrictions against access by the Company in excess of those set forth by regulations promulgated by the Federal Reserve Board and (B)&nbsp;such deposit account is not intended by the Company
or any Restricted Subsidiary to provide collateral to the depository institution; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Liens for taxes, assessments
or other governmental charges or claims, in each case not yet subject to penalties for <FONT STYLE="white-space:nowrap">non-payment</FONT> or which are being contested in good faith by appropriate proceedings; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;Liens in favor of issuers of surety bonds or letters of credit issued pursuant to the request of and for the
account of such Person in the ordinary course of its business; <U>provided</U>, <U>however</U>, that such letters of credit do not constitute Indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, licenses, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real property or Liens
incidental to the conduct of the business of such Person or to the ownership of its properties which were not Incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or
materially impair their use in the operation of the business of such Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;Liens securing Indebtedness
Incurred to finance the construction, purchase or lease of, or repairs, improvements or additions to, property, plant or equipment of such Person; <U>provided</U>, <U>however</U>, that the Lien may not extend to any other property owned by such
Person or any of its Restricted Subsidiaries at the time the Lien is Incurred (other than assets and property affixed or appurtenant thereto), and the Indebtedness (other than any interest thereon) secured by the Lien may not be Incurred more than
180 days after the later of the acquisition, completion of construction, repair, improvement, addition or commencement of full operation of the property subject to the Lien; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;Liens to secure Indebtedness permitted pursuant to Section&nbsp;6.03(b)(1);<I> </I><U>provided</U><I>,
</I><U>however</U><I>, </I>that if (x)&nbsp;on the date the secured Indebtedness is Incurred, and after giving pro forma effect to the Incurrence thereof, the Incurrence of such Indebtedness would result in the Consolidated Secured Debt Ratio
exceeding 3.75 to 1.0, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior thereto, then (y)&nbsp;the total amount of Indebtedness that may be
secured pursuant to this clause (7)&nbsp;shall not exceed the greater of (i)&nbsp;the maximum amount of Indebtedness that could be Incurred on such date without such ratio being so exceeded and (ii)&nbsp;an amount equal to the maximum amount of
Indebtedness that could then be incurred pursuant to Section&nbsp;6.03(b)(1), less the amount of Indebtedness secured by Liens Incurred pursuant to clause (18)&nbsp;below and outstanding on such date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;Liens existing on the Issue Date (other than Liens referred to in
the foregoing clause (7)); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;Liens on property or shares of Capital Stock of another Person at the time such
other Person becomes a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its Restricted Subsidiaries (other than assets and property affixed or appurtenant
thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&nbsp;&nbsp;&nbsp;&nbsp;Liens on property at the time such Person or any of its Subsidiaries acquires the property,
including any acquisition by means of a merger or consolidation with or into such Person or a Subsidiary of such Person; <U>provided</U>, <U>however</U>, that the Liens may not extend to any other property owned by such Person or any of its
Restricted Subsidiaries (other than assets and property affixed or appurtenant thereto); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&nbsp;&nbsp;&nbsp;&nbsp;Liens securing
Indebtedness or other obligations of a Subsidiary of such Person owing to such Person or a Wholly Owned Subsidiary of such Person; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&nbsp;&nbsp;&nbsp;&nbsp;Liens securing Hedging Obligations so long as such Hedging Obligations are permitted to be Incurred under this
Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&nbsp;&nbsp;&nbsp;&nbsp;any Lien on accounts receivable and related assets of the types specified in the definition of
&#147;<U>Qualified Receivables Transaction</U>&#148; incurred in connection with a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&nbsp;&nbsp;&nbsp;&nbsp;Liens in favor of the Company or the Subsidiary Guarantors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15)&nbsp;&nbsp;&nbsp;&nbsp;leases, subleases, licenses or sublicenses granted to third parties entered into in the ordinary course of
business which do not materially interfere with the conduct of the business of the Company and the Restricted Subsidiaries and which do not secure any Indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16)&nbsp;&nbsp;&nbsp;&nbsp;Liens securing judgments, decrees, orders or awards for the payment of money not constituting an Event of Default
in respect of which the Company shall in good faith be prosecuting an appeal or proceedings for review, which appeal or proceedings shall not have been finally terminated, or in respect of which the period within which such appeal or proceedings may
be initiated shall not have expired; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17)&nbsp;&nbsp;&nbsp;&nbsp;Liens to secure any Refinancing (or successive Refinancings) as a whole,
or in part, of any Indebtedness secured by any Lien referred to in the foregoing clause (6), (8), (9) or (10); <U>provided</U>, <U>however</U>, that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;such new Lien shall be limited to all or part of the same property and assets that secured or, under
the written agreements pursuant to which the original Lien arose, could secure the original Indebtedness (plus improvements and accessions to, such property or proceeds or distributions thereof); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the Indebtedness secured by such Lien at such time is not increased to any amount greater than the
sum of (i)&nbsp;the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clause (6), (8), (9) or (10)&nbsp;at the time the original Lien became a Permitted Lien and (ii)&nbsp;an amount necessary to pay
any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18)&nbsp;&nbsp;&nbsp;&nbsp;other Liens securing Indebtedness (other than Subordinated Obligations) to the extent the Incurrence of such
Indebtedness, when taken together with all other Indebtedness secured by Liens Incurred pursuant to this clause (18)&nbsp;and outstanding on the date such other Lien is Incurred, and after giving pro forma effect to the Incurrence of such
Indebtedness, would not result in the Consolidated Secured Debt Ratio exceeding 3.75 to 1.0, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45&nbsp;days prior
thereto; <U>provided</U><I>, </I><U>however</U>, notwithstanding whether this clause (18)&nbsp;would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
then be available to secure Indebtedness, any Lien securing Indebtedness originally secured pursuant to this clause (18)&nbsp;may secure Refinancing Indebtedness in respect of such Indebtedness,
as long as such Lien does not extend to any property other than all or part of the same property and assets that secured or, under the written agreements pursuant to which such original Lien arose, could have secured the original Indebtedness (plus
improvements and accessions to, such property or proceeds or distributions thereof), and such Refinancing Indebtedness shall be deemed to have been secured pursuant to this clause (18); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19)&nbsp;&nbsp;&nbsp;&nbsp;other Liens securing Indebtedness; provided that the aggregate principal amount of Indebtedness secured by such
Liens shall not exceed the greater of (A) $100,000,000 and (B) 3.0% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior
thereto (as of the date of granting such Liens and after giving pro forma effect to the Incurrence of such Indebtedness and the application of the net proceeds thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, &#147;Permitted Liens&#148; will not include any Lien described in clause (6), (9) or (10)&nbsp;above to the
extent such Lien applies to any Additional Assets acquired directly or indirectly from Net Available Cash pursuant to Section&nbsp;6.06. For purposes of this definition, the term &#147;Indebtedness&#148; shall be deemed to include interest on such
Indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, corporation, partnership, limited liability company, joint venture,
association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>principal</U>&#148; of a Security means the principal of the Security plus the premium, if any, payable on the Security which is due
or overdue or is to become due at the relevant time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Forma Cost Savings</U>&#148; means, with respect to any period, the
reduction in costs that were: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;directly attributable to an asset acquisition and calculated on a basis that is
consistent with Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act in effect and applied as of the Issue Date, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;implemented by the business that was the subject of any such asset acquisition within the six months prior to or
following the date of the asset acquisition and that are supportable and quantifiable by the underlying accounting records of such business, as if, in the case of each of clause (1)&nbsp;and (2), all such reductions in costs had been effected as of
the beginning of such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prospectus Supplement</U>&#148; means the Prospectus Supplement dated September&nbsp;30, 2020, and
used in connection with the offering of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Money Indebtedness</U>&#148; means Indebtedness
(1)&nbsp;consisting of the deferred purchase price of property, conditional sale obligations, obligations under any title retention agreement, other purchase money obligations and obligations in respect of industrial revenue bonds or similar
Indebtedness, in each case where the maturity of such Indebtedness does not exceed the anticipated useful life of the asset being financed, and (2)&nbsp;Incurred to finance the acquisition by the Company or a Restricted Subsidiary of such asset,
including additions and improvements, in the ordinary course of business, <U>provided</U>, <U>however</U>, that any Lien arising in connection with any such Indebtedness shall be limited to the specific asset being financed or, in the case of real
property or fixtures, including additions and improvements, the real property on which such asset is attached; <U>provided</U>, <U>further</U>, <U>however</U>, that such Indebtedness is Incurred within 180 days after such acquisition of such assets.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Qualified Receivables Transaction</U>&#148; means any transaction or series of transactions that may be entered into by the
Company or any of its Restricted Subsidiaries pursuant to which the Company or any of its Restricted Subsidiaries may sell, convey or otherwise transfer to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;a Receivables Entity (in the case of a transfer by the Company or any of its Restricted Subsidiaries) or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any other Person (in the case of a transfer by a Receivables
Entity), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or may grant a security interest in, any accounts receivable (whether now existing or arising in the future) of the Company or any of its
Restricted Subsidiaries, and any assets related thereto, including all collateral securing such accounts receivable, all contracts and all Guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts receivable
and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable; <U>provided</U>, <U>however</U>, that the
financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the chief financial officer of the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant of a security interest in any accounts receivable of the Company or any of its Restricted Subsidiaries to secure Indebtedness
permitted pursuant to Section&nbsp;6.03(b)(1) shall not be deemed a Qualified Receivables Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Quotation Agent</U>&#148;
means the Reference Treasury Dealer selected by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Receivables Entity</U>&#148; means (a)&nbsp;a Wholly Owned
Subsidiary of the Company that is designated by the Board of Directors (as provided below) as a Receivables Entity or (b)&nbsp;another Person engaging in a Qualified Receivables Transaction with the Company, which Person engages in the business of
the financing of accounts receivable, and in either of clause (a)&nbsp;or (b): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;no portion of the Indebtedness
or any other obligations (contingent or otherwise) of such entity </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;is Guaranteed by the Company
or any Subsidiary of the Company (excluding Guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization Undertakings), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;is recourse to or obligates the Company or any Subsidiary of the Company in any way (other than
pursuant to Standard Securitization Undertakings), or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;subjects any property or asset of the
Company or any Subsidiary of the Company, directly or indirectly, contingently or otherwise, to the satisfaction thereof (other than pursuant to Standard Securitization Undertakings); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the entity is not an Affiliate of the Company or is an entity with which neither the Company nor any Subsidiary of
the Company has any material contract, agreement, arrangement or understanding other than on terms that the Company reasonably believes to be no less favorable to the Company or such Subsidiary than those that might be obtained at the time from
Persons that are not Affiliates of the Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;is an entity to which neither the Company nor any
Subsidiary of the Company has any obligation to maintain or preserve such entity&#146;s financial condition or cause such entity to achieve certain levels of operating results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any such designation by the Board of Directors shall be evidenced to the Trustee by filing with the Trustee a certified copy of the resolution
of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such designation complied with the foregoing conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer</U>&#148; means Citigroup Global Markets Inc. and its successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reference Treasury Dealer Quotations</U>&#148; means, with respect to each Reference Treasury Dealer and any redemption date, the
average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue, expressed in each case as a percentage of its principal amount, quoted in writing to the Company by such Reference Treasury Dealer at 5:00 p.m.,
New York City time, on the third Business Day immediately preceding such redemption date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinance</U>&#148; means, in respect of any Indebtedness, to refinance, extend,
renew, refund, repay, prepay, purchase, redeem, defease or retire, or to issue other Indebtedness in exchange or replacement for, such Indebtedness. &#147;Refinanced&#148; and &#147;Refinancing&#148; shall have correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing Indebtedness</U>&#148; means Indebtedness that Refinances any Indebtedness of the Company or any Restricted Subsidiary
existing on the Issue Date or Incurred in compliance with this Indenture, including Indebtedness that Refinances Refinancing Indebtedness; <U>provided</U>, <U>however</U>, that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;such Refinancing Indebtedness has a Stated Maturity no earlier than the Stated Maturity of the Indebtedness being
Refinanced; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;such Refinancing Indebtedness has an Average Life at the time such Refinancing Indebtedness is
Incurred that is equal to or greater than the Average Life of the Indebtedness being Refinanced; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;such
Refinancing Indebtedness has an aggregate principal amount (or if Incurred with original issue discount, an aggregate issue price) that is equal to or less than the aggregate principal amount (or if Incurred with original issue discount, the
aggregate accreted value) then outstanding (plus fees and expenses, including any premium and defeasance costs) under the Indebtedness being Refinanced; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;if the Indebtedness being Refinanced is subordinated in right of payment to the Securities, such Refinancing
Indebtedness is subordinated in right of payment to the Securities at least to the same extent as the Indebtedness being Refinanced; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>,
<U>further</U>, <U>however</U>, that Refinancing Indebtedness shall not include (A)&nbsp;Indebtedness of a Subsidiary that is not a Subsidiary Guarantor that Refinances Indebtedness of the Company or a Subsidiary Guarantor or (B)&nbsp;Indebtedness
of the Company or a Restricted Subsidiary that Refinances Indebtedness of an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Refinancing
Transactions</U>&#148; means the initial offering of the Securities and the use of the proceeds thereof to redeem all of the Company&#146;s outstanding 5.75% Senior Notes due 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Business</U>&#148; means any business in which the Company or any of the Restricted Subsidiaries was engaged on the Issue
Date and any business related, ancillary or complementary to such business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Responsible Officer</U>&#148; means any officer
within the Corporate Trust Office of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers who at the time shall
have direct responsibility for the administration of the Indenture and also means, with respect to a particular corporate trust matter, any other officer to whom such matter is referred because of such person&#146;s knowledge of and familiarity with
the particular subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Cash and Cash Equivalents</U>&#148; means, as of any date, (a)&nbsp;the cash and cash
equivalents held by any Captive Insurance Subsidiary and committed to third-party administrators for payment of the Company&#146;s insurance claims, (b)&nbsp;the cash and cash equivalents held by Syndicated Persons to the extent that such cash and
cash equivalents are required by the owners of such Syndicated Persons to be held in separate accounts and not otherwise commingled with the assets of the Company, (c)&nbsp;the cash and cash equivalents held by any Restricted Subsidiary to the
extent that, and for so long as, such cash and cash equivalents may not be distributed to the owner or owners of the equity interests in such Restricted Subsidiary under the terms of such Restricted Subsidiary&#146;s charter or any agreement,
instrument, judgment, decree, order, statute, rule or governmental regulation applicable to such Restricted Subsidiary, and (d)&nbsp;the cash collateral deposited by the Company pursuant to Section&nbsp;2.05(c) or Section&nbsp;2.05(l) of the Credit
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Payment</U>&#148; with respect to any Person means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the declaration or payment of any dividends or any other distributions of any sort in respect of its Capital Stock
(including any payment in connection with any merger or consolidation involving such Person) or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
similar payment to the direct or indirect holders of its Capital Stock (other than (A)&nbsp;dividends or distributions payable solely in its Capital Stock (other than Disqualified Stock), (B)
dividends or distributions payable solely to the Company or a Restricted Subsidiary and (C)&nbsp;pro rata dividends or other distributions made by a Subsidiary that is not a Wholly Owned Subsidiary to minority stockholders (or owners of an
equivalent interest in the case of a Subsidiary that is an entity other than a corporation)); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the purchase,
repurchase, redemption, defeasance or other acquisition or retirement for value of any Capital Stock of the Company held by any Person (other than by a Restricted Subsidiary) or of any Capital Stock of a Restricted Subsidiary held by any Affiliate
of the Company (other than by a Restricted Subsidiary), including in connection with any merger or consolidation); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the purchase, repurchase, redemption, defeasance or other acquisition or retirement for value, prior to scheduled
maturity, scheduled repayment or scheduled sinking fund payment of any Subordinated Obligations of the Company or any Subsidiary Guarantor (other than (A)&nbsp;from the Company or a Restricted Subsidiary or (B)&nbsp;the purchase, repurchase,
redemption, defeasance or other acquisition or retirement of Subordinated Obligations purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of such
purchase, repurchase, redemption, defeasance or other acquisition or retirement); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the making of any
Investment (other than a Permitted Investment) in any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Subsidiary</U>&#148; means any Subsidiary of the
Company that is not an Unrestricted Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sale/Leaseback Transaction</U>&#148; means an arrangement relating to property
owned by the Company or a Restricted Subsidiary on the Issue Date or thereafter acquired by the Company or a Restricted Subsidiary whereby the Company or a Restricted Subsidiary transfers such property to a Person and the Company or a Restricted
Subsidiary leases it from such Person, other than leases between the Company and a Restricted Subsidiary or between Restricted Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Senior Indebtedness</U>&#148; means with respect to any Person: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness of such Person, whether outstanding on the Issue Date or thereafter Incurred; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;all other Obligations of such Person (including interest accruing on or after the filing of any petition in
bankruptcy or for reorganization relating to such Person whether or not post-filing interest is allowed in such proceeding) in respect of Indebtedness described in clause (1)&nbsp;above </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">unless, in the case of clauses (1)&nbsp;and (2), in the instrument creating or evidencing the same or pursuant to which the same is outstanding, it is
provided that such Indebtedness or other obligations are subordinate in right of payment to the Securities or the Subsidiary Guarantee of such Person, as the case may be; <U>provided</U>, <U>however</U>, that Senior Indebtedness shall not include:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;any obligation of such Person to the Company or any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;any liability for federal, state, local or other taxes owed or owing by such Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;any accounts payable or other liability to trade creditors arising in the ordinary course of
business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;any Indebtedness or other Obligation of such Person which is subordinate or junior in
any respect to any other Indebtedness or other Obligation of such Person; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;that portion of
any Indebtedness which at the time of Incurrence is Incurred in violation of this Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Shareholder Litigation</U>&#148; means the federal securities class actions and the
derivative actions brought against the Company and/or certain of its former directors and officers and certain other parties in the United States District Court for the Northern District of Alabama and the Circuit Court in Jefferson County, Alabama
relating to financial reporting and related activity that occurred at the Company during periods ended in March 2003. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Significant Subsidiary</U>&#148; means any Restricted Subsidiary that would be a &#147;Significant Subsidiary&#148; of the Company
within the meaning of Rule <FONT STYLE="white-space:nowrap">1-02</FONT> under Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated by the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard</U><U></U><U>&nbsp;&amp; Poor&#146;s</U>&#148; means Standard&nbsp;&amp; Poor&#146;s Ratings Services, a Standard&nbsp;&amp;
Poor&#146;s Financial Services LLC business, or any successor rating agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standard Securitization Undertakings</U>&#148;
means representations, warranties, covenants and indemnities entered into by the Company or any Subsidiary of the Company that, taken as a whole, are customary in an accounts receivable transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Stated Maturity</U>&#148; means, with respect to any security, the date specified in such security as the fixed date on which the
final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision providing for the repurchase of such security at the option of the holder thereof upon the
happening of any contingency unless such contingency has occurred). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subordinated Obligation</U>&#148; means, with respect to a
Person, any Indebtedness of such Person (whether outstanding on the Issue Date or thereafter Incurred) which is subordinate or junior in right of payment to the Securities or a Subsidiary Guarantee of such Person, as the case may be, pursuant to a
written agreement to that effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantee</U>&#148; means a Guarantee by a Subsidiary Guarantor of the
Company&#146;s obligations with respect to the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary Guarantor</U>&#148; means each Subsidiary of the Company
that executes this Indenture as a guarantor on the Issue Date and each other Subsidiary of the Company that thereafter guarantees the Securities pursuant to the terms of this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndicated Person</U>&#148; means a Person the equity interests of which constitute Syndicated Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Syndication</U>&#148; means the sale of partnership or other equity interests (&#147;<U>Syndicated Interests</U>&#148;) in
Subsidiaries of the Company or other Persons controlled by the Company that own or operate health care facilities to (i)&nbsp;participating physicians, radiologists and other specialists, (ii)&nbsp;professional corporations and other legal entities
owned or controlled by such participating physicians, radiologists and other specialists and (iii)&nbsp;participating hospitals and other health care providers. For purposes of this definition, &#147;controlled&#148; shall have the meaning set forth
in the definition of &#147;Affiliate.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Temporary Cash Investments</U>&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any investment in direct obligations of the United States of America or any agency thereof or obligations
guaranteed by the United States of America or any agency thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;investments in demand and time deposit
accounts, certificates of deposit and money market deposits maturing within 180 days of the date of acquisition thereof issued by a bank or trust company which is organized under the laws of the United States of America, any State thereof or any
foreign country recognized by the United States of America, and which bank or trust company has capital, surplus and undivided profits aggregating in excess of $250,000,000 (or the foreign currency equivalent thereof) or any money-market fund
sponsored by a registered broker dealer or mutual fund distributor; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;repurchase obligations with a term of not
more than 30 days for underlying securities of the types described in clause (1)&nbsp;above entered into with a bank meeting the qualifications described in clause (2)&nbsp;above; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;investments in commercial paper, maturing not more than 270 days
after the date of acquisition, issued by a corporation (other than an Affiliate of the Company) organized and in existence under the laws of the United States of America or any foreign country recognized by the United States of America with a rating
at the time as of which any investment therein is made of <FONT STYLE="white-space:nowrap">&#147;P-1&#148;</FONT> (or higher) according to Moody&#146;s or <FONT STYLE="white-space:nowrap">&#147;A-1&#148;</FONT> (or higher) according to Standard and
Poor&#146;s; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;investments in securities issued or fully guaranteed by any state, commonwealth or territory of
the United States of America, or by any political subdivision or taxing authority thereof, and rated at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s or &#147;A2&#148; by Moody&#146;s; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;eligible banker&#146;s acceptances, repurchase agreements and <FONT STYLE="white-space:nowrap">tax-exempt</FONT>
municipal bonds having a maturity of less than one year, in each case having a rating of, or evidencing the full recourse obligation of a person whose senior debt is rated, at least &#147;A&#148; by Standard&nbsp;&amp; Poor&#146;s and at least
&#147;A2&#148; by Moody&#146;s; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;investments in money market funds that invest substantially all their
assets in securities of the types described in clauses (1)&nbsp;through (6) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Uniform Commercial Code</U>&#148; means the
New York Uniform Commercial Code as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Unrestricted Subsidiary</U>&#148; means: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any Subsidiary of the Company that at the time of determination shall be designated an Unrestricted Subsidiary by
the Board of Directors in the manner provided below; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any Subsidiary of an Unrestricted Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Subsidiary of the Company (including any newly acquired or newly formed Subsidiary) to be an
Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Capital Stock or Indebtedness of, or holds any Lien on any property of, the Company or any other Subsidiary of the Company that is not a Subsidiary of the Subsidiary
to be so designated; <U>provided</U>, <U>however</U>, that either (A)&nbsp;the Subsidiary to be so designated has total assets of $1,000 or less or (B)&nbsp;if such Subsidiary has assets greater than $1,000, such designation would be permitted under
Section&nbsp;6.04. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; <U>provided</U>,
<U>however</U>, that immediately after giving effect to such designation (A)&nbsp;the Company could Incur $1.00 of additional Indebtedness under Section&nbsp;6.03(a) and (B)&nbsp;no Default shall have occurred and be continuing. Any such designation
by the Board of Directors shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the resolution of the Board of Directors giving effect to such designation and an Officers&#146; Certificate certifying that such designation
complied with the foregoing provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Stock</U>&#148; of a Person means all classes of Capital Stock of such Person
then outstanding and normally entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Wholly Owned Subsidiary</U>&#148; means a Restricted Subsidiary all the Capital Stock of which (other than directors&#146; qualifying
shares) is owned by the Company or one or more other Wholly Owned Subsidiaries. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
3.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Form</U>. Provisions relating to the Securities are set forth in Exhibit A hereto, which is hereby incorporated in and expressly made a part of this Supplemental Indenture. The Securities and the Trustee&#146;s
certificate of authentication thereto shall be substantially in the form of Exhibit A, which is hereby incorporated in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and expressly made a part of this Supplemental Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule, agreements to which the Company is
subject, if any, or usage (<U>provided</U> that any such notation, legend or endorsement is in a form acceptable to the Company). Each Security shall be dated the date of its authentication. The Securities shall be issuable only in registered form
without interest coupons and only in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The terms of the Securities set forth in Exhibit A are part of the terms of this Supplemental Indenture. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT
OF BASE INDENTURE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article I of Base Indenture</U>. Section&nbsp;1.01 of the Base
Indenture is hereby amended, but only with respect to the Securities, by the deletion of the definitions of the following terms: &#147;Affiliate,&#148; &#147;Business Day,&#148; &#147;Code,&#148; &#147;Corporate Trust Office,&#148;
&#147;Indebtedness,&#148; &#147;Interest Payment Date,&#148; &#147;Mandatory Sinking Fund Payment,&#148; &#147;Officer&#146;s Certificate,&#148; &#147;Opinion of Counsel,&#148; &#147;Optional Sinking Fund Payment,&#148; &#147;Person,&#148;
&#147;Responsible Officer,&#148; &#147;Senior Indebtedness&#148; and &#147;Stated Maturity&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article III of Base Indenture</U>. Article III of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Section&nbsp;3.14 at the end thereof:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 3.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuance of Additional Securities</U>. After the Issue Date, the Company shall be
entitled, subject to its compliance with Section&nbsp;6.03, to issue Additional Securities under this Indenture, which Securities shall have identical terms as the Securities issued on the Issue Date, other than with respect to the date of issuance
and issue price and first payment of interest. All the Securities issued under this Indenture shall be treated as a single class for all purposes of this Indenture, including waivers, amendments, redemptions and offers to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to any Additional Securities, the Company shall set forth in a resolution of the Board of Directors and an Officers&#146;
Certificate, a copy of each of which shall be delivered to the Trustee, the following information: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the aggregate principal amount of such Additional Securities to be authenticated and delivered
pursuant to this Indenture and the provision of Section&nbsp;6.03 that the Company is relying on to issue such Additional Securities; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the issue price, the issue date, the CUSIP number and the ISIN of such Additional Securities;
<U>provided</U>, <U>however</U>, that no Additional Securities may be issued at a price that would cause such Additional Securities to have &#147;original issue discount&#148; within the meaning of Section&nbsp;1273 of the Code.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article IV of Base Indenture</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Section 4.02(a) of the Base Indenture is hereby amended, but only with respect to the Securities, by
(i)&nbsp;deleting the words &#147;the Trustee shall select, by lot or in such other manner as the Trustee shall deem appropriate&#148;, and replacing such deleted words with &#147;if the Securities are Global Securities, the Securities to be
redeemed will be selected by the Depositary in accordance with applicable Depositary procedures, and if the Securities to be redeemed are not Global Securities, the Trustee shall select, on a <U>pro</U> <U>rata</U> basis to the extent
practicable&#148; and (ii)&nbsp;adding the following sentence at the end of Section&nbsp;4.02(a): &#147;Any redemption referenced in the notice to the Trustee may be cancelled by the Company at any time prior to the notice of redemption being sent
to any Holder and thereafter shall be null and void.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Section 4.03(a) of the Base Indenture is hereby
amended, but only with respect to the Securities, by deleting the words &#147;not less than 30&#148; and replacing such deleted words with &#147;not less than 10&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Section 4.03 of the Base Indenture is hereby amended, but only
with respect to the Securities, by adding a new clause (c)&nbsp;to the end of such section as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notice of any redemption of the Securities may, at the Company&#146;s discretion, be given prior to
the completion of a transaction (including an equity offering, incurrence of Indebtedness, refinancing, acquisition or other transaction) and any redemption may, at the Company&#146;s discretion, be subject to one or more conditions precedent,
including, but not limited to, completion of a related transaction. If such redemption is so subject to satisfaction of one or more conditions precedent, such notice shall describe each such condition, and if applicable, shall state that, in the
Company&#146;s discretion, the Redemption Date may be delayed until such time (including more than 60 calendar days after the date the notice of redemption was delivered to the Holders of Securities, including by electronic transmission) as any or
all such conditions shall be satisfied, or such redemption may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the Redemption Date, or by the Redemption Date as so delayed. In
addition, the Company may provide in such notice that payment of the Redemption Price and performance of the Company&#146;s obligations with respect to such redemption may be performed by another Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Section 4.05 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the
words &#147;have a Stated Maturity&#148; and replacing such deleted words with &#147;become due and payable&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article V of Base Indenture</U>. Article V of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE V </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SUCCESSOR
COMPANY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 5.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>When Company May Merge or Transfer Assets</U>. The Company shall not consolidate with or
merge with or into, or convey, transfer or lease, in one transaction or a series of transactions, directly or indirectly, all or substantially all its assets to, any Person, unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the resulting, surviving or transferee Person (the &#147;<U>Successor Company</U>&#148;) shall be a
Person organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and the Successor Company (if not the Company) shall expressly assume, by a supplemental indenture hereto, executed and
delivered to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Securities and this Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;immediately after giving pro forma effect to such transaction (and treating any Indebtedness which
becomes an obligation of the Successor Company or any Subsidiary thereof as a result of such transaction as having been Incurred by the Successor Company or such Subsidiary at the time of such transaction), no Default shall have occurred and be
continuing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;immediately after giving pro forma effect to such transaction, (A)&nbsp;the
Successor Company would be able to Incur an additional $1.00 of Indebtedness pursuant to Section&nbsp;6.03(a) or (B)&nbsp;the Consolidated Coverage Ratio for the Successor Company would be equal to or greater than such ratio for the Company and its
Restricted Subsidiaries immediately prior to such transaction; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall have
delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indenture (if any) comply with this Indenture, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that clause (3)&nbsp;shall not be applicable to (A)&nbsp;a Restricted Subsidiary consolidating with, merging
into or transferring all or part of its properties and assets to the Company (so long as no Capital Stock of the Company is distributed to any Person) or (B)&nbsp;the Company merging with an Affiliate of the Company solely for the purpose and with
the sole effect of reincorporating the Company in another jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;5.01, the sale, lease, conveyance, assignment, transfer
or other disposition of all or substantially all of the properties and assets of one or more Subsidiaries of the Company, which properties and assets, if held by the Company instead of such Subsidiaries, would constitute all or substantially all of
the properties and assets of the Company on a consolidated basis, shall be deemed to be the transfer of all or substantially all of the properties and assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Successor Company shall be the successor to the Company and shall succeed to, and be substituted for, and may exercise every right and
power of, the Company under this Indenture, and the predecessor Company, except in the case of a lease, shall be released from the obligation to pay the principal of and interest on the Securities.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article VI of Base Indenture</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Article VI of the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the
following new Sections 6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 6.02. <U>SEC Reports</U>. Whether or
not the Company is subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, the Company shall file with the SEC (subject to the next sentence), and provide the Trustee and Holders with, such annual and other reports as
are specified in Sections 13 and 15(d) of the Exchange Act and applicable to a U.S. corporation subject to such Sections, such reports to be so filed and provided at the times specified for the filings of such reports under such Sections and
containing all the information, audit reports and exhibits required for such reports. If, at any time, the Company is not subject to the periodic reporting requirements of the Exchange Act for any reason, the Company shall nevertheless continue
filing the reports specified in the preceding sentence with the SEC within the time periods required unless the SEC will not accept such a filing. Delivery of such reports, information and documents to the Trustee is for informational purposes only
and the Trustee&#146;s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company&#146;s compliance with any of its covenants hereunder (as
to which the Trustee is entitled to rely on Officer&#146;s Certificates). The Company agrees that it shall not take any action for the purpose of causing the SEC not to accept such filings. If, notwithstanding the foregoing, the SEC will not accept
such filings for any reason, the Company shall post the reports specified in the preceding sentence on its website within the time periods that would apply if the Company were required to file such reports with the SEC. At any time that any of the
Company&#146;s Subsidiaries are Unrestricted Subsidiaries, then the quarterly and annual financial information in the reports required by this paragraph shall include a reasonably detailed presentation, either on the face of the financial statements
or in the footnotes thereto, of the financial condition and results of operations of the Company and its Restricted Subsidiaries separate from the financial condition and results of operations of the Unrestricted Subsidiaries of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">The Company also shall comply with the other provisions of Section&nbsp;314(a) of the TIA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Indebtedness</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted
Subsidiary to, Incur, directly or indirectly, any Indebtedness; <U>provided</U>, <U>however</U>, that the Company and the Subsidiary Guarantors shall be entitled to Incur Indebtedness if, on the date of such Incurrence and after giving effect
thereto on a pro forma basis the Consolidated Coverage Ratio exceeds 2.0 to 1.0. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing
paragraph (a), the Company and the Restricted Subsidiaries shall be entitled to Incur any or all of the following Indebtedness: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness Incurred pursuant to the Credit Agreement; <U>provided</U>, <U>however</U>, that,
immediately after giving effect to any such Incurrence, the aggregate principal amount of all Indebtedness Incurred under this clause (1)&nbsp;and then outstanding does not exceed $1,551,000,000 less the sum of all principal payments with respect to
such Indebtedness made pursuant to Section&nbsp;6.06(a)(3)(A) and in satisfaction of Section&nbsp;6.06; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness owed to and held by the Company or a
Restricted Subsidiary; <U>provided</U>, <U>however</U>, that (A)&nbsp;any subsequent issuance or transfer of any Capital Stock that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any subsequent transfer of such
Indebtedness (other than to the Company or a Restricted Subsidiary) shall be deemed, in each case, to constitute the Incurrence of such Indebtedness by the obligor thereon, (B)&nbsp;if the Company is the obligor on such Indebtedness, such
Indebtedness is expressly subordinated to the prior payment in full in cash of all obligations with respect to the Securities, and (C)&nbsp;if a Subsidiary Guarantor is the obligor on such Indebtedness, such Indebtedness is expressly subordinated to
the prior payment in full in cash of all obligations of such Subsidiary Guarantor with respect to its Subsidiary Guarantee; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the Securities (excluding any Additional Securities); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness outstanding on the Issue Date (other than Indebtedness described in clause (1), (2) or
(3)&nbsp;of this Section&nbsp;6.03(b)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness of a Restricted Subsidiary Incurred and
outstanding on or prior to the date on which such Subsidiary was acquired by the Company (other than Indebtedness Incurred in connection with, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or
series of related transactions pursuant to which such Subsidiary became a Subsidiary or was acquired by the Company); <U>provided</U>, <U>however</U>, that on the date of such acquisition and after giving pro forma effect thereto, the Company would
have been entitled to Incur at least $1.00 of additional Indebtedness pursuant to Section&nbsp;6.03(a); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;Refinancing Indebtedness in respect of Indebtedness Incurred pursuant to Section&nbsp;6.03(a) or
pursuant to clause (3), (4) or (5)&nbsp;or this clause (6)&nbsp;of this Section&nbsp;6.03(b); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;Hedging Obligations directly related to Indebtedness permitted to be Incurred by the Company and its
Restricted Subsidiaries pursuant to this Indenture or entered into in the ordinary course of business and not for speculative purposes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;obligations in respect of performance, bid and surety bonds and completion guarantees provided by
the Company or any Restricted Subsidiary in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness
arising from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; <U>provided</U>, <U>however</U>, that such Indebtedness is extinguished
within three Business Days of its Incurrence; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness consisting of the Subsidiary
Guarantee of a Subsidiary Guarantor and any Guarantee by the Company or a Subsidiary Guarantor of Indebtedness or other obligations of the Company or any Restricted Subsidiary (other than Indebtedness Incurred pursuant to clause (5)&nbsp;of this
Section&nbsp;6.03(b)) so long as the Incurrence of such Indebtedness or other obligations by the Company or such Restricted Subsidiary is permitted under the terms of this Indenture; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&nbsp;&nbsp;&nbsp;&nbsp;(A) Purchase Money Indebtedness, (B)&nbsp;Finance Lease Obligations and (C)&nbsp;Attributable Debt,
and Refinancing Indebtedness in respect thereof, in an aggregate principal amount on the date of Incurrence that, when added to all other Indebtedness Incurred pursuant to this clause (11)&nbsp;and then outstanding, does not exceed 15% of
Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness Incurred by a Receivables Entity in a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&nbsp;&nbsp;&nbsp;&nbsp;Preferred Stock issued by any Restricted Subsidiary formed to operate a single health care
facility; <U>provided</U> that the amount of such Preferred Stock, when added to the aggregate amount of all other such Preferred Stock of Restricted Subsidiaries then outstanding, does not exceed 1% of Consolidated Tangible Assets, as determined
based on the consolidated balance sheet of the Company as of the end of the most recent fiscal quarter ending at least 45 days prior thereto; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness of the Company or of any of its
Restricted Subsidiaries in an aggregate principal amount that, when taken together with all other Indebtedness of the Company and its Restricted Subsidiaries outstanding on the date of such Incurrence (other than Indebtedness permitted by clauses
(1)&nbsp;through (13) of this Section&nbsp;6.03(b) or by Section&nbsp;6.03(a)) does not exceed the greater of (A) $300,000,000 and (B) 7.5% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of
the end of the most recent fiscal quarter ending at least 45 days prior thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the
foregoing, neither the Company nor any Subsidiary Guarantor shall incur any Indebtedness pursuant to Section&nbsp;6.03(b) if the proceeds thereof are used, directly or indirectly, to Refinance any Subordinated Obligations of the Company or any
Subsidiary Guarantor unless such Indebtedness shall be subordinated to the Securities or the applicable Subsidiary Guarantee to at least the same extent as such Subordinated Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of determining compliance with this Section&nbsp;6.03: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;all Indebtedness outstanding under the Credit Agreement on the Issue Date shall be treated as
Incurred under clause (b)(1) of this Section&nbsp;6.03; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;in the event that an item of
Indebtedness (or any portion thereof) meets the criteria of more than one of the types of Indebtedness described above, the Company, in its sole discretion, shall classify such item of Indebtedness (or any portion thereof) at the time of Incurrence
and shall only be required to include the amount and type of such Indebtedness in one of the above clauses (<U>provided</U> that any Indebtedness originally classified as Incurred pursuant to any of clauses (b)(2) through (b)(14) of this
Section&nbsp;6.03 may later be reclassified as having been Incurred pursuant to paragraph (a)&nbsp;or any other of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03 to the extent that such reclassified Indebtedness could be Incurred pursuant
to paragraph (a)&nbsp;or one of clauses (b)(2) through (b)(14) of this Section&nbsp;6.03, as the case may be, if it were Incurred at the time of such reclassification); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the Company shall be entitled to divide and classify an item of Indebtedness in more than one of the
types of Indebtedness described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Restricted Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary, directly or indirectly, to make a Restricted
Payment if at the time the Company or such Restricted Subsidiary makes such Restricted Payment: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;a Default shall have occurred and be continuing (or would result therefrom); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the Company is not entitled to Incur an additional $1.00 of Indebtedness pursuant to
Section&nbsp;6.03(a); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the aggregate amount of such Restricted Payment and all other
Restricted Payments since the Issue Date would exceed the sum of (without duplication): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;50% of
the Consolidated Net Income accrued during the period (treated as one accounting period) from and including July&nbsp;1, 2006 to the end of the most recent fiscal quarter ending at least 45 days prior to the date of such Restricted Payment (or, in
case such Consolidated Net Income shall be a deficit, minus 100% of such deficit); <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;100% of the aggregate Net Cash Proceeds received by the Company from the issuance or sale of its
Capital Stock (other than Disqualified Stock) subsequent to the Issue Date </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
(other than an issuance or sale to a Subsidiary of the Company and other than an issuance or sale to an employee stock ownership plan or to a trust established by the Company or any of its
Subsidiaries for the benefit of their employees) and 100% of any cash capital contribution received by the Company from its shareholders subsequent to the Issue Date; <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;the amount by which Indebtedness of the Company is reduced on the Company&#146;s balance sheet upon
the conversion or exchange subsequent to the Issue Date of any Indebtedness of the Company convertible or exchangeable for Capital Stock (other than Disqualified Stock) of the Company (less the amount of any cash, or the fair value of any other
property, distributed by the Company upon such conversion or exchange); <U>provided</U>, <U>however</U>, that the foregoing amount shall not exceed the Net Cash Proceeds received by the Company or any Restricted Subsidiary from the sale of such
Indebtedness (excluding Net Cash Proceeds from sales to a Subsidiary of the Company or to an employee stock ownership plan or to a trust established by the Company or any of its Subsidiaries for the benefit of their employees); <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to the net reduction in the Investments (other than Permitted Investments) made by
the Company or any Restricted Subsidiary in any Person resulting from repurchases, repayments or redemptions of such Investments by such Person, proceeds realized on the sale of such Investment and proceeds representing the return of capital
(excluding dividends and distributions), in each case received by the Company or any Restricted Subsidiary; <U>provided</U>, <U>however</U>, that the foregoing sum shall not exceed, in the case of any such Person, the amount of Investments
(excluding Permitted Investments) previously made (and treated as a Restricted Payment) by the Company or any Restricted Subsidiary in such Person; <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;in the case of the redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary, the
portion (proportionate to the Company&#146;s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Unrestricted Subsidiary at the time such Unrestricted Subsidiary is redesignated as a Restricted Subsidiary, except
to the extent that the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to Section&nbsp;6.04(b)(11) or to the extent that such Investment constituted a Permitted Investment; <U>plus</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F)&nbsp;&nbsp;&nbsp;&nbsp;$50,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The preceding provisions shall not prohibit: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any Restricted Payment made out of the Net Cash Proceeds of the substantially concurrent sale of, or
made by exchange for, Capital Stock of the Company (other than Disqualified Stock and other than Capital Stock issued or sold to a Subsidiary of the Company or an employee stock ownership plan or to a trust established by the Company or any of its
Subsidiaries for the benefit of their employees) or a substantially concurrent cash capital contribution received by the Company from its shareholders; <U>provided</U>, <U>however</U>, that (A)&nbsp;such Restricted Payment shall be excluded from the
calculation of the amount of Restricted Payments and (B)&nbsp;the Net Cash Proceeds from such sale or such cash capital contribution (to the extent so used for such Restricted Payment) shall be excluded from the calculation of amounts under
Section&nbsp;6.04(a)(3)(B); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any purchase, repurchase, redemption, defeasance or other
acquisition or retirement for value of Subordinated Obligations of the Company or a Subsidiary Guarantor made by exchange for, or out of the proceeds of the substantially concurrent Incurrence of, Indebtedness of such Person that is permitted to be
Incurred pursuant to Section&nbsp;6.03; <U>provided</U>, <U>however</U>, that such purchase, repurchase, redemption, defeasance or other acquisition or retirement for value shall be excluded from the calculation of the amount of Restricted Payments;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;dividends paid within 60 days after the date of declaration thereof if at such date of
declaration such dividend would have complied with this Section&nbsp;6.04; <U>provided</U>, <U>however</U>, that such dividend shall be included in the calculation of the amount of Restricted Payments; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;so long as no Default has occurred and is
continuing, the purchase, redemption or other acquisition of shares of Capital Stock of the Company or any of its Subsidiaries from employees, former employees, directors or former directors of the Company or any of its Subsidiaries (or permitted
transferees of such employees, former employees, directors or former directors), pursuant to the terms of the agreements (including employment agreements) or plans (or amendments thereto) approved or ratified by the Board of Directors under which
such individuals purchase or sell or are granted the option to purchase or sell, shares of such Capital Stock; <U>provided</U>, <U>however</U>, that the aggregate amount of such Restricted Payments (excluding amounts representing cancellation of
Indebtedness) shall not exceed $10,000,000 in any calendar year (<U>provided</U> that (A)&nbsp;if the Company and its Restricted Subsidiaries make less than $10,000,000 in the aggregate of such Restricted Payments in any calendar year, the unused
amount for such calendar year may be carried over to the next succeeding calendar year (but not any other calendar year thereafter) and (B)&nbsp;the amount payable in any calendar year may be increased by an amount up to the sum of (i)&nbsp;the
amount of cash proceeds from the sale of Capital Stock (other than Disqualified Stock) of the Company to employees, former employees, directors or former directors of the Company or any of its Subsidiaries, to the extent that the cash proceeds from
the sale of such Capital Stock have not otherwise been applied to the payment of Restricted Payments by virtue of Section&nbsp;6.04(a)(3)(B), plus (ii)&nbsp;the cash proceeds of key man life insurance policies received by the Company or its
Restricted Subsidiaries after the Issue Date, less (iii)&nbsp;the amount of repurchases and other acquisitions previously made with the cash proceeds described in clauses (i)&nbsp;and (ii) above); <U>provided</U> <U>further</U>, <U>however</U>, that
(x)&nbsp;such repurchases and other acquisitions shall be excluded from the calculation of the amount of Restricted Payments and (y)&nbsp;cash proceeds referred to in clause (B)(i) above used to make Restricted Payments under this
Section&nbsp;6.04(b)(4) shall be excluded from the calculation of amounts under Section&nbsp;6.04(a)(3)(B); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;the declaration and payments of dividends on Disqualified Stock issued pursuant to
Section&nbsp;6.03; <U>provided</U>, <U>however</U>, in each case, that at the time of payment of such dividend, no Default shall have occurred and be continuing (or result therefrom); <U>provided</U> <U>further</U>, <U>however</U>, that dividends
referred to in this clause (5)&nbsp;shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;repurchases of Capital Stock deemed to occur upon exercise of stock options if such Capital Stock
represents a portion of the exercise price of such options; <U>provided</U>, <U>however</U>, that such Restricted Payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;cash payments in lieu of the issuance of fractional shares in connection with the exercise of
warrants, options or other securities convertible into or exchangeable for Capital Stock of the Company; <U>provided</U>, <U>however</U>, that any such cash payment shall not be for the purpose of evading the limitation of this Section&nbsp;6.04;
<U>provided</U> <U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;in the event of a Change of Control, and if no Default shall have occurred and be continuing, the
payment, purchase, redemption, defeasance or other acquisition or retirement of Subordinated Obligations of the Company or any Subsidiary Guarantor, in each case, at a purchase price not greater than 101% of the principal amount of such Subordinated
Obligations, plus any accrued and unpaid interest thereon; <U>provided</U>, <U>however</U>, that prior to such payment, purchase, redemption, defeasance or other acquisition or retirement, the Company (or a third party to the extent permitted by
this Indenture) has made a Change of Control Offer with respect to the Securities as a result of such Change of Control and has repurchased all Securities validly tendered and not withdrawn in connection with such Change of Control Offer;
<U>provided</U> <U>further</U>, <U>however</U>, that such payments, purchases, redemptions, defeasances or other acquisitions or retirements shall be excluded from the calculation of the amount of Restricted Payments; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;payments of intercompany subordinated Indebtedness, the Incurrence of which was permitted under
Section&nbsp;6.03(b)(2); <U>provided</U>, <U>however</U>, that no Default has occurred and is continuing or would otherwise result therefrom; <U>provided</U> <U>further</U>, <U>however</U>, that such payments shall be excluded from the calculation
of the amount of Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&nbsp;&nbsp;&nbsp;&nbsp;any Restricted Payment, so long as the Leverage Ratio is
no more than 3.0 to 1.0, both as of the date thereof and on a pro forma basis after giving effect to such Restricted Payment; <U>provided</U>, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
however, that (A)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be continuing (or result therefrom) and (B)&nbsp;such payments shall be excluded from the
calculation of the amount of Restricted Payments; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&nbsp;&nbsp;&nbsp;&nbsp;Restricted Payments in an amount that, when
taken together with all Restricted Payments made pursuant to this clause (11), does not exceed the greater of (A) $200,000,000 and (B) 5.0% of Consolidated Tangible Assets, as determined based on the consolidated balance sheet of the Company as of
the end of the most recent fiscal quarter ending at least 45 days prior thereto; <U>provided</U>, <U>however</U>, that (I)&nbsp;at the time of each such Restricted Payment, no Default shall have occurred and be continuing (or result therefrom) and
(II)&nbsp;such payments shall be excluded from the calculation of the amount of Restricted Payments; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&nbsp;&nbsp;&nbsp;&nbsp;any purchase or other acquisition or retirement for value of shares of Capital Stock of Encompass
Health Home Health Holdings, Inc. (f/k/a HealthSouth Home Health Holdings, Inc.) held by any Person other than the Company or any of its Subsidiaries on the Issue Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount of any Restricted Payment that is not made in cash shall be determined in a manner consistent with the determination
of the amount of an Investment as set forth in the final sentence of the first paragraph of the definition of &#147;Investment&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Restrictions on Distributions from Restricted Subsidiaries</U>. The Company shall not,
and shall not permit any Restricted Subsidiary to, create or otherwise cause or permit to exist or become effective any consensual encumbrance or restriction on the ability of any Restricted Subsidiary to (a)&nbsp;pay dividends or make any other
distributions on its Capital Stock to the Company or a Restricted Subsidiary or pay any Indebtedness owed to the Company, (b)&nbsp;make any loans or advances to the Company or (c)&nbsp;transfer any of its property or assets to the Company, except:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;with respect to clauses (a), (b) and (c), </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction pursuant to applicable law, rule, regulation or order or an agreement
in effect at or entered into on the Issue Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction with respect to
a Restricted Subsidiary pursuant to an agreement relating to any Indebtedness Incurred by such Restricted Subsidiary on or prior to the date on which such Restricted Subsidiary was acquired by the Company (other than Indebtedness Incurred as
consideration in, or to provide all or any portion of the funds or credit support utilized to consummate, the transaction or series of related transactions pursuant to which such Restricted Subsidiary became a Restricted Subsidiary or was acquired
by the Company) and outstanding on such date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction pursuant to any
amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing of an agreement referred to in clause (A)&nbsp;or (B) above; <U>provided</U>, <U>however</U>, that such amendment, modification, restatement,
renewal, increase, supplement, refunding, replacement or refinancing is no more restrictive, as reasonably determined by the Company, with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment,
modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction with respect to a Restricted Subsidiary imposed pursuant to an
agreement entered into for the sale or disposition of all or substantially all the Capital Stock or assets of such Restricted Subsidiary pending the closing of such sale or disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;restrictions on cash or other deposits or net worth imposed by customers under contracts entered
into in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F)&nbsp;&nbsp;&nbsp;&nbsp;any limitation or prohibition on the disposition
or distribution of assets or property in joint venture agreements, asset sale agreements, stock sale agreements and other similar agreements, which limitation or prohibition is applicable only to the assets that are the subject of such agreements;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction existing under or by reason of contractual requirements of a
Receivables Entity in connection with a Qualified Receivables Transaction provided that such restrictions apply only to such Receivables Entity; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(H)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction arising in the ordinary course of business, not relating to any
Indebtedness, that does not, individually or in the aggregate, materially detract from the value of the property or assets of the Company and its Restricted Subsidiaries, taken as whole, or adversely affect the Company&#146;s ability to make
principal and interest payments on the Securities, in each case, as determined in good faith by the Company; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;with respect to clause (c)&nbsp;only, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction consisting of customary nonassignment provisions in leases governing
leasehold interests to the extent such provisions restrict the transfer of the lease or the property leased thereunder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;any encumbrance or restriction contained in Finance Lease Obligations, any agreement governing
Purchase Money Indebtedness, security agreements or mortgages securing Indebtedness of a Restricted Subsidiary to the extent such encumbrance or restriction restricts the transfer of the property subject to such Finance Lease Obligations, Purchase
Money Indebtedness, security agreements or mortgages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Sales of Assets and
Subsidiary Stock</U>. (a)&nbsp;The Company shall not, and shall not permit any Restricted Subsidiary to, directly or indirectly, consummate any Asset Disposition unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the Company or such Restricted Subsidiary receives consideration at the time of such Asset
Disposition at least equal to the Fair Market Value (including as to the value of all <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration) of the shares and assets subject to such Asset Disposition; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;at least 75% of the consideration thereof received by the Company or such Restricted Subsidiary is
in the form of cash or cash equivalents; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;an amount equal to 100% of the Net Available Cash
from such Asset Disposition, other than any Asset Disposition that constitutes a Syndication or a resyndication transaction in the ordinary course of business, is applied by the Company or such Restricted Subsidiary, as the case may be: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;to the extent the Company elects (or is required by the terms of any Indebtedness), to prepay,
repay, redeem or purchase Senior Indebtedness of the Company or a Subsidiary Guarantor or Indebtedness (other than any Disqualified Stock) of a Restricted Subsidiary that is not a Subsidiary Guarantor (in each case other than Indebtedness owed to
the Company or an Affiliate of the Company) within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;to the extent the Company elects (including with respect to the balance of such Net Available Cash
after application (if any) in accordance with clause (A)), to acquire Additional Assets within one year from the later of the date of such Asset Disposition or the receipt of such Net Available Cash; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;to the extent of the balance of such Net
Available Cash after application (if any) in accordance with clauses (A)&nbsp;and (B), to make an offer to the Holders (and to holders of other Senior Indebtedness of the Company designated by the Company) to purchase Securities (and such other
Senior Indebtedness of the Company) pursuant to and subject to the conditions contained in this Indenture; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that in
connection with any prepayment, repayment or purchase of Indebtedness made to satisfy clause (A)&nbsp;or (C) above, the Company or such Restricted Subsidiary shall permanently retire such Indebtedness and shall cause the related loan commitment (if
any) to be permanently reduced in an amount equal to the principal amount so prepaid, repaid or purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing
provisions of this Section&nbsp;6.06, the Company and the Restricted Subsidiaries shall not be required to apply any Net Available Cash in accordance with this Section&nbsp;6.06 except to the extent that the aggregate Net Available Cash from all
Asset Dispositions which is not applied in accordance with this Section&nbsp;6.06 exceeds $50,000,000. Pending application of Net Available Cash pursuant to this Section&nbsp;6.06, such Net Available Cash shall be invested in Temporary Cash
Investments or applied to temporarily reduce revolving credit indebtedness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the purposes of this Section&nbsp;6.06, the following are
deemed to be cash or cash equivalents: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the assumption or discharge of any liabilities (as shown
on the Company&#146;s or such Restricted Subsidiary&#146;s most recent balance sheet or in the footnotes thereto) of the Company or such Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Securities) that are
assumed by the transferee of such assets and for which the Company and all of the Restricted Subsidiaries have been released by all creditors in writing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;securities received by the Company or any Restricted Subsidiary from the transferee that are
converted by the Company or such Restricted Subsidiary within 180 days into cash, to the extent of cash received in that conversion; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;all Temporary Cash Investments; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;any Designated Noncash Consideration having an aggregate Fair Market Value that, when taken together
with all other Designated Noncash Consideration previously received and then outstanding, does not exceed at the time of the receipt of such Designated Noncash Consideration (with the Fair Market Value of each item of Designated Noncash
Consideration being measured at the time received and without giving effect to subsequent changes in value) $30,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event of an Asset Disposition that requires the purchase of Securities (and other Senior Indebtedness of the
Company) pursuant to Section&nbsp;6.06(a)(3)(C), the Company shall purchase Securities tendered pursuant to an offer by the Company for the Securities (and such other Senior Indebtedness) (the &#147;<U>Offer</U>&#148;) at a purchase price of 100% of
their principal amount (or, in the event such other Senior Indebtedness of the Company was issued with significant original issue discount, 100% of the accreted value thereof) without premium, plus accrued but unpaid interest (or, in respect of such
other Senior Indebtedness of the Company, such lesser price, if any, as may be provided for by the terms of such Senior Indebtedness) in accordance with the procedures (including prorating in the event of oversubscription) set forth in this
Indenture. If the aggregate purchase price of the securities tendered pursuant to the Offer exceeds the Net Available Cash allotted to their purchase, the Company shall select the securities to be purchased on a <U>pro</U> <U>rata</U> basis but in
round denominations, which in the case of the Securities will be denominations of $2,000 principal amount or any greater integral multiple of $1,000, subject to applicable DTC procedures. The Company shall not be required to make such an Offer to
purchase Securities (and other Senior Indebtedness of the Company) pursuant to this Section&nbsp;6.06 if the Net Available Cash available therefor is less than $20,000,000 (which lesser amount shall be carried forward for purposes of determining
whether such an offer is required with respect to the Net Available Cash from any subsequent Asset Disposition). Upon completion of such an Offer, Net Available Cash shall be deemed to be reduced by the aggregate amount of such Offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;(i) Promptly, and in any event within 10 days after the Company
becomes obligated to make an Offer, the Company shall deliver to the Trustee and send, by first-class mail (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send
electronically) to each Holder, a written notice stating that the Holder may elect to have his Securities purchased by the Company either in whole or in part (subject to prorating as described in Section&nbsp;6.06(b) in the event the Offer is
oversubscribed) in amounts of $2,000 and any greater integral multiple of $1,000 of principal amount at the applicable purchase price. The notice shall specify a purchase date not less than 30 days nor more than 60 days after the date of such notice
(the &#147;<U>Purchase Date</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Not later than the date upon which written notice of
an Offer is delivered to the Trustee as provided below, the Company shall deliver to the Trustee an Officers&#146; Certificate as to (A)&nbsp;the amount of the Offer (the &#147;<U>Offer Amount</U>&#148;), including information as to any other Senior
Indebtedness included in the Offer for repurchase, (B)&nbsp;the allocation of the Net Available Cash from the Asset Dispositions pursuant to which such Offer is being made and (C)&nbsp;the compliance of such allocation with the provisions of
Section&nbsp;6.06(a). By 11:00 a.m. New York City time on the Purchase Date, the Company shall irrevocably deposit with the Trustee or with a Paying Agent (or, if the Company or a Wholly Owned Subsidiary is acting as Paying Agent, segregate and hold
in trust) an amount equal to the Offer Amount to be held for payment in accordance with the provisions of this Section&nbsp;6.06. Upon the expiration of the period for which the Offer remains open (the &#147;<U>Offer Period</U>&#148;), the Company
shall deliver to the Trustee for cancellation the Securities or portions thereof which have been properly tendered to and are to be accepted by the Company. The Trustee (or the Paying Agent, if not the Trustee) shall, on the Purchase Date, mail or
deliver payment (or cause the delivery of payment) to each tendering Holder in the amount of the purchase price. In the event that the aggregate purchase price of the Securities delivered by the Company to the Trustee is less than the Offer Amount
applicable to the Securities, the Trustee shall deliver the excess to the Company immediately after the expiration of the Offer Period for application in accordance with this Section&nbsp;6.06. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Holders electing to have a Security purchased shall be required to surrender the Security, with an
appropriate form duly completed, to the Company at the address specified in the notice at least three Business Days prior to the Purchase Date. A Holder shall be entitled to withdraw its election if the Trustee or the Company receives, not later
than one Business Day prior to the Purchase Date, a telex, facsimile transmission or letter setting forth the name of such Holder, the principal amount of the Security that was delivered for purchase by such Holder and a statement that such Holder
is withdrawing its election to have such Security purchased. Holders whose Securities are purchased only in part shall be issued new Securities equal in principal amount to the unpurchased portion of the Securities surrendered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;At the time the Company delivers Securities to the Trustee which are to be accepted for purchase,
the Company shall also deliver an Officers&#146; Certificate stating that such Securities are to be accepted by the Company pursuant to and in accordance with the terms of this Section&nbsp;6.06. A Security shall be deemed to have been accepted for
purchase at the time the Trustee, directly or through an agent, mails or delivers payment therefor to the surrendering Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall comply, to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act
and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.06. To the extent that the provisions of any securities laws or regulations conflict with provisions of this
Section&nbsp;6.06, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Section&nbsp;6.06 by virtue of its compliance with such securities laws or
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Transactions with Affiliates</U>. (a)&nbsp;The Company shall not, and
shall not permit any Restricted Subsidiary to, enter into or permit to exist any transaction (including the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase, sale, lease or exchange of any property, employee compensation arrangements or the rendering of any service) with, or for the benefit of, any Affiliate of the Company (an
&#147;<U>Affiliate Transaction</U>&#148;) unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the terms of the Affiliate Transaction are no
less favorable to the Company or such Restricted Subsidiary than those that could be obtained at the time of the Affiliate Transaction in <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> dealings with a Person who is not an Affiliate; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;if such Affiliate Transaction involves an amount in excess of $50,000,000, the terms of the
Affiliate Transaction are set forth in writing and a majority of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the Company disinterested with respect to such Affiliate Transaction have determined in good faith that the
criteria set forth in clause (1)&nbsp;are satisfied and have approved the relevant Affiliate Transaction as evidenced by a resolution of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The provisions of Section&nbsp;6.07(a) shall not prohibit: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;any Investment (other than a Permitted Investment) or other Restricted Payment, in each case
permitted to be made pursuant to Section&nbsp;6.04; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;any employment or consulting agreement,
employee benefit plan, officer or director indemnification agreement or any similar arrangement entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business or approved by the Board of Directors, and payments
pursuant thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;loans or advances to employees in the ordinary course of business of the
Company or its Restricted Subsidiaries, but in any event not to exceed $10,000,000 in the aggregate outstanding at any one time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the payment of reasonable fees or other reasonable compensation to, or the provision of customary
benefits or indemnification arrangements to, directors of the Company and its Restricted Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;any transaction with the Company, a Restricted Subsidiary or any Person that would constitute an
Affiliate Transaction solely because the Company or a Restricted Subsidiary owns an equity interest in or otherwise controls such Restricted Subsidiary or Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;the issuance or sale of any Capital Stock (other than Disqualified Stock) of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;any agreement as in effect on the Issue Date or any renewals or extensions of any such agreement (so
long as such renewals or extensions are not less favorable in any material respect to the Company or the Restricted Subsidiaries) and the transactions evidenced thereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;the provision of services to directors or officers of the Company or any of its Restricted
Subsidiaries of the nature provided by the Company or any of its Restricted Subsidiaries to customers in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&nbsp;&nbsp;&nbsp;&nbsp;transactions effected as a part of a Qualified Receivables Transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&nbsp;&nbsp;&nbsp;&nbsp;any transaction entered into by a Person prior to the time such Person becomes a Restricted
Subsidiary or is merged or consolidated into the Company or a Restricted Subsidiary (provided such transaction is not entered into in contemplation of such event); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&nbsp;&nbsp;&nbsp;&nbsp;any transaction with the Company&#146;s or any Restricted Subsidiary&#146;s customers, clients,
suppliers, landlords, lessors, or purchasers or sellers of goods or services, in each case, in the ordinary course of business and otherwise in compliance with the terms of the Indenture that are fair to the Company, or are on terms at least as
favorable as would reasonably have been entered into at such time with a Person who is not an Affiliate of the Company (as determined in good faith by the Board of Directors or senior management of the Company). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Change of Control</U>. (a)&nbsp;Upon the occurrence
of a Change of Control, each Holder shall have the right to require that the Company purchase all or any part of such Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase plus
accrued and unpaid interest, if any, to the date of purchase (subject to the right of Holders of record on the relevant Record Date to receive interest due on the relevant Interest Payment Date), in accordance with Section&nbsp;6.08(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Within 30 days following any Change of Control, the Company shall mail (or with respect to Global Securities, to
the extent permitted or required by applicable Depositary procedures or regulations, send electronically) a notice to each Holder with a copy to the Trustee (the &#147;<U>Change of Control Offer</U>&#148;) stating: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;that a Change of Control has occurred and that such Holder has the right to require the Company to
purchase such Holder&#146;s Securities at a purchase price in cash equal to 101% of the principal amount thereof on the date of purchase, plus accrued and unpaid interest, if any, to the date of purchase (subject to the right of Holders of record on
the relevant Record Date to receive interest on the relevant Interest Payment Date); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the
circumstances and relevant facts and financial information regarding such Change of Control; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the purchase date (which shall be no earlier than 30 days nor later than 60 days from the date
such notice is sent); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the instructions, as determined by the Company, consistent with this
Section&nbsp;6.08, that a Holder must follow in order to have its Securities purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall not
be required to make a Change of Control Offer following a Change of Control if a third party makes the Change of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Indenture applicable to a
Change of Control Offer made by the Company and purchases all Securities validly tendered and not withdrawn under such Change of Control Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall comply, to the extent applicable, with the requirements of Section&nbsp;14(e) of the Exchange Act
and any other securities laws or regulations in connection with the repurchase of Securities pursuant to this Section&nbsp;6.08. To the extent that the provisions of any securities laws or regulations conflict with the provisions of this
Section&nbsp;6.08, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Section&nbsp;6.08 by virtue thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Holders electing to have a Security purchased will be required to surrender the Security, with an appropriate form
duly completed, to the Company at the address specified in the notice at least three Business Days prior to the purchase date. Holders will be entitled to withdraw their election if the Trustee or the Company receives not later than one Business Day
prior to the purchase date, a telegram, telex, facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security which was delivered for purchase by the Holder and a statement that such Holder is withdrawing
his election to have such Security purchased. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;On the purchase date, all Securities purchased by the Company
under this Section&nbsp;6.08 shall be delivered by the Company to the Trustee for cancellation, and the Company shall pay the purchase price plus accrued and unpaid interest, if any, to the Holders entitled thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Liens</U>. The Company shall not, and shall not permit any Restricted Subsidiary to,
directly or indirectly, Incur or permit to exist any Lien (the &#147;<U>Initial Lien</U>&#148;) of any nature whatsoever on any of its properties (including Capital Stock of a Restricted Subsidiary), whether owned at the Issue Date or thereafter
acquired, securing any Indebtedness, other than Permitted Liens, without effectively providing that the Securities shall be secured equally and ratably with (or prior to) the obligations so secured for so long as such obligations are so secured.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any Lien created for the benefit of the Holders pursuant to the preceding sentence shall
provide by its terms that such Lien shall be automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Sale/Leaseback Transactions</U>. The Company shall not, and shall not permit any
Restricted Subsidiary to, enter into any Sale/Leaseback Transaction with respect to any property unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the Company or such Restricted Subsidiary would be entitled to (A)&nbsp;Incur Indebtedness in an
amount equal to the Attributable Debt with respect to such Sale/Leaseback Transaction pursuant to Section&nbsp;6.03 and (B)&nbsp;create a Lien on such property securing such Attributable Debt without equally and ratably securing the Securities
pursuant to Section&nbsp;6.09; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the gross proceeds received by the Company or any Restricted
Subsidiary in connection with such Sale/Leaseback Transaction are at least equal to the Fair Market Value of such property; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;the Company applies the proceeds of such transaction in compliance with Section&nbsp;6.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 6.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Future Guarantors</U>. (a)&nbsp;The Company shall cause each Restricted Subsidiary that Guarantees
any Indebtedness of the Company or any Subsidiary Guarantor in respect of the Credit Agreement or Capital Markets Indebtedness (or Incurs any such Indebtedness) to, at the same time, execute and deliver to the Trustee a Guaranty Agreement pursuant
to which such Restricted Subsidiary will Guarantee payment of the Securities on the same terms and conditions as those set forth in Article V of the Supplemental Indenture.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Sections 6.04 and 6.06 of the Base Indenture are hereby deleted in their entirety, but only with respect to the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Sections 6.02, 6.03, 6.05 and 6.07 of the Base Indenture are hereby amended, but only with respect
to the Securities, by renumbering such Sections 6.12, 6.13, 6.14, and 6.15, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments of Article VII of Base Indenture</U>. (a) Section 7.01(b) of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(b)&nbsp;&nbsp;&nbsp;&nbsp;the Company (A)&nbsp;defaults in the payment of principal of any Security when the same becomes due and
payable at its Stated Maturity, upon optional redemption, upon declaration of acceleration or otherwise or (B)&nbsp;fails to purchase Securities when required pursuant to this Indenture or the Securities;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Section 7.01(c) the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read
in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(c)&nbsp;&nbsp;&nbsp;&nbsp;the Company fails to comply with Section&nbsp;5.01;&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Sections 7.01(d), (e) and (f)&nbsp;of the Base Indenture are hereby amended and restated, but only with respect to
the Securities, to read in their entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(d)&nbsp;&nbsp;&nbsp;&nbsp;the Company or any Subsidiary Guarantor fails to
comply with any of its agreements contained in the Securities or this Indenture (other than those referred to in (a), (b) or (c)&nbsp;above) and such failure continues for 60 days after the notice from the Trustee or the Holders specified below;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the Company, any Subsidiary Guarantor or any Significant Subsidiary pursuant to or within the meaning of any
Bankruptcy Law: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;commences a voluntary case; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;consents to the entry of an order for relief against it in an involuntary case; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;consents to the appointment of a Custodian of it
or for any substantial part of its property; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;makes a general assignment for the benefit of
its creditors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or takes any comparable action under any foreign laws relating to insolvency; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;is for relief against the Company, any Subsidiary Guarantor or any Significant Subsidiary in an
involuntary case; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;appoints a Custodian of the Company, any Subsidiary Guarantor or any
Significant Subsidiary or for any substantial part of its property; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;orders the winding up or
liquidation of the Company, any Subsidiary Guarantor or any Significant Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or any similar relief is granted under any foreign
laws and the order or decree remains unstayed and in effect for 60 days;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 of the Base Indenture is hereby amended,
but only with respect to the Securities, by the addition of the following new Sections 7.01(g), (h) and (i)&nbsp;as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;(g)&nbsp;&nbsp;&nbsp;&nbsp;Indebtedness of the Company, any Subsidiary Guarantor or any Significant Subsidiary is not paid within any
applicable grace period after final maturity or is accelerated by the holders thereof because of a default and the total amount of such Indebtedness unpaid or accelerated exceeds $50,000,000 or its foreign currency equivalent at the time; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;any judgment or decree for the payment of money in excess of $50,000,000 (or its foreign currency equivalent at the
time) is entered against the Company, any Subsidiary Guarantor or any Significant Subsidiary, remains outstanding for a period of 60 consecutive days following the entry of such judgment or decree and is not discharged, waived or effectively stayed;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;any Subsidiary Guarantee ceases to be in full force and effect (other than in accordance with the terms of
such Subsidiary Guarantee) or any Subsidiary Guarantor denies or disaffirms its obligations under its Subsidiary Guarantee; or&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Section 7.01(g) of the Base Indenture is hereby amended, but only with respect to the Securities, by renumbering
such section 7.01(j) and by replacing the semi-colon at the end of such section with a period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The paragraph
immediately following Section&nbsp;7.01(g) of the Base Indenture and the last paragraph of Section&nbsp;7.01 of the Base Indenture are hereby deleted, but only with respect to the Securities, and replaced with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The foregoing shall constitute Events of Default whatever the reason for any such Event of Default and whether such Event of Default is
voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">However, a default under Section (d)&nbsp;of this Section&nbsp;7.01 will not constitute an Event of Default until the Trustee or the holders of
at least 25% in principal amount of the outstanding Securities notify the Company of the default and the Company does not cure such default within the time specified after receipt of such notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The term &#147;<U>Bankruptcy Law</U>&#148; means Title 11, United States Code, or any
similar federal or state law for the relief of debtors. The term &#147;<U>Custodian</U>&#148; means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice in the form of an Officers&#146;
Certificate of any Event of Default under clause (g)&nbsp;or (i) and any event which with the giving of notice or the lapse of time or both would become an Event of Default under clause (d)&nbsp;or (h), its status and what action the Company is
taking or proposes to take with respect thereto.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Section 7.02 of the Base Indenture is hereby amended,
but only with respect to the Securities, by adding the following sentences to end of the Section: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;The holders of a majority in
principal amount of the Securities by notice to the Trustee may rescind an acceleration and its consequences if the rescission would not conflict with any judgment or decree and if all existing Events of Default have been cured or waived except
nonpayment of principal or interest that has become due solely because of acceleration. No such rescission shall affect any subsequent Default or impair any right consequent thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In the case of any Event of Default occurring by reason of any willful action (or inaction) taken (or not taken) by or on behalf of the Company
with the intention of avoiding payment of the premium that the Company would have had to pay if the Company then had elected to redeem the Securities pursuant to the optional redemption provisions hereof, an equivalent premium shall also become and
be immediately due and payable to the extent permitted by law upon the acceleration of the Securities.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Section 7.07 the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in
its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 7.07. <U>Limitation on Suits</U>. Except to enforce the right to receive payment of principal or
interest when due, no Holder may pursue any remedy with respect to this Indenture or the Securities unless: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the Holder gives to the Trustee written notice stating that an Event of Default is continuing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the holders of at least 25% in principal amount of the outstanding Securities make a written request to the Trustee
to pursue the remedy; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;such Holder or Holders offer to the Trustee satisfactory security or indemnity against
any loss, liability or expense; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;the Trustee does not comply with the request within 60 days after receipt of
the request and the offer of security or indemnity; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the holders of a majority in principal amount of the
outstanding Securities do not give the Trustee a direction inconsistent with the request during such <FONT STYLE="white-space:nowrap">60-day</FONT> period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A Holder may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder. In the
event that the definitive Securities are not issued to any beneficial owner promptly after the Registrar has received a request from the Holder of a Global Security to issue such definitive Securities to such beneficial owner or its nominee, the
Company expressly agrees and acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to this Indenture, the right of such beneficial holder of Securities to pursue such remedy with respect to the portion of the Global
Security that represents such beneficial holder&#146;s Securities as if such definitive Securities had been issued. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article XI of Base Indenture</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.03 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Within 90 days after the occurrence thereof, and if known to the Trustee, the Trustee shall give to the Holders of the
Securities of a series notice of each Default or Event of Default with respect to the Securities of such series known to the Trustee, by transmitting such notice to Holders at their mailing addresses as the same shall then appear on the Register of
the Company (or with respect to Global Securities, to the extent permitted or required by applicable Depositary procedures or regulations, electronically), unless such Default shall have been cured or waived before the giving of such notice (the
term &#147;Default&#148; being hereby defined to be the events specified in Section&nbsp;7.01, which are, or after notice or lapse of time or both would become, Events of Default as defined in said Section). Except in the case of a Default or Event
of Default in payment of the principal of or interest on any of the Securities of such series when and as the same shall become payable, or to make any sinking fund payment as to Securities of the same series, the Trustee shall be protected in
withholding such notice, if and so long as a committee of Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Holders of the Securities of such series.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article XII of Base Indenture</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Article XII of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as follows:
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#147;ARTICLE XII </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Discharge
of Indenture; Defeasance </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.01. <U>Discharge of Liability on Securities; Defeasance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;When (1)&nbsp;the Company delivers to the Trustee all outstanding Securities (other than Securities replaced
pursuant to Section&nbsp;3.07) for cancellation or (2)&nbsp;all outstanding Securities have become due and payable, whether at maturity or on a redemption date as a result of the sending of a notice of redemption pursuant to Article IV hereof and
the Company irrevocably deposits with the Trustee funds in an amount sufficient, or U.S. Government Obligations the principal of and interest on which will be sufficient, or a combination thereof sufficient, to pay at maturity or upon redemption all
outstanding Securities, including interest thereon to maturity or such redemption date (other than Securities replaced pursuant to Section&nbsp;3.07), and if in either case the Company pays all other sums payable hereunder by the Company, then this
Indenture shall, subject to Section&nbsp;12.01(c), cease to be of further effect. The Trustee shall acknowledge satisfaction and discharge of this Indenture on demand of the Company accompanied by an Officers&#146; Certificate and an Opinion of
Counsel, each stating that all conditions precedent set forth herein relating to the satisfaction and discharge of this Indenture have been satisfied, and at the cost and expense of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to Sections 12.01(c) and 12.02, the Company at any time may terminate (1)&nbsp;all its obligations under
the Securities and this Indenture (&#147;legal defeasance option&#148;) or (2)&nbsp;its obligations under Sections 6.02, 6.03, 6.04, 6.05, 6.06, 6.07, 6.08, 6.09, 6.10 and 6.11 and the operation of Sections 7.01(e), 7.01(f), 7.01(g) and 7.01(h)
(but, in the case of Sections 7.01(e) and (f), with respect to Subsidiary Guarantors and Significant Subsidiaries only) and the limitations contained in Section&nbsp;5.01(a)(3) (&#147;covenant defeasance option&#148;). The Company may exercise its
legal defeasance option notwithstanding its prior exercise of its covenant defeasance option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company exercises its legal
defeasance option, payment of the Securities may not be accelerated because of an Event of Default with respect thereto. If the Company exercises its covenant defeasance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
option, payment of the Securities may not be accelerated because of an Event of Default specified in Sections 7.01(e), 7.01(f), 7.01(g) or 7.01(h) (but, in the case of Sections 7.01(e) and (f),
with respect to Subsidiary Guarantors and Significant Subsidiaries only) or because of the failure of the Company to comply with Section&nbsp;5.01(a)(3). If the Company exercises its legal defeasance option or its covenant defeasance option, each
Subsidiary Guarantor, if any, shall be released from all of its obligations with respect to its Subsidiary Guarantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon satisfaction
of the conditions set forth herein and upon request of the Company, the Trustee shall acknowledge in writing the discharge of those obligations that the Company terminates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding clauses (a)&nbsp;and (b) above, the Company&#146;s obligations in Sections 3.04, 3.06, 3.07 and
6.12 and in this Article XII shall survive until the Securities have been paid in full. Thereafter, the Company&#146;s obligations in Sections 11.01, 12.04 and 12.05 shall survive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to Defeasance</U>. The Company may exercise its legal defeasance option or its covenant
defeasance option only if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;the Company irrevocably deposits in trust with the Trustee money or
U.S. Government Obligations, or a combination thereof, for the payment of the principal of and interest on the Securities to redemption or maturity, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;the Company delivers to the Trustee a certificate from a nationally recognized firm of independent
accountants expressing their opinion that the payments of principal and interest when due and without reinvestment on the deposited U.S. Government Obligations plus any deposited money without investment will provide cash at such times and in such
amounts as will be sufficient to pay principal of and interest when due on all the Securities to maturity or redemption, as the case may be; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;123 days pass after the deposit is made and during the 123 day period no Default specified in
Section&nbsp;7.01(e) or (f)&nbsp;with respect to the Company occurs which is continuing at the end of the period; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;the deposit does not constitute a default under any other agreement binding on the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;the Company delivers to the Trustee an Opinion of Counsel to the effect that the trust resulting
from the deposit does not constitute, or is qualified as, a regulated investment company under the Investment Company Act of 1940; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;in the case of the legal defeasance option, the Company shall have delivered to the Trustee an
Opinion of Counsel stating that (A)&nbsp;the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (B)&nbsp;since the date of this Indenture there has been a change in the applicable federal income tax
law, in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the beneficial owners of the Securities will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and
defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;in the case of the covenant defeasance option, the Company shall have delivered to the Trustee an
Opinion of Counsel to the effect that the beneficial owners of the Securities will not recognize income, gain or loss for federal income tax purposes as a result of such covenant defeasance and will be subject to federal income tax on the same
amounts, in the same manner and at the same times as would have been the case if such covenant defeasance had not occurred; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&nbsp;&nbsp;&nbsp;&nbsp;the Company delivers to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each
stating that all conditions precedent to the defeasance and discharge of the Securities as contemplated by this Article XII have been complied with. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before or after a deposit, the Company may make arrangements satisfactory to the Trustee for
the redemption of Securities at a future date in accordance with Article IV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Application of
Trust Money</U>. The Trustee shall hold in trust money or U.S. Government Obligations deposited with it pursuant to this Article XII. It shall apply the deposited money and the money from U.S. Government Obligations through the Paying Agent and in
accordance with this Indenture to the payment of principal of and interest on the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION
12.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Repayment to Company</U>. The Trustee and the Paying Agent shall promptly turn over to the Company upon request any excess money or securities held by them at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to any applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon request any money held by
them for the payment of principal or interest that remains unclaimed for two years, and, thereafter, Holders entitled to the money must look to the Company for payment as general creditors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnity for Government Obligations</U>. The Company shall pay and shall indemnify the Trustee
against any tax, fee or other charge imposed on or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">SECTION 12.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reinstatement</U>. If the Trustee or Paying Agent is unable to apply any money or U.S. Government
Obligations in accordance with this Article XII by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company&#146;s and
each Subsidiary Guarantor&#146;s obligations under this Indenture, each Subsidiary Guarantee and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article XII until such time as the Trustee or Paying
Agent is permitted to apply all such money or U.S. Government Obligations in accordance with this Article XII; <U>provided</U>, <U>however</U>, that, if the Company has made any payment of principal of or interest on any Securities because of the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.09.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article XIII of Base Indenture</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.01 of the Base Indenture is hereby amended and restated, but only with respect to the Securities, to read in its entirety as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 13.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Personal Liability</U>. No director, officer, employee,
incorporator or stockholder of the Company or any Subsidiary Guarantor shall have any liability for any obligations of the Company or any Subsidiary Guarantor under the Securities, any Subsidiary Guarantee or this Indenture or for any claim based
on, in respect of, or by reason of such obligations or their creation. By accepting a Security, each Holder shall waive and release all such liability. The waiver and release shall be part of the consideration for the issue of the Securities.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article XIV of Base Indenture</U>. (a)&nbsp;Sections 14.01 and 14.02 of the Base
Indenture are hereby amended and restated, but only with respect to the Securities, to read in their entirety as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Without Consent of Holders</U>. The Company, the Subsidiary Guarantors and the
Trustee may amend this Indenture or the Securities without notice to or consent of any Holder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) to cure any ambiguity,
omission, defect or inconsistency; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) to comply with Article V; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) to provide for uncertificated Securities in addition to or in place of
certificated Securities; <U>provided</U>, <U>however</U>, that the uncertificated Securities are issued in registered form for purposes of Section&nbsp;163(f) of the Code or in a manner such that the uncertificated Securities are described in
Section&nbsp;163(f)(2)(B) of the Code; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) to add Guarantees with respect to the Securities, including any Subsidiary
Guaranties, or to secure the Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) to add to the covenants of the Company or a Subsidiary Guarantor for the
benefit of the Holders or to surrender any right or power herein conferred upon the Company or a Subsidiary Guarantor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)
to make any change that does not adversely affect the rights of any Holder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) to conform the text of this Indenture or
the Securities to any provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement to the extent that such provision of the &#147;Description of Notes&#148; section of the Prospectus Supplement was intended to be a verbatim
recitation of a provision of this Indenture or the Securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) to comply with any requirement of the SEC in connection
with qualifying, or maintaining the qualification of, this Indenture under the TIA; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) to make any amendment to the
provisions of this Indenture relating to the transfer and legending of Securities; <U>provided</U>, <U>however</U>, that (A)&nbsp;compliance with this Indenture as so amended would not result in Securities being transferred in violation of the
Securities Act or any other applicable securities law and (B)&nbsp;such amendment does not materially and adversely affect the rights of Holders to transfer Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.01 becomes effective, the Company shall mail (or with respect to Global
Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section&nbsp;14.01. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION
14.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>With Consent of Holders</U>. (a)&nbsp;The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture, but only with respect to the Securities, or the Securities with the written consent of the
holders of at least a majority in principal amount of the Securities then outstanding (including consents obtained in connection with a purchase of, or tender offer or exchange for, the Securities) and any past Default or compliance with any
provisions may also be waived with the consent of the holders of at least a majority in principal amount of the Securities then outstanding. Notwithstanding the foregoing, without the consent of each Holder affected thereby, an amendment or waiver
may not: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) reduce the amount of Securities whose Holders must consent to an amendment; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) reduce the rate of or extend the time for payment of interest on any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) reduce the principal of or change the Stated Maturity of any Security; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) (i) reduce the amount payable upon the redemption of any Security or (ii)&nbsp;change the time at which any Security may be
redeemed, in each case in accordance with Article IV; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) make any Security payable in money other than that stated in the
Security; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) impair the right of any Holder to receive payment of principal of and
interest on such Holder&#146;s Securities on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder&#146;s Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) make any change in the amendment provisions that require each Holder&#146;s consent or in the waiver provisions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) make any change in the ranking or priority of any Security that would adversely affect the Securityholders; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) make any change in, or release other than in accordance with this Indenture, any Subsidiary Guarantee that would adversely
affect the Securityholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It shall not be necessary for the consent of the Holders under this Section&nbsp;14.02 to
approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">After an amendment under this Section&nbsp;14.02 becomes effective, the Company shall mail (or with respect to Global
Securities, to the extent permitted or required by applicable Depositary procedures or regulations, send electronically) to Holders a notice briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein,
shall not impair or affect the validity of an amendment under this Section&nbsp;14.02.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Article XIV of
the Base Indenture is hereby amended, but only with respect to the Securities, by the addition of the following new Sections 14.07 and 14.08: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;SECTION 14.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Revocation and Effect of Consents and Waivers</U>. A consent to an amendment or
a waiver by a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the consenting Holder&#146;s Security, even if notation of the consent or waiver is not
made on the Security. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder&#146;s Security or portion of the Security if the Trustee receives the notice of revocation before the date on which the amendment
or waiver becomes effective. After an amendment or waiver becomes effective, it shall bind every Holder. An amendment or waiver becomes effective upon execution of such amendment or waiver by the Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give
their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately preceding paragraph, those Persons who were Holders at such
record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record
date. No such consent shall be valid or effective for more than 120 days after such record date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">SECTION
14.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment for Consent</U>. Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any consideration, whether by way of interest, fee or otherwise, to any Holder for
or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture or the Securities unless such consideration is offered to all Holders and is paid to all Holders that so consent, waive or agree to amend in
the time frame set forth in solicitation documents relating to such consent, waiver or agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
4.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Article XVI of Base Indenture</U>. Section&nbsp;16.11 of the Base Indenture is hereby amended, but only with respect to the Securities, by deleting the first sentence of such section and replacing such
deleted sentence with the following: &#147;This Indenture and the Securities shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect to applicable principles of conflicts of law to the extent
that the application of the laws of another jurisdiction would be required thereby.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment of Base Indenture</U>. The Base Indenture
is hereby amended, but only with respect to the Securities, (a)&nbsp;by replacing cross-references to Sections and Articles therein to reflect the <FONT STYLE="white-space:nowrap">re-numbering</FONT> of such Sections and Articles as amended herein
and (b)&nbsp;so that any definitions, and any definitions included exclusively within such definitions, in the Base Indenture shall be deemed deleted or amended when all references in the Base Indenture to such definitions would be eliminated or
amended as a result of the amendments effected by this Supplemental Indenture. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSIDIARY GUARANTEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Guarantees</U>. (a)&nbsp;Each Subsidiary Guarantor hereby unconditionally and irrevocably guarantees,
jointly and severally, to each Holder and to the Trustee and its successors and assigns (i)&nbsp;the full and punctual payment of principal of and interest on the Securities when due, whether at maturity, by acceleration, by redemption or otherwise,
and all other monetary obligations of the Company under the Indenture and the Securities and (ii)&nbsp;the full and punctual performance within applicable grace periods of all other obligations of the Company under the Indenture and the Securities
(all the foregoing being hereinafter collectively called the &#147;<U>Guaranteed Obligations</U>&#148;). Each Subsidiary Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or
further assent from such Subsidiary Guarantor and that such Subsidiary Guarantor will remain bound under this Article V notwithstanding any extension or renewal of any Obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary Guarantor waives presentation to, demand of, payment from and protest to the Company of any of the
Guaranteed Obligations and also waives notice of protest for nonpayment. Each Subsidiary Guarantor waives notice of any default under the Securities or the Guaranteed Obligations. The obligations of each Subsidiary Guarantor hereunder shall not be
affected by (1)&nbsp;the failure of any Holder or the Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person (including any Subsidiary Guarantor) under the Indenture, the Securities or any
other agreement or otherwise; (2)&nbsp;any extension or renewal of any thereof; (3)&nbsp;any rescission, waiver, amendment or modification of any of the terms or provisions of the Indenture, the Securities or any other agreement; (4)&nbsp;the
release of any security held by any Holder or the Trustee for the Guaranteed Obligations or any of them; (5)&nbsp;the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or
(6)&nbsp;except as set forth in Section&nbsp;5.06, any change in the ownership of such Subsidiary Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Subsidiary Guarantor
further agrees that its Subsidiary Guarantee herein constitutes a guarantee of payment, performance and compliance when due (and not a guarantee of collection) and waives any right to require that any resort be had by any Holder or the Trustee to
any security held for payment of the Guaranteed Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly set forth in Sections 5.02,
5.05, 5.06 and 12.01(b), the obligations of each Subsidiary Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise,
and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the
foregoing, the obligations of each Subsidiary Guarantor herein shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to assert any claim or demand or to enforce any remedy under the Indenture, the
Securities or any other agreement, by any waiver or modification of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the obligations, or by any other act or thing or omission or delay to do any other act or
thing which may or might in any manner or to any extent vary the risk of such Subsidiary Guarantor or would otherwise operate as a discharge of such Subsidiary Guarantor as a matter of law or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary Guarantor further agrees that its Subsidiary Guarantee herein shall continue to be effective or be
reinstated, as the case may be, if at any time payment, or any part thereof, of principal of or interest on any Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company
or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing and not in limitation of any other right which any Holder or
the Trustee has at law or in equity against any Subsidiary Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Obligation when and as the same shall become due, whether at maturity, by acceleration,
by redemption or otherwise, or to perform or comply with any other Obligation, each Subsidiary Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash, to the Holders or the
Trustee an amount equal to the sum of (A)&nbsp;the unpaid amount of such Guaranteed Obligations, (B)&nbsp;accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by law) and (C)&nbsp;all other monetary
Guaranteed Obligations of the Company to the Holders and the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary Guarantor agrees that it
shall not be entitled to any right of subrogation in respect of any Obligations guaranteed hereby until payment in full of all Obligations. Each Subsidiary Guarantor further agrees that, as between it, on the one hand, and the Holders and the
Trustee, on the other hand, (A)&nbsp;the maturity of the Guaranteed Obligations guaranteed hereby may be accelerated as provided in Article VII of the Indenture for the purposes of any Subsidiary Guarantee herein, notwithstanding any stay,
injunction or other prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby, and (B)&nbsp;in the event of any declaration of acceleration of such Guaranteed Obligations as provided in Article VII of the
Indenture, such Guaranteed Obligations (whether or not due and payable) shall forthwith become due and payable by such Subsidiary Guarantor for the purposes of this Section&nbsp;5.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Each Subsidiary Guarantor also agrees to pay any and all costs and expenses (including reasonable attorneys&#146;
fees and expenses) incurred by the Trustee or any Holder in enforcing any rights under this Section&nbsp;5.01. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
5.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation on Liability</U>. Any term or provision of the Indenture to the contrary notwithstanding, the maximum aggregate amount of the Guaranteed Obligations guaranteed hereunder by any Subsidiary Guarantor shall
not exceed the maximum amount that can be hereby guaranteed without rendering the Indenture, as it relates to such Subsidiary Guarantor, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer or similar laws affecting
the rights of creditors generally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. This Article V shall be binding
upon each Subsidiary Guarantor and its successors and assigns and shall inure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the
rights and privileges conferred upon that party in the Indenture and in the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Waiver</U>. Neither a failure nor a delay on the part of either the Trustee or the Holders in
exercising any right, power or privilege under this Article V shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and
benefits of the Trustee and the Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article V at law, in equity, by statute or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Modification</U>. No modification, amendment or waiver of any provision of this Article V, nor the
consent to any departure by any Subsidiary Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be effective only in the specific instance and for
the purpose for which given. No notice to or demand on any Subsidiary Guarantor in any case shall entitle such Subsidiary Guarantor to any other or further notice or demand in the same, similar or other circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Release of Subsidiary Guarantor</U>. A Subsidiary Guarantor will be automatically released from its
obligations under this Article&nbsp;V: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) upon the sale or other disposition (including by way of consolidation or
merger) of such Subsidiary Guarantor, including the sale or disposition of Capital Stock of such Subsidiary Guarantor, following which such Subsidiary Guarantor is no longer a Subsidiary of the Company; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) upon the sale or disposition of all or substantially all of the assets
of such Subsidiary Guarantor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case other than to the Company or an Affiliate of the Company and as permitted by the Indenture and
if in connection therewith the Company provides an Officers&#146; Certificate to the Trustee to the effect that the Company shall comply with its obligations under Section&nbsp;6.06 in respect of such disposition. Upon any sale or disposition
described in clause (1)&nbsp;or (2) above, the obligor on the related Subsidiary Guarantee will be released from its obligations thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Subsidiary Guarantor also will be automatically released from its obligations under this Article V: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) upon the designation of such Subsidiary Guarantor as an Unrestricted Subsidiary in accordance with the terms of the
Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) at such time as any Guarantee by such Subsidiary Guarantor of the obligations under the Credit Agreement
and under all Capital Markets Indebtedness has been released and discharged, except a discharge or release by or as a result of payment under such Guarantee; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) if the Company exercises its legal defeasance option or its covenant defeasance option as described in Article XII of the
Indenture or if the Company&#146;s obligations under the Indenture are discharged in accordance with the terms of the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">For avoidance of doubt, clause (b)&nbsp;above shall include a situation whereby the Guarantee of Capital Markets Indebtedness
by a Subsidiary Guarantor, including the Securities, would be released and discharged (&#147;released&#148;) immediately upon such release under the Credit Agreement but for the existence of one or more guarantees of other Capital Markets
Indebtedness the terms of which also provide that such guarantees would be released immediately upon such release under the Credit Agreement, <I>provided that</I>, in each case, all conditions precedent to such release have been satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the request of the Company, the Trustee shall execute and deliver an appropriate instrument evidencing such release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>. Each Subsidiary Guarantor that makes a payment under its Subsidiary Guarantee shall
be entitled upon payment in full of all Guaranteed Obligations under the Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor&#146;s pro rata portion of such payment based on the
respective net assets of all the Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.01.&nbsp;&nbsp;&nbsp;&nbsp;<U>Integral Part</U>. This Supplemental Indenture constitutes an integral part of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.02.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adoption, Ratification and Confirmation</U>. The Base Indenture, as supplemented and amended by this
Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
6.03.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed an original; and all such counterparts shall together constitute but one and
the same instrument. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their original signatures for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.04.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. Should any provision of this Supplemental Indenture for any reason be declared
invalid or unenforceable, such decision shall not affect the validity or enforceability of any of the other provisions of this Supplemental Indenture, which other provisions shall remain in full force and effect and the application of such invalid
or unenforceable provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall be valid and be enforced to the fullest extent permitted by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.05.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. THIS SUPPLEMENTAL INDENTURE AND
THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE
REQUIRED THEREBY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.06.&nbsp;&nbsp;&nbsp;&nbsp;<U>Trustee Makes No Representation</U>. The Trustee makes no representation and
shall not be responsible or accountable as to the validity, execution by the other parties hereto or thereto or sufficiency of this Supplemental Indenture or of the Securities or Subsidiary Guarantees. The recitals and statements herein are deemed
to be those of the Company and Subsidiary Guarantors and not of the Trustee and the Trustee shall not be held responsible in any manner whatsoever for their correctness. The Trustee shall not be accountable for the use or application by the Company
of the Securities or the proceeds thereof. The Trustee assumes no responsibility for the accuracy or completeness of the information concerning the Company or its Affiliates or any other Person contained in the Prospectus Supplement or any related
documents or for any failure by the Company or any other Person to disclose events that may have occurred and may affect the significance or accuracy of such information, except to the extent such information relates to the Trustee. Neither the
Trustee nor any Paying Agent shall be responsible for determining whether any Asset Disposition has occurred and whether any related offer to purchase with respect to the Securities is required. Neither the Trustee nor any Paying Agent shall be
responsible for determining whether any Change of Control has occurred and whether any Change of Control Offer with respect to the Securities is required. Neither the Trustee nor any Paying Agent shall be responsible for monitoring the credit
ratings of the Company or making any request upon any rating agency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.07.&nbsp;&nbsp;&nbsp;&nbsp;<U>Damages Limitation</U>. In
no event shall the Trustee be responsible or liable for any special, indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit), irrespective of whether the Trustee has been advised of
the likelihood of such loss or damage and regardless of the form of action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.08.&nbsp;&nbsp;&nbsp;&nbsp;<U>U.S.A. PATRIOT
Act</U>. The Company and the Subsidiary Guarantors acknowledge that in accordance with Section&nbsp;326 of the U.S.A. PATRIOT Act, the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering,
is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Supplemental Indenture agree that they shall provide the
Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the U.S.A. PATRIOT Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Supplemental Indenture on the date
first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">ENCOMPASS HEALTH CORPORATION, as Issuer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patrick Darby</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Patrick Darby</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">GUARANTORS</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Advanced Homecare Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Advanced Homecare Management, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">AHM Texas LP, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Camellia Medical Systems, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">CareSouth Health System, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Continental Rehabilitation Hospital of Arizona, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">DOSIK, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EHHI Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health C Corp Sub Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Central Arkansas Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Home Health Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Home Health Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Jonesboro Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of City View, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Columbia, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Concord, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Dothan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Florence, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Manati, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Panama City, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of San Antonio, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of San Juan, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Texarkana, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of The Woodlands, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Tyler Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Yuma Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA HEALTHCARE, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA HOMECARE, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Guardian Home Care, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HealthSouth Rehabilitation Hospital of Austin, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Home Health Care of Bogalusa, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Home Health Care Systems, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Idaho Homecare Holdings, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Reliant Blocker Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">WellCare, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Wellmark Healthcare Services of El Paso, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">West Mississippi Home Health Services, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Western Neuro Care, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Abba Home Health, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">AHM Action Home Health, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Best Home Care LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">DRC Health Systems, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Continental Rehabilitation Hospital of</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Arizona,
Inc., its General Partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Rehabilitation Hospital of Tustin, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Western Neuro Care, Inc.,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">its Managing General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass of Fort Worth, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass of West Texas, LP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Hallmark Homecare, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Preferred Home Health, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Texas Senior Care, L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC, its General Partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">A&amp;B Home Health Solutions, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">AHM Texas GP, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Apex Hospice LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Home Health of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Home Health of East Tennessee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Home Health of the Gulf Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of Central Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of East Louisiana, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of Louisiana, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of North Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of Northeast Alabama LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of Northeast Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of South Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of Southwest Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Camellia Hospice of the Gulf Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareServices of the Treasure Coast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Columbus, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Dothan, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Gainesville, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Greensboro, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Lexington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of North Florida, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Panama City, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Richmond, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of South Carolina, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Tallahassee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of the Bay Area, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Valley, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Washington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Western Carolina, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings of Winchester, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth HHA Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CareSouth Hospice, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Continental Home Care, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Continental Medical Systems, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CS Health&nbsp;&amp; Wellness, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Day-By-Day</FONT></FONT> Staff Relief, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Acquisition Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Acquisition Holdings Subsidiary, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Alabama Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Arizona Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Arkansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Boise Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Bryan Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health California Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Colorado Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Deaconess Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Fairlawn Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health GKBJH Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Gulfport Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Birmingham, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Central Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Florida, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Kentucky, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Home Health of Ohio, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Hospice of Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Hospice of Pennsylvania, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Hospice of the Midwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Hospice of the Southwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Iowa Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Johnson City Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Joint Ventures Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Kansas Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Kentucky Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Littleton Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Lubbock Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Martin County Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Maryland Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Massachusetts Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Midland Odessa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Myrtle Beach Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Nevada Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health New Mexico Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Ohio Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Owned Hospitals Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Pennsylvania Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Properties, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Abilene, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Arlington, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Austin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Bluffton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Braintree, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Cypress, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Dallas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of East Valley, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Erie, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Franklin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Gadsden, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Harmarville, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Henderson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Humble, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Katy, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Kingsport, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Lakeview, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Largo, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Littleton, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Miami, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Middletown, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Modesto, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Murrieta, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Newnan, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Ocala, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Pearland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Petersburg, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Reading, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Richardson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Round Rock, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sarasota, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Shelby County, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sugar Land, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Sunrise, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of the <FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Toms River, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Utah, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Vineland, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital of York, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital The Vintage, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Hospital Vision Park, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Rehabilitation Institute of Tucson, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Savannah Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Sea Pines Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Sewickley Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health South Carolina Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health South Dakota Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Support Companies, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Encompass Health Texas Real Estate, LLC</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Tucson Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Tulsa Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Utah Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Walton Rehabilitation Hospital, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health West Tennessee Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health West Virginia Real Estate, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Westerville Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Health Winston-Salem Holdings, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of Austin, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of Colorado, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of DFW, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of East Texas, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of New England, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of the Mid Atlantic, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of the Midwest, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of the Southeast, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Home Health of the West, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Encompass Hospice of the West, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA ASSOCIATES, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">EXCELLA HOME HEALTH AGENCY, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HealthCare Innovations of Oklahoma, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HEALTHCARE INNOVATIONS OF WESTERN OKLAHOMA, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HealthCare Innovations-Travertine Health Services, L.L.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Hospice Care of Mississippi, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Orion Homecare, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Print Promotions Group, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Rebound, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Rehabilitation Hospital Corporation of America, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Rehabilitation Hospital of North Alabama, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Rehabilitation Hospital of Plano, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Saad Healthcare of St. Clair County LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">TH of San Antonio LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edmund M. Fay</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Edmund M. Fay</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signatures Continued on Next Page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stefan Victory</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Stefan Victory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Supplemental Indenture for 4.625% Senior Notes due 2031] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF FACE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Global Securities Legend] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS
SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#147;DTC&#148;), NEW YORK, NEW YORK OR A NOMINEE OF DTC, WHICH MAY BE
TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE
IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN
AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE
LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#146;S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS
SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Definitive Securities Legend] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH
TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.625% Senior Note Due 2031 </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">NO.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">CUSIP No. 29261A AE0</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ISIN No. US29261AAE01 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION, a Delaware corporation, promises to pay to Cede&nbsp;&amp; Co., or registered assigns, the principal sum of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dollars on April&nbsp;1, 2031. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest Payment Dates:
April&nbsp;1 and October 1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Record Dates: March&nbsp;15 and September 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Security are set forth on the other side of this Security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of authentication: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF REVERSE SIDE OF SECURITY] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>4.625% Senior Note Due 2031 </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation, a Delaware corporation (such corporation, and its successors and
assigns under the Indenture hereinafter referred to, being herein called the &#147;<U>Company</U>&#148;), promises to pay interest on the principal amount of this Security at the rate per annum shown above. The Company shall pay interest
semiannually on April&nbsp;1 and October&nbsp;1 of each year, commencing April&nbsp;1, 2021. Interest on the Securities will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from October&nbsp;5,
2020. Interest will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The Company shall pay interest on overdue principal at the rate borne by this
Security plus 1.0% per annum, and it shall pay interest on overdue installments of interest at the same rate to the extent lawful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Payment</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay interest on the Securities (except defaulted interest) to the
Persons who are registered holders of Securities at the close of business on the March&nbsp;15 or September&nbsp;15 next preceding the Interest Payment Date even if Securities are canceled after the Record Date and on or before the Interest Payment
Date. Holders must surrender Securities to a Paying Agent to collect principal payments. The Company shall pay principal and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts.
Payments in respect of the Securities represented by a Global Security (including principal and interest) will be made by wire transfer of immediately available funds to the accounts specified by the Depositary. The Company shall make all payments
in respect of a certificated Security (including principal and interest) by mailing a check to the registered address of each Holder thereof; <U>provided</U>, <U>however</U>, that payments on a certificated Security will be made by wire transfer to
a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no later than 10 days
immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Paying Agent and Registrar</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initially, Wells Fargo Bank, National Association, a national banking
association (the &#147;<U>Trustee</U>&#148;), will act as Paying Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-registrar</FONT> without notice. The Company or any of its
domestically incorporated Wholly Owned Subsidiaries may act as Paying Agent, Registrar or <FONT STYLE="white-space:nowrap">co-Registrar.</FONT> The transferor of any Security shall provide or cause to be provided to the Trustee all information
necessary to allow the Trustee to comply with any applicable tax reporting obligations, including without limitation any cost basis reporting obligations under Section&nbsp;6045 of the Code. In connection with any proposed exchange of a certificated
Security for a Global Security, there shall be provided to the Trustee all information necessary to allow the Trustee to comply with any applicable tax reporting obligations, including without limitation any cost basis reporting obligations under
Section&nbsp;6045 of the Code. The Trustee may rely on information provided to it by other Persons and shall have no responsibility to verify or ensure the accuracy of such information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. &nbsp;&nbsp;&nbsp;&nbsp;<U>Indenture</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company issued the Securities under the tenth supplemental indenture (the &#147;<U>Supplemental Indenture</U>&#148;), dated as of October&nbsp;5, 2020, to the indenture dated as of December&nbsp;1, 2009 (together with the Supplemental Indenture, the
&#147;<U>Indenture</U>&#148;), among the Company, the Subsidiary Guarantors and the Trustee. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15
U.S.C. &#167;&#167; 77aaa-77bbbb) (the &#147;<U>Act</U>&#148;). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred
to the Indenture and the Act for a statement of those terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are general unsecured obligations of the Company. The Company shall be
entitled, subject to its compliance with Section&nbsp;6.03 of the Indenture, to issue Additional Securities pursuant to Section&nbsp;3.14 of the Indenture. The Securities issued on the Issue Date, and any Additional Securities, will be treated as a
single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries to incur additional indebtedness; pay dividends or distributions on, or redeem or repurchase capital
stock; make investments; issue or sell capital stock of subsidiaries; engage in transactions with affiliates; create liens on assets; transfer or sell assets; guarantee indebtedness; restrict dividends or other payments of subsidiaries; consolidate,
merge or transfer all or substantially all of its assets; and engage in sale/leaseback transactions. These covenants are subject to important exceptions and qualifications. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. &nbsp;&nbsp;&nbsp;&nbsp;<U>Optional Redemption</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth below, the Company shall not be entitled to redeem the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On and after April&nbsp;1, 2026, the Company shall be entitled at its option to redeem all or a portion of the Securities upon not less than
10 nor more than 60 days&#146; notice, at the redemption prices (expressed in percentages of principal amount on the redemption date), plus accrued interest to the redemption date (subject to the right of Holders of record on the relevant Record
Date to receive interest due on the relevant Interest Payment Date), if redeemed during the <FONT STYLE="white-space:nowrap">12-month</FONT> period commencing on April&nbsp;1 of the years set forth below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Redemption&nbsp;Price</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102.313</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101.542</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2028</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.771</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2029 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.000</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, prior to April&nbsp;1, 2026, the Company shall be entitled at its option on one or more occasions to redeem
Securities (which includes Additional Securities, if any) in an aggregate principal amount not to exceed 35% of the aggregate principal amount of the Securities (which includes Additional Securities, if any) originally issued at a redemption price
(expressed as a percentage of principal amount) of 104.625%, plus accrued and unpaid interest to the redemption date, with the net cash proceeds from one or more Equity Offerings; <U>provided</U>, <U>however</U>, that (1)&nbsp;at least 65% of such
aggregate principal amount of Securities (which includes Additional Securities, if any) remains outstanding immediately after the occurrence of each such redemption (other than Securities held, directly or indirectly, by the Company or its
Affiliates); and (2)&nbsp;each such redemption occurs within 90 days after the date of the related Equity Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
April&nbsp;1, 2026, the Company shall be entitled at its option to redeem all or a portion of the Securities at a redemption price equal to 100% of the principal amount of the Securities plus the Applicable Premium as of, and accrued and unpaid
interest to, the redemption date (subject to the right of Holders on the relevant Record Date to receive interest due on the relevant Interest Payment Date). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. &nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Redemption</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of redemption will be mailed (or with respect to Global Securities, to the extent permitted or required by applicable DTC procedures or
regulations, send electronically) at least 10 days but not more than 60 days before the redemption date to each Holder of Securities to be redeemed at his registered address. Securities in denominations larger than $2,000 principal amount may be
redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to be redeemed on the redemption date is deposited with the Paying Agent on or
before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called for redemption. The Company may cancel a notice of redemption that has been
delivered to the Trustee at any time prior to the notice of redemption being sent to any Holder and thereafter shall be null and void. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption of the Securities may, at the Company&#146;s discretion, be given
prior to the completion of a transaction (including an equity offering, incurrence of indebtedness, refinancing, acquisition or other transaction) and any redemption may, at the Company&#146;s discretion, be subject to one or more conditions
precedent, including, but not limited to, completion of a related transaction. If such redemption is so subject to satisfaction of one or more conditions precedent, such notice shall describe each such condition, and if applicable, shall state that,
in the Company&#146;s discretion, the redemption date may be delayed until such time (including more than 60 calendar days after the date the notice of redemption was delivered to the Holders of the Securities, including by electronic transmission)
as any or all such conditions shall be satisfied, or such redemption may not occur and such notice may be rescinded in the event that any or all such conditions shall not have been satisfied by the redemption date, or by the redemption date as so
delayed. In addition, the Company may provide in such notice that payment of the redemption price and performance of the Company&#146;s obligations with respect to such redemption may be performed by another Person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. &nbsp;&nbsp;&nbsp;&nbsp;<U>Put Provisions</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon a Change of Control, any Holder will have the right to cause the Company to repurchase all or any part of the Securities of such Holder at
a repurchase price equal to 101% of the principal amount of the Securities to be repurchased plus accrued interest to the date of repurchase (subject to the right of Holders of record on the relevant Record Date to receive interest due on the
related Interest Payment Date) as provided in, and subject to the terms of, the Indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. &nbsp;&nbsp;&nbsp;&nbsp;<U>Guarantee</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The payment by the Company of the principal of and interest on the Securities is fully and unconditionally guaranteed on a joint and several
senior unsecured basis by each of the Subsidiary Guarantors to the extent set forth in the Indenture. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Denominations;
Transfer; Exchange</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Securities are in registered form without coupons in denominations of $2,000 principal amount and any greater
integral multiple of $1,000. A Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and
fees required by law or permitted by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be
redeemed) or any Securities for a period of 15 days before a selection of Securities to be redeemed or 15 days before an Interest Payment Date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Persons Deemed Owners</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in paragraph 2 hereof, the registered Holder of this Security may
be treated as the owner of it for all purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. &nbsp;&nbsp;&nbsp;&nbsp;<U>Unclaimed Money</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If money for the payment of principal or interest on any Securities remains unclaimed for two years, the Trustee or Paying Agent shall pay the
money back to the Company at its request at the end of the two years after such principal or interest has become due or payable, unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must
look only to the Company as general creditors and not to the Trustee for payment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. &nbsp;&nbsp;&nbsp;&nbsp;<U>Discharge and Defeasance</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain conditions, the Company at any time shall be entitled to terminate some or all of its obligations under the Securities and
the Indenture if the Company irrevocably deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. &nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment, Waiver</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions set forth in the Indenture, (a)&nbsp;the Indenture and the Securities may be amended with the written consent of
the holders of at least a majority in principal amount outstanding of the Securities and (b)&nbsp;any default or noncompliance with any provision may be waived with the written consent of the holders of a majority in principal amount outstanding of
the Securities. Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Subsidiary Guarantors and the Trustee shall be entitled to amend the Indenture or the Securities to cure any
ambiguity, omission, defect or inconsistency, or to comply with Article V of the Indenture, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to add guarantees with respect to the Securities,
including Subsidiary Guarantees, or to add additional covenants or surrender rights and powers conferred on the Company or the Subsidiary Guarantors, or to conform the text of the Indenture or the Securities to any provision of the &#147;Description
of Notes&#148; section of the Prospectus Supplement under certain circumstances, or to comply with any requirement of the SEC in connection with qualifying the Indenture under the Act, or to make any change that does not adversely affect the rights
of any Securityholder, or to make amendments to provisions of the Indenture relating to the form, authentication, transfer and legending of the Securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. &nbsp;&nbsp;&nbsp;&nbsp;<U>Defaults and Remedies</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Indenture, Events of Default include (a)&nbsp;default for 30 days in payment of interest on the Securities; (b)&nbsp;default in
payment of principal on the Securities at maturity, upon redemption pursuant to paragraph 5 of the Securities, upon acceleration or otherwise, or failure by the Company to redeem or purchase Securities when required; (c)&nbsp;failure by the Company
or any Subsidiary Guarantor to comply with other agreements in the Indenture or the Securities, in certain cases subject to notice and lapse of time; (d)&nbsp;certain accelerations (including failure to pay within any grace period after final
maturity) of other Indebtedness of the Company, any Subsidiary Guarantor or any Significant Subsidiary if the amount accelerated (or so unpaid) exceeds $50&nbsp;million; (e)&nbsp;certain events of bankruptcy or insolvency with respect to the
Company, a Subsidiary Guarantor or any Significant Subsidiary; (f)&nbsp;certain judgments or decrees for the payment of money in excess of $50&nbsp;million against the Company, a Subsidiary Guarantor or any Significant Subsidiary; and
(g)&nbsp;certain defaults with respect to Subsidiary Guarantees. If an Event of Default occurs and is continuing, the Trustee or the holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable
immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the Securities being due and payable immediately upon the occurrence of such Events of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the
Indenture or the Securities unless it receives indemnity or security satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The
Trustee may withhold from Securityholders notice of any continuing Default (except a Default in payment of principal or interest) if it determines that withholding notice is in the interest of the Holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. &nbsp;&nbsp;&nbsp;&nbsp;<U>Trustee Dealings with the Company</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to certain limitations imposed by the Act, the Trustee under the Indenture, in its individual or any other capacity, may become the
owner or pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any
Paying Agent, Registrar, <FONT STYLE="white-space:nowrap">co-Registrar</FONT> or <FONT STYLE="white-space:nowrap">co-Paying</FONT> Agent may do the same with like rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. &nbsp;&nbsp;&nbsp;&nbsp;<U>No Recourse Against Others</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A director, officer, employee or stockholder, as such, of the Company or any Subsidiary Guarantor shall not have any liability for any
obligations of the Company or any Subsidiary Guarantor under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and
releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Authentication</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Security shall not be valid until an authorized signatory of the Trustee (or an
authenticating agent) manually signs the certificate of authentication on the other side of this Security. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Abbreviations</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Customary abbreviations may be used in the name of a Securityholder or an assignee, such as
TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19. &nbsp;&nbsp;&nbsp;&nbsp;<U>CUSIP Numbers</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers
to be printed on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as
contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE
STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish to any Securityholder upon written request and without charge to the Securityholder a copy of the Indenture which has
in it the text of the form of this Security. Requests may be made to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Attention: General Counsel </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ASSIGNMENT FORM </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To assign this Security, fill in the form below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I or we
assign and transfer this Security to </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Print or type assignee&#146;s name, address and zip code) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(Insert assignee&#146;s Social
Security or Tax I.D. No.)&nbsp;&nbsp;&nbsp;&nbsp; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> agent to transfer this Security on the books of the Company. The agent may substitute another to act for him. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:12pt ;">DATE: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;YOUR SIGNATURE:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sign exactly as your name appears on the other side of this Security.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[TO BE ATTACHED TO GLOBAL SECURITIES] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following increases or decreases in this Global Security have been made: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Date of Exchange</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;decrease<BR>in&nbsp;Principal amount<BR>of&nbsp;this&nbsp;Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount&nbsp;of&nbsp;increase<BR>in&nbsp;Principal&nbsp;amount<BR>of&nbsp;this&nbsp;Global<BR>Security</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal&nbsp;amount&nbsp;of<BR>this Global Security<BR>following such<BR>decrease&nbsp;or&nbsp;increase</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Signature&nbsp;of<BR>authorized&nbsp;officer&nbsp;of<BR>Trustee&nbsp;or&nbsp;Securities<BR>Custodian</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OPTION OF HOLDER TO ELECT PURCHASE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have this Security purchased by the Company pursuant to Section&nbsp;6.06 or 6.08 of the Indenture, check the
box:&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you want to elect to have only part of this Security purchased by the Company pursuant to Section&nbsp;6.06 or
6.08 of the Indenture, state the amount in principal amount: $ </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Your
<BR>Signature:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(Sign exactly as your name appears on the other side of this Security.)</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature&nbsp;Guarantee:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:6.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;(Signature&nbsp;must&nbsp;be&nbsp;guaranteed)</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signatures must be guaranteed by an &#147;eligible guarantor institution&#148; meeting the requirements of the Registrar,
which requirements include membership or participation in the Security Transfer Agent Medallion Program (&#147;<U>STAMP</U>&#148;) or such other &#147;signature guarantee program&#148; as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[FORM OF GUARANTY AGREEMENT] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">GUARANTY AGREEMENT (this &#147;<U>Guaranty Agreement</U>&#148;) dated as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; among [GUARANTOR] (the &#147;<U>New Guarantor</U>&#148;), a subsidiary of ENCOMPASS HEALTH CORPORATION (or its successor), a
Delaware corporation (the &#147;<U>Company</U>&#148;), the subsidiary guarantors party to the Indenture (defined below) (the &#147;<U>Subsidiary Guarantors</U>&#148;), in favor of WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee under the
Indenture (the &#147;<U>Trustee</U>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H : </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS the Company and the Subsidiary Guarantors (the &#147;<U>Existing Guarantors</U>&#148;) have heretofore executed and delivered to the
Trustee a tenth supplemental indenture (the &#147;<U>Tenth Supplemental Indenture</U>&#148;) dated as of October&nbsp;5, 2020, to the indenture (together with the Tenth Supplemental Indenture, the &#147;<U>Indenture</U>&#148;) dated as of
December&nbsp;1, 2009, providing for the issuance of the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Securities</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS Section&nbsp;6.11 of the Indenture provides that under certain circumstances the Company is required to cause the New Guarantor to
execute and deliver to the Trustee an agreement pursuant to which the New Guarantor shall unconditionally guarantee all the Company&#146;s obligations under the Securities pursuant to a Subsidiary Guarantee on the terms and conditions set forth
herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is
hereby acknowledged, the New Guarantor and the Company mutually covenant and agree for the equal and ratable benefit of the holders of the Securities as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Agreement to Guarantee</U>. The New Guarantor hereby agrees, jointly and severally with all Existing Guarantors, to unconditionally
guarantee the Company&#146;s obligations under the Securities on the terms and subject to the conditions set forth in Article V of the Tenth Supplemental Indenture and to be bound by all other applicable provisions of the Indenture and the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Ratification of Indenture; Supplemental Indentures and Guaranty Agreements Part of Indenture</U>. Except as expressly
amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Guaranty Agreement shall form a part of the Indenture for all purposes, and
every holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Governing Law</U>. <B>THIS
GUARANTY AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT GIVING EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION
WOULD BE REQUIRED THEREBY.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Trustee Makes No Representation</U>. The Trustee makes no representation and shall not be
responsible or accountable as to the validity, execution by the parties hereto or thereto or sufficiency of this Guaranty Agreement or the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Counterparts</U>. The parties may sign any number of copies of this Guaranty Agreement. Each signed copy shall be an original, but all
of them together represent the same agreement. Signatures of the parties hereto transmitted by facsimile or PDF may be used in lieu of the originals and shall be deemed to be their original signatures for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Effect of Headings</U>. The Section headings herein are for convenience only and shall not affect the construction thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Guaranty Agreement to be duly
executed as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[NEW GUARANTOR],</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;by</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ENCOMPASS HEALTH CORPORATION,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;by</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d12659dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Maynard, Cooper&nbsp;&amp; Gale, P.C.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">October&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as
counsel to Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), and special counsel to each of the subsidiaries of the Company named on <U>Schedule</U><U></U><U>&nbsp;I</U> attached hereto (the &#147;<U>Subsidiary
Guarantors</U>&#148;), in connection with the issuance of $400,000,000 in aggregate principal amount of the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Notes</U>&#148;) and the related guarantees of such Notes issued by the Subsidiary
Guarantors (the &#147;<U>Guarantees</U>,&#148; and together with the Notes, the &#147;<U>Securities</U>&#148;). Such issuance has been made pursuant to (i)&nbsp;the Company&#146;s Registration Statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> (File No.&nbsp;333-248942), including a base prospectus dated September&nbsp;21, 2020 (the &#147;<U>Base Prospectus</U>&#148;), initially filed with the Securities and Exchange Commission (the
&#147;<U>Commission</U>&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), on September&nbsp;21, 2020 (the &#147;<U>Registration Statement</U>&#148;), (ii)&nbsp;the preliminary prospectus supplement
dated September&nbsp;30, 2020 and filed with the Commission on September&nbsp;30, 2020 pursuant to Rule 424(b) under the Securities Act (together with the Base Prospectus, the &#147;<U>Preliminary Prospectus</U>&#148;), (iii)&nbsp;the document
identified by the Company as a &#147;free writing prospectus&#148; (within the meaning of Rule&nbsp;433 and Rule&nbsp;405 under the Securities Act) (the &#147;<U>FWP</U>&#148;) dated September&nbsp;30, 2020 and filed with the Commission on
September&nbsp;30, 2020 pursuant to Rule 433(d) under the Securities Act and (iv)&nbsp;the final prospectus supplement dated September&nbsp;30, 2020 and filed with the Commission on October&nbsp;1, 2020 pursuant to Rule 424(b) under the Securities
Act (together with the Base Prospectus, the &#147;<U>Prospectus</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes and the Guarantees are being issued under an
Indenture, dated as of December&nbsp;1, 2009 (the &#147;<U>Base Indenture</U>&#148;), between the Company and Wells Fargo Bank, National Association (as successor to The Bank of Nova Scotia Trust Company of New York), as trustee (the
&#147;<U>Trustee</U>&#148;), as supplemented by a tenth supplemental indenture, dated as of October&nbsp;5, 2020, among the Company, the Guarantors and the Trustee, relating to the Notes (the &#147;<U>Supplemental Indenture</U>&#148; and, together
with the Base Indenture, the &#147;<U>Indenture</U>&#148;). The Notes are being sold pursuant to an Underwriting Agreement, dated September&nbsp;30, 2020 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, Truist
Securities, Inc., as representative of the several underwriters named in Schedule&nbsp;1 therein (the &#147;<U>Underwriters</U>&#148;), and the Underwriters. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering our opinions herein, we have relied upon certificates signed by officers of the
Company and the Subsidiary Guarantors with respect to various factual matters without having independently verified such factual matters, and certificates, correspondence and representations from public officials referred to below. We are opining
herein solely as to (i)&nbsp;the Alabama Business and Nonprofit Entity Code, the Delaware General Corporation Law, the Delaware Limited Liability Company Act, the Delaware Revised Uniform Limited Partnership Act, the Florida Business Corporation
Act, and the Georgia Limited Liability Company Act (collectively, the &#147;<U>Business Codes</U>&#148;), as applicable to those certain Subsidiary Guarantors that are identified in <U>Schedule I</U> hereto as being incorporated or otherwise
organized under Alabama, Delaware, Florida or Georgia law (the &#147;<U>Specified Guarantors</U>&#148;), and (ii)&nbsp;with respect to the opinions set forth in paragraphs 6 and 7 below, the internal laws of the State of New York. We express no
opinion with respect to the applicability thereto, or the effect thereon, of the federal laws of the United States or the laws of any other jurisdiction or, in the case of the States of Alabama, Delaware, Florida and Georgia, any laws other than the
Business Codes listed above, or as to any matters of municipal law or the laws of any local agencies within any state. Additionally, we are not rendering any opinion, and we are not providing any assurance, as to compliance with any antifraud law,
rule or regulation or any state &#147;blue sky&#148; securities law relating to the Securities or the offering, issuance or sale thereof. We are not admitted to practice in the State of Delaware; however, we are generally familiar with the Delaware
General Corporation Law, the Delaware Limited Liability Company Act and the Delaware Revised Uniform Limited Partnership Act as currently in effect and have made such inquiries as we consider necessary to render the opinions below. We call to your
attention that certain of the Subsidiary Guarantors are incorporated or otherwise organized, as the case may be, in the States of Idaho, Massachusetts, Mississippi, New Mexico, South Carolina and Texas, as indicated in <U>Schedule I</U> hereto.
Various matters concerning the laws of the States of Idaho, Massachusetts, Mississippi, New Mexico, South Carolina and Texas are addressed in the letters of Bradley Arant Boult Cummings LLP, Hawley Troxell Ennis&nbsp;&amp; Hawley LLP and
Snell&nbsp;&amp; Wilmer L.L.P. and we express no opinion with respect to those matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering our opinions herein, we have
examined originals or copies of the following documents: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Registration Statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Preliminary Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the FWP; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Prospectus; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;the Underwriting Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;the Indenture, including the Guarantees contained therein; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;the global note executed by the Company pursuant to the
Indenture, dated as of October&nbsp;5, 2020, representing the Notes (the &#147;<U>Global Note</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;the certificate of incorporation and bylaws for the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;the certificate of incorporation, articles of incorporation, articles of organization, certificate of formation,
bylaws, limited liability company agreement, operating agreement and partnership agreement or the equivalents thereto, as applicable, for each Specified Guarantor; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;certain resolutions adopted by the Company&#146;s board of directors, and a committee thereof, relating to the
Securities and certain related matters; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;certain resolutions adopted by the board of directors, board of
managers or partners, as applicable, and any resolutions authorizing the same, of each Specified Guarantor, relating to the Securities and certain related matters; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate with respect to various factual matters signed by an officer of the Company dated as of the date of
this opinion letter; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate with respect to various factual matters signed by an officer of each of
the Subsidiary Guarantors dated as of the date of this opinion letter; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;certificates of public officials
or other written evidence of good standing, existence or compliance, as applicable, for each of the Company and the Specified Guarantors in its respective jurisdiction of incorporation or formation, as applicable (the &#147;<U>Public
Certificates</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of
such documents, corporate records, certificates of officers of the Company and the Subsidiary Guarantors and of public officials and other instruments or documents as we have deemed necessary or advisable for the purposes of rendering these
opinions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed the genuineness of all signatures, the legal capacity of each natural person signing any document reviewed by
us, the authority of each person signing in a representative capacity (other than with respect to the Company and the Specified Guarantors) any document reviewed by us, the authenticity of all documents submitted to us as originals, the conformity
to authentic original documents of all copies submitted to us or filed with the Commission as conformed and certified or reproduced copies, and the absence of duress, fraud or mutual mistake of material facts on the part of the parties to any
agreement with respect to which an opinion is expressed herein. We have further assumed (a)&nbsp;that, other than with respect to the Company and each of the Specified Guarantors, the Underwriting Agreement, the Indenture and the Global Note
(collectively, the &#147;<U>Subject Documents</U>&#148;) have been duly authorized, executed and delivered by the parties thereto, (b)&nbsp;that, other than with respect to the Company and each of the Specified Guarantors, the Subject Documents
constitute legally valid and binding obligations of the parties thereto, enforceable against each of them in accordance with their respective terms, and (c)&nbsp;that the status of the Subject Documents as legally valid and
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
binding obligations of the parties is not affected by any (i)&nbsp;breaches of, or defaults under, agreements or instruments, (ii)&nbsp;violations of statutes, rules, regulations or court or
governmental orders, or (iii)&nbsp;failures to obtain required consents, approvals or authorizations from, or make required registrations, declarations or filings with, governmental authorities. To the extent that the obligations of the Company and
the Subsidiary Guarantors under the Notes may be dependent upon such matters, we also assume for purposes of this opinion letter that (i)&nbsp;the Trustee is in compliance generally and with respect to acting as a trustee under the Indenture, with
all applicable laws and regulations; and (ii)&nbsp;the Global Note will be duly authenticated by the Trustee in the manner provided in the Indenture. As to any facts material to these opinions, we have relied to the extent we deemed appropriate and
without independent investigation upon statements and representations of officers and other representatives of the Company, the Subsidiary Guarantors and others and have assumed that such matters remain true and correct through the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to our opinion in paragraph 1 below with respect to the Company&#146;s and the Specified Guarantors&#146; good standing, we have
based our opinions solely upon examination of the Public Certificates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the qualifications,
assumptions and limitations herein set forth, we are of the opinion that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company and the
Specified Guarantors is validly existing and in good standing under the laws of its respective jurisdiction of incorporation or formation, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&nbsp;&nbsp;&nbsp;&nbsp;The Company has the requisite corporate power under the laws of the State of Delaware to execute, deliver and
perform its obligations under the Indenture and to issue the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Specified Guarantors has the
requisite corporate, limited liability company or partnership power, as applicable, under the laws of its state of incorporation or formation, as applicable, to execute, deliver and perform its obligations under the Indenture and to issue the
Guarantees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by the Company of the Indenture and the performance of its obligations
thereunder, including the issuance of the Notes in accordance with the provisions of the Indenture, have been duly authorized by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;The execution and delivery by each of the Specified Guarantors of the Indenture and the performance of its
obligations thereunder, including the issuance of the Guarantees in accordance with the provisions of the Indenture, have been duly authorized by each of the Specified Guarantors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&nbsp;&nbsp;&nbsp;&nbsp;The Notes are legally valid and binding obligations of the Company, enforceable against the Company in accordance
with their terms. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 5
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&nbsp;&nbsp;&nbsp;&nbsp;The Guarantees are legally valid and binding obligations of the
Subsidiary Guarantors, enforceable against the Subsidiary Guarantors in accordance with their respective terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions expressed in
paragraphs 6 and 7 above with respect to the valid and binding nature of obligations of the Securities are subject to the following exceptions, limitations and qualifications: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;we express no opinion with respect to any provision of any of the Subject Documents relating to: (a)&nbsp;the
effect of bankruptcy, insolvency, reorganization, receivership, moratorium or other laws affecting creditors&#146; rights (including, without limitation, the effect of statutory and other law regarding fraudulent conveyances, fraudulent transfers
and preferential transfers); (b) <FONT STYLE="white-space:nowrap">non-reliance,</FONT> exculpation, disclaimer, limitation of liability, indemnification, contribution, waiver, limitation or exclusion of remedies; (c)&nbsp;liquidated damages,
forfeitures, default interest, late charges, make-whole premiums, payment of attorneys&#146; fees, collection upon acceleration of amounts that might be determined to constitute unearned interest thereon, or other economic remedies, in each case to
the extent that it constitutes a penalty, is prohibited by law or is deemed to be contrary to public policy; (d)&nbsp;concepts or principles of materiality, reasonableness, equity, good faith, fair dealing or unconscionability (regardless of whether
the Securities are considered in a proceeding in equity or at law); (e) governing law (except for the enforceability of any provision choosing New York law as a Subject Document&#146;s governing law pursuant to the statutes referred to in paragraph
(ii)&nbsp;below); (f) the waiver of the right to trial by jury or of usury, stay, extension and similar laws; (g)&nbsp;rights or remedies not being exclusive, not preventing the concurrent assertion of any other right or remedy, being cumulative and
exercisable in addition to any other right and remedy, or any delay or omission to exercise any right or remedy not impairing any right or remedy or not constituting a waiver thereof; (h)&nbsp;any obligation or agreement to use best efforts,
reasonable best efforts or commercially reasonable efforts; (i)&nbsp;any requirement that a party take further action or enter into further agreements or instruments or provide further assurances; (j)&nbsp;any requirement that amendments or waivers
be in writing insofar as they suggest that oral or other modifications, amendments or waivers could not be effectively agreed upon by the parties or that the doctrine of promissory estoppel might not apply; (k)&nbsp;service of process by any method
not provided for under applicable statute or court rule; and (l)&nbsp;the severability of any provisions to the foregoing effect to the extent such provisions are unenforceable; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to the extent that any opinions set forth herein relate to the enforceability of the choice of New York law and
selection of a New York forum or exclusive jurisdiction provisions in any of the Subject Documents, such opinions are subject to the qualifications that such enforceability may be subject to, in each case, (a)&nbsp;the exceptions and limitations in
Sections <FONT STYLE="white-space:nowrap">5-1401</FONT> and <FONT STYLE="white-space:nowrap">5-1402</FONT> of the New York General Obligations Law and (b)&nbsp;principles of comity and constitutionality. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 6
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion letter is rendered as of the date hereof, and we assume no obligation to revise
or supplement the opinions contained herein in the event of any future changes in the facts or laws relating to the matters covered by such opinions. This opinion letter is being furnished in accordance with the requirements of Item 16 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> and Item 601(b)(5)(i) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as promulgated by the Commission under the Securities Act, and is limited to the matters expressly stated herein, and no opinions
are to be inferred or may be implied beyond those expressly stated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as an exhibit
to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> dated October&nbsp;5, 2020, which is incorporated by reference into the Registration Statement, and to the reference to our firm under the heading &#147;Legal
Matters&#148; in the Prospectus. In giving such consent, we do not admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated
thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Maynard, Cooper&nbsp;&amp; Gale, P.C.</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SCHEDULE I </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Subsidiary Guarantors </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A&amp;B Home Health Solutions, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Abba Home Health, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advanced Homecare Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Advanced Homecare Management, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Action Home Health, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Texas GP, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AHM Texas LP, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apex Hospice LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Best Home Care LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of East Tennessee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Home Health of the Gulf Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Central Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of East Louisiana, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Louisiana, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of North Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Northeast Alabama LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Northeast Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of South Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Southwest Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Hospice of the Gulf Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Camellia Medical Systems, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareServices of the Treasure Coast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth Health System, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Columbus, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Dothan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Gainesville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Greensboro, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Lexington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of North Florida, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Panama City, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Richmond, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of South Carolina, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of the Bay Area, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Washington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Western Carolina, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings of Winchester, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth HHA Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CareSouth Hospice, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Home Care, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Medical Systems, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continental Rehabilitation Hospital of Arizona, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CS Health&nbsp;&amp; Wellness, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Georgia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Day-By-Day</FONT></FONT> Staff
Relief, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DOSIK, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DRC Health Systems, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EHHI Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings Subsidiary, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Acquisition Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Alabama Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arizona Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Arkansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Boise Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Bryan Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health C Corp Sub Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health California Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Central Arkansas Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Colorado Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Deaconess Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Fairlawn Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health GKBJH Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Gulfport Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Birmingham, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Central Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Florida, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Home Health of Ohio, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of Pennsylvania, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of the Midwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Hospice of the Southwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Iowa Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Johnson City Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Joint Ventures Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Jonesboro Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kansas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Kentucky Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Littleton Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Lubbock Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Martin County Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Maryland Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Massachusetts Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Midland Odessa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Myrtle Beach Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Nevada Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health New Mexico Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Ohio Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Owned Hospitals Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Pennsylvania Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Properties, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Abilene, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Albuquerque, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Altamonte Springs, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Arlington, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bakersfield, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Bluffton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Braintree, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cardinal Hill, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cincinnati, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of City View, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Colorado Springs, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Columbia, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Concord, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Cypress, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dallas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Desert Canyon, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Dothan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of East Valley, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Erie, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">South&nbsp;Carolina</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fort Smith, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Franklin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Fredericksburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Gadsden, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Harmarville, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Henderson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Humble, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Katy, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Kingsport, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Lakeview, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Largo, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Las Vegas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Littleton, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Manati, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Mechanicsburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Miami, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Middletown, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Modesto, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Montgomery, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Murrieta, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Newnan, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Nittany Valley, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Kentucky, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northern Virginia, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Northwest Tucson, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Ocala, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Panama City, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Pearland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Petersburg, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Reading, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Richardson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Round Rock, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Antonio, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of San Juan, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sarasota, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Scottsdale, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Shelby County, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Spring Hill, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sugar Land, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Sunrise, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tallahassee, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Texarkana, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of the
<FONT STYLE="white-space:nowrap">Mid-Cities,</FONT> LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of The Woodlands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Toms River, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Treasure Coast, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Tustin, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Utah, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Vineland, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Western Massachusetts, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of York, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital The Vintage, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital Vision Park, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Institute of Tucson, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alabama</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Savannah Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sea Pines Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Sewickley Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Carolina Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health South Dakota Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Support Companies, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Texas Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tucson Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tulsa Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Tyler Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Utah Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health ValleyofTheSun Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Guarantor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>State&nbsp;of<BR>Incorporation&nbsp;or<BR>Organization</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Walton Rehabilitation Hospital, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Tennessee Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health West Virginia Real Estate, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Westerville Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Winston-Salem Holdings, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Health Yuma Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of Austin, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of Colorado, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of DFW, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of East Texas, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of New England, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Mid Atlantic, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Midwest, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the Southeast, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Florida</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Home Health of the West, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass Hospice of the West, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass of Fort Worth, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Encompass of West Texas, LP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA ASSOCIATES, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HEALTHCARE, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HOME HEALTH AGENCY, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EXCELLA HOMECARE, INC.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Massachusetts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guardian Home Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hallmark Homecare, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthCare Innovations of Oklahoma, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HEALTHCARE INNOVATIONS OF WESTERN OKLAHOMA, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthCare Innovations-Travertine Health Services, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Austin, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HealthSouth Rehabilitation Hospital of Fort Worth, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Home Health Care of Bogalusa, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Home Health Care Systems, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hospice Care of Mississippi, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Idaho Homecare Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Orion Homecare, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Idaho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred Home Health, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Print Promotions Group, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rebound, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital Corporation of America, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of North Alabama, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rehabilitation Hospital of Plano, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reliant Blocker Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Saad Healthcare of St. Clair County LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Texas Senior Care, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TH of San Antonio LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">WellCare, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">New Mexico</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wellmark Healthcare Services of El Paso, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Texas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">West Mississippi Home Health Services, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Mississippi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Western Neuro Care, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Delaware</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>d12659dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Bradley Arant Boult Cummings LLP] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special
counsel to each of the Opinion Guarantors (as defined below), each Opinion Guarantor being a direct or indirect subsidiary of Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the Opinion
Guarantors&#146; guarantee, along with the other Guarantors (as defined below), of the $400,000,000 aggregate principal amount of the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Notes</U>&#148;). The Notes are being issued under an
Indenture (the &#147;<U>Base Indenture</U>&#148;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#147;<U>Trustee</U>&#148;), dated as of December&nbsp;1, 2009, as amended and supplemented by the Tenth Supplemental
Indenture thereto (the &#147;<U>Supplemental Indenture</U>&#148; and, together with the Base Indenture, the &#147;<U>Indenture</U>&#148;), dated as of October&nbsp;5, 2020, among the Company, the guarantors named therein (the
&#147;<U>Guarantors</U>&#148;) and the Trustee. The Notes are being guaranteed by the Guarantors pursuant to the guarantees included in the Indenture (the &#147;<U>Guarantees</U>&#148;), and are being sold pursuant to an Underwriting Agreement dated
as of September&nbsp;30, 2020 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, Truist Securities, Inc., as representative of the Underwriters named in Schedule&nbsp;1 to the Underwriting Agreement (the
&#147;<U>Underwriters</U>&#148;), and the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined originals or copies, certified
or otherwise identified to our satisfaction, of: (i)&nbsp;the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-248942)</FONT> filed by the Company and the <FONT
STYLE="white-space:nowrap">co-registrants</FONT> named therein with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), on
September&nbsp;21, 2020 (such registration statement, as amended and including the form of prospectus included therein and the documents incorporated by reference therein at the time of effectiveness pursuant to Rule 430B under the Securities Act,
being referred to herein as the &#147;<U>Registration Statement</U>&#148;); (ii) the prospectus dated September&nbsp;21, 2020, included in the Registration Statement, relating to the offering from time to time of the Company&#146;s securities and
the related guarantees of the <FONT STYLE="white-space:nowrap">co-registrants</FONT> (the &#147;<U>Base Prospectus</U>&#148;); (iii) the preliminary prospectus supplement dated September&nbsp;30, 2020, relating to the Notes, in the form filed on
September&nbsp;30, 2020, with the Commission, pursuant to Rule 424(b) under the Securities Act (the &#147;<U>Preliminary Prospectus</U>&#148;); (iv) the document identified by the Company as a &#147;free writing prospectus&#148; (within the meaning
of Rule 433 and Rule 405 under the Securities Act) (the &#147;<U>FWP</U>&#148;) dated September 30, 2020, and filed with the Commission on September 30, 2020, pursuant to Rule 433(d) under the Securities Act; (v)&nbsp;the prospectus supplement dated
September 30, 2020, and filed with the Commission on October 1, 2020, pursuant to Rule 424(b) under the Securities Act (such prospectus supplement, together with the Base Prospectus, being referred to herein as the &#147;<U>Prospectus</U>&#148;);
(vi) the Underwriting Agreement; (vii)&nbsp;the Indenture; (viii)&nbsp;the form of the Notes, including the Guarantees therein, attached to the Supplemental Indenture; (ix)&nbsp;the global note executed by the Company pursuant to the Indenture, in
the aggregate principal amount of $400,000,000, representing the Notes purchased and sold pursuant to the Underwriting Agreement; (x)&nbsp;the articles of incorporation, articles of organization, certificate of organization or other constituent
documents, as applicable, and bylaws or operating agreements (or certificates of assumed name and the partnership agreements or similar documents) of each of the Guarantors listed on <U>Appendix</U><U></U><U>&nbsp;I</U> to this opinion (the
&#147;<U>Opinion Guarantors</U>&#148;); (xi)&nbsp;certain resolutions adopted by the board of directors, board of managers, members or partners, as applicable, and any resolutions authorizing the same, of each Opinion Guarantor, relating to the
Notes and Guarantees and certain related matters; (xii)&nbsp;originals, or copies certified or otherwise identified, of certificates of public officials (the &#147;<U>Public Certificates</U>&#148;) and of representatives of the Company and the
Opinion Guarantors and (xiii)&nbsp;statutes and such other documents as we have deemed necessary or appropriate for the basis of our opinions set forth herein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed the genuineness of all signatures, the legal capacity of each natural person
signing any document reviewed by us, the authority of each person signing in a representative capacity (other than with respect to the Opinion Guarantors) any document reviewed by us, the authenticity of all documents submitted to us as originals,
the conformity to authentic original documents of all copies submitted to us or filed with the Commission as conformed and certified or reproduced copies, and the absence of duress, fraud or mutual mistake of material facts on the part of the
parties to any agreement with respect to which an opinion is expressed herein. In conducting our examination of documents, we have also assumed that, to the extent such documents purport to constitute agreements, such documents constitute valid and
binding obligations of such parties and, except with respect to the Opinion Guarantors, (i)&nbsp;the power, corporate or other, of all parties thereto to enter into and perform all obligations thereunder, (ii)&nbsp;the due authorization by all
requisite action, corporate or other, thereof, and (iii)&nbsp;the due execution and delivery by such parties of such documents. As to any facts material to our opinion, we have made no independent investigation of such facts and have relied, to the
extent that we deem such reliance proper, upon certificates of public officials and officers or other representatives of the Company and Guarantors. We have further assumed that the Public Certificates have been properly given and are accurate as of
the date thereof and as of the date of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions set forth herein are limited in all respects to the Massachusetts
Business Corporation Act, the Massachusetts Limited Liability Company Act, the Mississippi Business Corporation Act, the Revised Mississippi Limited Liability Company Act, the South Carolina Business Corporation Act of 1988, the South Carolina
Uniform Limited Liability Company Act of 1996 and the Texas Business Organizations Code, and we do not express any opinion with respect to the federal laws of the United States or of any other jurisdiction, or any effect which such laws may have on
the opinions expressed herein. The opinions set forth below are limited to the laws, including the rules and regulations, as in effect on the date hereof, which laws are subject to change with possible retroactive effect, and the facts as they
currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such laws, rules or regulations or the interpretations thereof or such facts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the limitations, qualifications, exceptions and assumptions set forth herein, we are of the opinion
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors is validly existing under the laws of its respective jurisdiction of
incorporation or formation, as applicable. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors has the requisite corporate, limited liability company or partnership power, as
applicable, under the laws of its state of incorporation or formation, as applicable, to execute, deliver and perform its obligations under the Indenture, including the Guarantees of the Notes in accordance with the provisions of the Indenture.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The execution and delivery by each of the Opinion Guarantors of the Indenture and the performance of its
obligations thereunder, including the Guarantees of the Notes in accordance with the provisions of the Indenture, have been duly authorized by each of the Opinion Guarantors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Opinion Guarantors have each duly executed and delivered the Supplemental Indenture. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion rendered in paragraph (1)&nbsp;above with respect to the existence of the Opinion Guarantors under the laws of their respective
jurisdiction of incorporation or formation is based solely on our review of the Public Certificates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is being delivered in accordance with the requirements of Item 601(b)(5) of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> dated October&nbsp;5, 2020, which is incorporated by reference into the Registration Statement, and to the references to this firm under the caption &#147;Legal Matters&#148; in the Prospectus. In giving this
consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Bradley Arant Boult Cummings LLP</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Opinion Guarantors </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Excella
Associates, L.L.C., a Massachusetts limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Excella Healthcare, Inc., a Massachusetts corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Excella Home Health Agency, LLC, a Massachusetts limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Excella Homecare, Inc., a Massachusetts corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass
Health Rehabilitation Hospital of Western Massachusetts, LLC, a Massachusetts limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Home Health of the Gulf Coast, LLC, a
Mississippi limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Central Mississippi, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of North Mississippi, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Northeast Mississippi, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of South Alabama, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of Southwest Mississippi, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Hospice of the Gulf Coast, LLC , a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Camellia Medical Systems, Inc., a Mississippi corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Home
Health Care Systems, Inc., a Mississippi corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hospice Care of Mississippi, LLC, a Mississippi limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">West Mississippi Home Health Services, Inc., a Mississippi corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Rehabilitation Hospital of Florence, Inc., a South Carolina corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abba Home Health, L.P., a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AHM Action
Home Health, LP, a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Apex Hospice LLC, a Texas limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Best Home Care LP, a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dosik, Inc., a
Texas corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DRC Health Systems, L.P., a Texas limited partnership </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Home Health of Austin, LLC, a Texas limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Home Health of DFW, LLC, a Texas limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass of Fort Worth, LP, a Texas limited partnership </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass of West Texas, LP, a Texas limited partnership </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hallmark Homecare, L.P., a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare
Innovations of Oklahoma, L.L.C., a Texas limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare Innovations of Western Oklahoma, L.L.C., a Texas limited liability company
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare Innovations &#150; Travertine Health Services, L.L.C., a Texas limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preferred Home Health, L.P., a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Texas
Senior Care, L.P., a Texas limited partnership </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TH of San Antonio LLC, a Texas limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wellmark Healthcare Services of El Paso, Inc., a Texas corporation </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.3
<SEQUENCE>6
<FILENAME>d12659dex53.htm
<DESCRIPTION>EX-5.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Hawley Troxell Ennis&nbsp;&amp; Hawley LLP] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">October&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as
special counsel to each of the Opinion Guarantors (as defined below), each Opinion Guarantor being a direct or indirect subsidiary of Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the
Opinion Guarantors&#146; guarantee, along with the other Guarantors (as defined below), of the $400,000,000 aggregate principal amount of the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Notes</U>&#148;). The Notes are being issued
under an Indenture (the &#147;<U>Base Indenture</U>&#148;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#147;<U>Trustee</U>&#148;), dated as of December&nbsp;1, 2009, as amended and supplemented by the Tenth
Supplemental Indenture thereto (the &#147;<U>Tenth Supplemental Indenture</U>&#148;), dated as of October&nbsp;5, 2020, among the Company, the guarantors named therein (the &#147;<U>Guarantors</U>&#148;) and the Trustee relating to the Notes. The
Base Indenture, as amended and supplemented by the Tenth Supplemental Indenture is referenced herein as the &#147;<U>Indenture</U>.&#148; The Notes are being guaranteed by the Guarantors pursuant to the guarantees included in the Indenture (the
&#147;<U>Guarantees</U>&#148;), and are being sold pursuant to an Underwriting Agreement dated as of September&nbsp;30, 2020 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, Truist Securities, Inc. as
representative of the Underwriters and the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined originals or copies, certified
or otherwise identified to our satisfaction, of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-248942)</FONT> filed by the Company and the <FONT STYLE="white-space:nowrap">co-registrants</FONT> named therein with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the
Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), on September&nbsp;21, 2020 (the &#147;<U>Registration Statement</U>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the prospectus dated September&nbsp;21, 2020, included in the Registration Statement, relating to the offering
from time to time of the Company&#146;s securities and the related guarantees of the <FONT STYLE="white-space:nowrap">co-registrants</FONT> (the &#147;<U>Base Prospectus</U>&#148;); </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the preliminary prospectus supplement dated September&nbsp;30, 2020, relating to the offering of the Notes, in
the form filed on September&nbsp;30, 2020, with the Commission, pursuant to Rule 424(b)(5) under the Securities Act (the &#147;<U>Preliminary Prospectus</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the pricing term sheet, dated September&nbsp;30, 2020, relating to the offering of the Notes, filed with the
Commission as a free writing prospectus on September&nbsp;30, 2020 pursuant to Rule 433(d) under the Act (together with the Preliminary Prospectus, the &#147;<U>General Disclosure Package</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the final prospectus, consisting of the Base Prospectus, as supplemented by a final prospectus supplement,
dated September&nbsp;30, 2020, related to the offering of the Notes, filed with the Commission on October&nbsp;1, 2020 pursuant to Rule 424(b) under the Act (the &#147;<U>Prospectus</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Indenture, including the Guarantees contained therein; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the global note executed by the Company pursuant to the Indenture, in the aggregate principal amount of
$400,000,000, representing the Notes purchased and sold pursuant to the Underwriting Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the articles of incorporation, articles of organization, certificate of organization or other constituent
documents, as applicable, and bylaws or operating agreements (or certificates of assumed name and the partnership agreements or similar documents) of each of the Guarantors listed on <U>Appendix I</U> to this opinion (the &#147;<U>Opinion
Guarantors</U>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">certain resolutions adopted by the board of directors, board of managers or partners, as applicable, and any
resolutions authorizing the same, of each Opinion Guarantor, relating to the Notes and Guarantees and certain related matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">originals, or copies certified or otherwise identified, of certificates of public officials (the
&#147;<U>Public Certificates</U>&#148;) and of representatives of the Company and the Opinion Guarantors; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(xii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">statutes and such other documents as we have deemed necessary or appropriate for the basis of our opinions set
forth herein. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed the genuineness of all signatures, the legal capacity of each natural person
signing any document reviewed by us, the authority of each person signing in a representative capacity (other than with respect to the Opinion Guarantors) any document reviewed by us, the authenticity of all documents submitted to us as originals,
the conformity to authentic original documents of all copies submitted to us or filed with the Commission as conformed and certified or reproduced copies, and the absence of duress, fraud or mutual mistake of material facts on the part of the
parties to any agreement with respect to which an opinion is expressed herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In conducting our examination of documents, we have also
assumed that, to the extent such documents purport to constitute agreements, such documents constitute valid and binding obligations of such parties and, except with respect to the Opinion Guarantors, </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the power, corporate or other, of all parties thereto to enter into and perform all obligations thereunder,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due authorization by all requisite action, corporate or other, thereof, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the due execution and delivery by such parties of such documents. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As to any facts material to our opinion, we have made no independent investigation of such facts and have relied, to the extent that we deem
such reliance proper, upon certificates of public officials and officers or other representatives of the Company and Guarantors. We have further assumed that the Public Certificates have been properly given and are accurate as of the date thereof
and as of the date of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions set forth herein are limited in all respects to the Idaho Uniform Limited Liability
Company Act and Idaho Business Corporation Act, and we do not express any opinion with respect to the federal laws of the United States or of any other jurisdiction, or any effect which such laws may have on the opinions expressed herein. The
opinions set forth below are limited to the laws, including the rules and regulations, as in effect on the date hereof, which laws are subject to change with possible retroactive effect, and the facts as they currently exist. We assume no obligation
to revise or supplement this opinion in the event of future changes in such laws, rules or regulations or the interpretations thereof or such facts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the limitations, qualifications, exceptions and assumptions set forth herein, we are of the opinion
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors is validly existing under the laws of the state of Idaho. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October 5, 2020 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the Opinion Guarantors has the requisite corporate, limited liability company or partnership power, as
applicable, under the laws of the state of Idaho, to perform its obligations under the Indenture, including the Guarantees of the Notes in accordance with the provisions of the Indenture. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The performance by each of the Opinion Guarantors of its obligations under the Indenture, including the
Guarantees of the Notes in accordance with the provisions of the Indenture, have been duly authorized by each of the Opinion Guarantors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reserved. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion rendered in paragraph (1)&nbsp;above with respect to the existence of the Opinion Guarantors under the laws of the state of Idaho
is based solely on our review of the Public Certificates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is being delivered in accordance with the requirements of Item
601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> dated October&nbsp;5, 2020, which is incorporated by reference into the Registration Statement, and to the references to this firm under the caption &#147;Legal Matters&#148; in the Prospectus. In giving this
consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission promulgated&nbsp;thereunder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/S/ HAWLEY TROXELL ENNIS&nbsp;&amp; HAWLEY LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Appendix I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Opinion Guarantors </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Home
Health of the West, LLC, an Idaho limited liability company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Hospice of the West, LLC, an Idaho limited liability company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardian Home Care, Inc., an Idaho corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Idaho Homecare
Holdings, Inc., an Idaho corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orion Homecare, LLC, an Idaho limited liability company </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.4
<SEQUENCE>7
<FILENAME>d12659dex54.htm
<DESCRIPTION>EX-5.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Letterhead of Snell&nbsp;&amp; Wilmer L.L.P.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">October&nbsp;5, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Encompass Health
Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9001 Liberty Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35242
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have acted as
special counsel to WellCare, Inc., a New Mexico corporation (&#147;<U>WellCare</U>&#148;) and a subsidiary of Encompass Health Corporation, a Delaware corporation (the &#147;<U>Company</U>&#148;), in connection with the guarantee by WellCare and the
other Guarantors (as defined below) of the $400,000,000 aggregate principal amount of the Company&#146;s 4.625% Senior Notes due 2031 (the &#147;<U>Notes</U>&#148;). The Notes are being issued under an Indenture (the &#147;<U>Base
Indenture</U>&#148;) between the Company and Wells Fargo Bank, National Association, as trustee (the &#147;<U>Trustee</U>&#148;), dated as of December&nbsp;1, 2009, as amended and supplemented by the Tenth Supplemental Indenture thereto (the
&#147;<U>Supplemental Indenture</U>&#148;), dated as of October&nbsp;5, 2020 relating to the Notes, among the Company, the guarantors named therein (the &#147;<U>Guarantors</U>&#148;) and the Trustee. The Base Indenture, as amended and supplemented
by the Supplemental Indenture, is referenced herein as the &#147;<U>Indenture</U>.&#148; The Notes are being guaranteed by the Guarantors pursuant to the guarantees included in the Indenture (the &#147;<U>Guarantees</U>&#148;), and are being sold
pursuant to an Underwriting Agreement dated as of September&nbsp;30, 2020 (the &#147;<U>Underwriting Agreement</U>&#148;), among the Company, the Guarantors, and Truist Securities, Inc. as representative of the underwriters listed on Schedule 1 to
the Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This opinion is being delivered in accordance with the requirements of Item 601(b)(5) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> under the Securities Act of 1933, as amended (the &#147;<U>Securities Act</U>&#148;). This opinion is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters
expressly stated. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Documents Examined </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (Registration <FONT
STYLE="white-space:nowrap">No.&nbsp;333-248942)</FONT> filed by the Company and the <FONT STYLE="white-space:nowrap">co-registrants</FONT> named therein with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) under the
Securities Act on September&nbsp;21, 2020 (such registration statement, including the form of prospectus included therein and the documents incorporated by reference therein at the time of effectiveness pursuant to Rule 430B under the Securities
Act, being referred to herein as the &#147;<U>Registration Statement</U>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the prospectus dated September&nbsp;21, 2020, included in the Registration Statement, relating to the offering
from time to time of the Company&#146;s securities and the related guarantees of the <FONT STYLE="white-space:nowrap">co-registrants</FONT> (the &#147;<U>Base Prospectus</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the preliminary prospectus supplement dated September&nbsp;30, 2020, relating to the Notes, in the form filed
on September&nbsp;30, 2020, with the Commission, pursuant to Rule 424(b)(5) under the Securities Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the prospectus supplement dated September&nbsp;30, 2020, relating to the Notes, in the form filed on
October&nbsp;1, 2020, with the SEC, pursuant to Rule 424(b)(5) under the Securities Act (such prospectus supplement, together with the Base Prospectus, being referred to herein as the &#147;<U>Prospectus</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Indenture; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the form of the Notes, including the Guarantees therein, attached to the Supplemental Indenture;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the global note executed by the Company pursuant to the Indenture, in the aggregate principal amount of
$400,000,000, representing the Notes purchased and sold pursuant to the Underwriting Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Articles of Incorporation and Amended and Restated Bylaws of WellCare (collectively, the &#147;<U>Governing
Documents</U>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the certificate of good standing for WellCare dated September&nbsp;18, 2020 (the &#147;<U>Certificate of Good
Standing</U>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Action by Written Consent of the Sole Shareholder of WellCare dated January&nbsp;1, 2020 relating to
WellCare&#146;s authority to guarantee indebtedness of an unlimited amount, on a secured or unsecured basis, of any one or more of its direct or indirect owners; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Action by Written Consent of the Board of Directors of WellCare dated January&nbsp;1, 2020 relating to
WellCare&#146;s authority to guarantee indebtedness of an unlimited amount, on a secured or unsecured basis, of any one or more of its direct or indirect owners (the &#147;<U>Consent</U>&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Officers&#146; Certificate of WellCare attached hereto as <U>Exhibit A</U> (the &#147;<U>Officers&#146;
Certificate</U>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">statutes and such other documents as we have deemed necessary or appropriate for the basis of our opinions set
forth herein. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have also examined certificates of public officials, corporate documents, records, and other
certificates and instruments, and such matters of law, and have made such other investigations, as we have deemed necessary or appropriate to enable us to render the opinions herein expressed. Without limiting the foregoing, as to various questions
of fact material to our opinions, we have relied upon the statements and representations of the parties set forth in the Officers&#146; Certificate and the other transaction documents identified above, all without independent verification. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Opinions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing and the further qualifications and limitations set forth below, and as a result of our consideration of
such questions of law as we deem relevant, we are of the opinion, as of the date hereof, that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">WellCare is a validly existing corporation in good standing under the laws of the State of New Mexico.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">WellCare has all requisite corporate power and authority to execute and deliver the Supplemental Indenture and
perform its obligations under the Indenture, including the Guarantees of the Notes in accordance with the provisions of the Indenture. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">WellCare has duly authorized the execution, and delivery of the Supplemental Indenture and the performance of
its obligations under the Indenture, including the Guarantees of the Notes in accordance with the provisions of the Indenture. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assumptions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In rendering the foregoing opinions, we have made the following assumptions. We have made these assumptions without independent verification,
and with the understanding that we are under no duty to inquire about or perform any investigation regarding such matters. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The genuineness of all signatures not witnessed. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The authenticity of original documents and the conformity to the originals of all documents submitted as
copies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each natural person executing any of the documents reviewed by us possesses the legal competency and capacity
necessary for such individual to execute such documents and to carry out such individual&#146;s obligations thereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To the extent any of the documents reviewed by us purport to constitute agreements, such documents constitute
valid and binding obligations of such parties and, except with respect to WellCare, (i)&nbsp;the power, corporate or other, of all parties thereto to enter into and perform all obligations thereunder, (ii)&nbsp;the due authorization by all requisite
action, corporate or other, thereof, and (iii)&nbsp;the due execution and delivery by such parties of such documents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That the factual matters, and the representations and warranties as to factual matters contained in the
documents, records, certificates, and other documents we have reviewed and obtained are true, correct, and complete in all respects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">That no fraud or dishonesty exists with respect to any matters relevant to our opinions. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>D.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Qualifications </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The opinions set forth above are subject to the following qualifications and limitations: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The opinion expressed in paragraph B.1 above as to the valid existence and good standing of WellCare is based
solely upon our review of the Certificate of Good Standing, and our opinion with respect to such matters is rendered as of the date of such certificate and limited accordingly. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The opinions expressed in paragraphs B.2 and B.3 above are based solely on our review of the Governing
Documents and the Consent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We express no opinion on federal securities laws and regulations or state &#147;Blue Sky&#148; laws and
regulations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We render no opinion herein as to matters involving the laws of any jurisdiction other than the State of New
Mexico. We express no opinion on the law of any other jurisdiction or principles regarding conflicts of law or choice of law, and we assume no responsibility for the applicability or effect of any such laws or principles. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We express no opinion on (i)&nbsp;federal and state antitrust and unfair competition laws and regulations;
(ii)&nbsp;compliance with fiduciary duty requirements; (iii)&nbsp;the statutes, codes, and ordinances, the judicial and administrative decisions, and the rules and regulations of counties, towns, municipalities, and political subdivisions to the
extent they deal with any of the foregoing; and (iv)&nbsp;federal and state environmental, land use, subdivision, tax, intellectual property, racketeering, banking, antifraud, anti-terrorism, embargoed persons, anti-money laundering, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">truth-in-lending,</FONT></FONT> equal credit opportunity, consumer protection, health and safety, ERISA, and labor and employment laws and regulations. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This opinion letter is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.
Without limiting the foregoing, the opinions expressed in this letter are based upon the law and facts as we understand them in effect on the date hereof, and we assume no obligation to revise or supplement this opinion should such law be changed by
legislative action, judicial decision, or otherwise, or should any facts or other matters upon which we have relied be changed. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as an exhibit to the
Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> dated October&nbsp;5, 2020, which is incorporated by reference into the Registration Statement, and to the references to this firm under the caption &#147;Legal
Matters&#148; in the Prospectus. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission
promulgated thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Snell&nbsp;&amp; Wilmer L.L.P.</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ehc-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/5/2020 9:22:11 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:ehc="http://www.encompasshealth.com/20200930"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.encompasshealth.com/20200930"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehc-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ehc-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/5/2020 9:22:11 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ehc-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/5/2020 9:22:11 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ehc-20200930.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d12659d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehc-20200930.xsd" xlink:type="simple"/>
    <context id="duration_2020-09-30_to_2020-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000785161</identifier>
        </entity>
        <period>
            <startDate>2020-09-30</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-09-30_to_2020-09-30"
      id="Hidden_dei_EntityRegistrantName">Encompass Health Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-09-30_to_2020-09-30">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-09-30_to_2020-09-30"
      id="Hidden_dei_EntityCentralIndexKey">0000785161</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-09-30_to_2020-09-30">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-09-30_to_2020-09-30">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-09-30_to_2020-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-09-30_to_2020-09-30">001-10315</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-09-30_to_2020-09-30">63-0860407</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-09-30_to_2020-09-30">9001 Liberty Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-09-30_to_2020-09-30">Birmingham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-09-30_to_2020-09-30">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-09-30_to_2020-09-30">35242</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-09-30_to_2020-09-30">(205)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-09-30_to_2020-09-30">967-7116</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-09-30_to_2020-09-30">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-09-30_to_2020-09-30">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-09-30_to_2020-09-30">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-09-30_to_2020-09-30">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-09-30_to_2020-09-30">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-09-30_to_2020-09-30">EHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-09-30_to_2020-09-30">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-09-30_to_2020-09-30">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140456111154248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Encompass Health Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000785161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">63-0860407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9001 Liberty Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Birmingham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">35242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">967-7116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  %K15$'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  !:T51Q-9L9^T    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VG50^CFHGA2$%Q0O(5D=C?8-"$9:??M3>MN%]$'\)B9/]]\
M ].9*$U(^)Q"Q$0.\]7D^R%+$S?L0!0E0#8']#K7)3&4YBXDKZD\TQZB-A]Z
MC]!P?@L>25M-&F9@%5<B4YTUTB34%-();\V*CY^I7V#6 /;H<: ,HA; U#PQ
M'J>^@PM@AA$FG[\+:%?B4OT3NW2 G9)3=FMJ',=Z;)=<V4' V]/CR[)NY89,
M>C!8?F4GZ1AQP\Z37]N[^^T#4PUO>"5XQ6^VHI7-M>3B?7;]X7<1]L&ZG?O'
MQF=!U<&ONU!?4$L#!!0    (  %K15&97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MK?8GUOV-D5EQ2EQ* V?.XC*"4SY7M@%\OY+2'&_LP;/\W6#T+U!+ P04
M"  !:T51@ZFE ]0!   R!@  #0   'AL+W-T>6QE<RYX;6S55=N*U$ 0_96F
M/\">1'9!20(J+ @J"SL/OG:22M+0-SN5,=FOMSN=V[@,J ^B+Y,ZIZI/G;Y.
MUN,DX:D#0#(JJ?N<=HCV+6-]U8'B_2MC0?M,8YSBZ*%K66\=\+H/@Y1DZ>ET
MSQ07FA:9'M2#PIY49M"8TQ-E1=88O3.O:21\*5= +ESF] .7HG1BKN5*R"G2
M:2 J(XTCZ*U 3I/ ],\QG4047"XZ2FCC LEBA_A;+N4_)5;4>RBDW RF-!)%
M9CDB./W@P5P\DR]29(G/D_4.6\>G)+VC^X#YXYN4QM7@MC8)7:DBD] $.TZT
M7?BBL2PD$8WR02UX:S2?/:PCEL#+5B#E4]C"K\V5]MB0N!<?Z[ -)$QU#;VA
M)8PR$03]HUK4/LC>_9$LL>)B\/W@9Z-G_&TP"(\.&C'.>&RV_K?4D]OJW%HY
MO9.BU0KBW'^Y89'Q=1SIC!//OELX*94GP%%R 8>B.C+?';=G&'$]36-SVW/Z
M'WK^N^O<@@;'Y=&T/_K_\BK_CF.VW)[#%;VZH!M+PD.8TR_A?96[!U(.0J+0
M"^I$78-^<4^]//+2/^!7^KZ^AH8/$L];,J=[_!EJ,:@W6]5C6)>E:H\_A?<H
MN9\;[O\2Q0]02P,$%     @  6M%49>*NQS     $P(   L   !?<F5L<R\N
M<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9
M>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:
M+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU
M1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*
MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  !:T51'#AEZC\!   \ @  #P
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M=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @  6M%420>FZ*M    ^ $
M !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50
MJ4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*
M9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI
M?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI
M5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    (  %K15%ED'F2&0$
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M;W!S+V%P<"YX;6Q02P$"% ,4    "  !:T51Q-9L9^T    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  !:T51
MF5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    (  %K15$:"" U,00  $,0   8              "
M@0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  !:T51
M@ZFE ]0!   R!@  #0              @ %S#   >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    (  %K15&7BKL<P    !,"   +              "  7(.  !?
M<F5L<R\N<F5L<U!+ 0(4 Q0    (  %K15$<.&7J/P$  #P"   /
M      "  5L/  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  !:T51)!Z;
MHJT   #X 0  &@              @ ''$   >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  !:T5199!YDAD!  #/ P  $P
M    @ &L$0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #V
%$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d12659d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d12659d8k.htm">d12659d8k.htm</File>
    <File>d12659dex11.htm</File>
    <File>d12659dex42.htm</File>
    <File>d12659dex51.htm</File>
    <File>d12659dex52.htm</File>
    <File>d12659dex53.htm</File>
    <File>d12659dex54.htm</File>
    <File>ehc-20200930.xsd</File>
    <File>ehc-20200930_lab.xml</File>
    <File>ehc-20200930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d12659d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d12659d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehc-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehc-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehc-20200930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehc",
   "nsuri": "http://www.encompasshealth.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d12659d8k.htm",
      "contextRef": "duration_2020-09-30_to_2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d12659d8k.htm",
      "contextRef": "duration_2020-09-30_to_2020-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.encompasshealth.com//20200930/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-20-263689-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-263689-xbrl.zip
M4$L#!!0    (  %K15%\_)85T1\  'W$   -    9#$R-C4Y9#AK+FAT;>T]
M:7/C-I;?IVK^ \I)INPJW9(ON=M;;K6[XQFW[;6=27:_I" 2DCA-D0Q 6M;^
M^GWO > A49?;5R=.5=J22 (/[[X OONO^['/[H147AB\WVK6&EM,!$[H>L'P
M_582#ZH'6^R_CO_^MW>C&&Z$FP/5=87W?FL4QU&W7K_O2[^FA%,;AG=UN%!O
M-9J'U4:SVFYNF=L358VGD5#I,P.N^K50#NOV2LE#01@$R3A]9#*9U&@J?,R-
M91V?J\--5;A+2,^QS]W[7O"U\-BD30\U#P\/ZW35WCIW9SI!J]%HU_%RGRMA
M;Q<CIW WHFD<<:5&@OOQJ ;?X$%X]+#=2*%17ADL<%.S_MN7\QMG),:\Z@4J
MYH&3SI3$<B%<AW6X:F_T5-AI-?>7+,+<D3YPO^C>)MP;P)+%;Q^NS[/;X_+[
MLUOKL>2!&H1RS&-@(1QIM]IH55M[N4&JP""%@2S#K!KG(,<1RG/*N0XNX.W-
M(@/A+=XRS,P@':^Z,WQM;MZKZXOFUL7<A3*R1<(BN(M_8R_VQ?%!]5_OZOHC
M_#86,6<X0E7\D7AW[[=Z81"+(*[> DMO,4=_>[\5B_NX3B.R.CY7-X,RQM[U
M0W>*']^YWAU3\=07[[=<3T4^GZ+DB*UC]LZ[[^(30IK/GNN*0'^&6RZTV##/
M?;_U,UWZ':3W]], X)Q>BZ&GD"#Q!1\#3 '\"Q,(KUM^G6"^CZ_% .Y*)%'P
M=Y2%:N.PVF[\'H>Y;UO'IU9RV,\D.JP7RNA=O0#8'* 9#"=C$;CP?_S)Y\.-
M)Q]P7XE5DY5BI0=32NZ?!:ZX_Y>8SJ-E[H8-06O ?_L'N\V]YCQ\]1D22C$0
M$E204/ =5557D3*!N1AIN2YJR/=;RAM'/C(Y_3:2" IHLJK55+5[Y=JK7#HR
M1%9:6R<^@;8]?E<O+L<LOK!@^J["1.JO).M=@VTBWAK8MH\)HEWZU7/QAX$G
M)",01*GBZIW]JTBOV8<1ZM+Q(R!HZ*9?00G)^"./Q7$&FWTRNY;!ZBZXUUY)
MITWGJ1>PDV(SPUX]KRGJH%&."WH%GZIRWQL&70?6(N16\?K$<^-1]Z"VZP5'
MN7M],8B/QEP.O:"*G[N,)W%H?Y'><&1^PN$B.QB:@^I(T%5P1J)TB#B,NKFO
M_3".PS']T@\E@&Y_:4;W3(6^Y[(?&O3?UO$_?FCN-8[>U:-%$[573]1Z\$2Y
M83LP")M? !L ::K*^S_1;1ZDWP=\[/G3[JTW%HI=B F[#L<\.*)K$PUW/_3=
MHQ+R_')Q=GOZD=W<GMR>WBP&I_%,X-R<]GZY/KL].[UA)Q<?V>EOO9]/+CZ?
MLM[EER]G-S=GEQ??!&/K,6#\E:L1N+QQ&%38QQYK-78[AS-0S4RYBB^+[+!*
MGDKY<N]!?%EKP&U%UCS2,MIJ_C2_]C5E-%N,51%EY-+$> :>^G1Y_86]4Q$/
M4C4T\F)1A5\< 99S(GD$IF21"_$Q=!+T('(NU_IFFMRYHGU^5T=0CM\XYDDX
MYE$D''30]>G%+;L^O;J\OGUYC7.52)6 !\WBD-T(!WE.8ZS99J%DS=UM=^?E
MH0P'+!X)!#"17NS!\Z?WSH@'0\%.G)C!Y>9AN[,8SF<C+SH_",ZUB$(9LVW[
M77!P?H2*F;B#.YFDR\+=Z2Z.+ZQRN"(/ZE0[5IMJ":9#V?=;$/YV71A@#(^/
M7#Z= D0B *LH(OBQ+Z2F>KM18?CXO&9Y4RF/KU):G<?@N:(!8ICEJ'KW51VF
M=5=%U>5A<*@9RQ@4]DT:H/$8B]P^O><@Z0BREB^[",854Y%P,-QQF1>PW@C"
M%2%GM=8;RSZ.%7P4:BY4>II%SX E4QZ\B4%M]<(DB.6T%[K?I )1-C">C44D
MPSN<%G7@1^'S":C#%4IO(ZY_%/=RF]:.=O@2S)]D_P3KIUR/K#1*00%/C\GP
MF#/D?5\P1_@^.K.4AP=<XO>(NZ[];N8R/.R$OL\C);KVPW(4S+*59O-FH_&3
M$8INP\#9;=@8'2&3^H];#/UW&S]AUB9V9Z[>"1E[#O<-;O6*[5SEC^B+G0-[
M%?XQ<TI[2\2'HMJ7@G_%O+GGBBZ_"T%D-UKQULR\+,<#K"#?79)L-K,6("9
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M==Q-L 1/>&8V]AL.*8MC'O#IZ "5Z]*;J]F4U?@LD.2S8"'H/M*;'TB7EB[
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M<0\PWA-@RQU6S2V\Y=/YWA^)!X--Z3QC('KB<XE'OIC3"U)HB*QXIE/50<P
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M]^''KUIV-SE?/17916>HY[=B;:\\W 9"6Z/.6:>VCR?9E)]?>$+'2&]<.'E
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M:7/;R-4V_%U5^@^HR9.45 5KM-@>;W&5+,NV$ME629J9Y'WJ^0"230DC$&
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MWN=/3@!@COP8!]MJ/CU82J'DR"C.<)7!M4W%_L4T<^@4[N'S,8V&=<!]#&_
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MEB'(I/]E$JO>..17T'D%+J>?1/&("B9'T14[\+#2GDPHE<VD !KO9.C-V*K
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M*0U!V^-?>JVKIV=24IX*=7)T ,630F^F8"TB:XBK6Z4G$NAI8?/L'-F7-K5
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M117]R$Z=O<Z*TO3H\)[PWXQ#[9)![J-&90$+0.6,)X/YBBCG;'1(@P[QN[-
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MT0Q/4_4E. S<Y/@R"/=C$_I[ZT<'G+/'):)\E]X!0E4WF]XU<XTZ@>&\']D
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MP\ER28ZZ=T7^57 QZ2T[H0J;31/@M!OL4RR6G%R4S/?P8)>!S.7>T']DJ2K
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MBD&T&K&OBVN5]*92 [H2!$^NHCPX71&U<#%)\[A8"4Y8 E"G^Y"+71DST3;
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ME#]1VG4%:'WB0R#?!&$X&AD :D)4$&-5N>:HA5H  (\ N";4A-@@,#6+0F!
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MB9%H/ 9+OR"-/B > 6-X5E2&K,5@*!X&D=?U8)B3XX'6* Z$I7;C(=8E5R&
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M2]O:JSFM :@9ZZPW/ <K]_62/H2_+WQ/E6Y"E</R*HKZ^Q_/4>9;5[W/ZRG
M#;)&QM$?EOF1 =B"V, ]:<<Z!E9DH!"1@C>3!H!8 .KM3L3#(H!)\2,$S@.7
M_Z.<%PK2-\O-&4'V=F5W<G_T._G.?>( )_@(8_W0>J^6^)OQ/?0.HO?O?G=
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M!O>_IM/ $__-:/_[=]H?M?^=^M_$_)]=YF#\C!<-[($[?^#N!%CK!'CP-9T
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M6>  T=]Y!O9%QJ\$"V;,!V,ZVI>,*(QV 9?*0/%6;J_O[JBGPH#&^02DN]V
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M-^QF^G6'99%Y1#3><%Q0FP+5HPTHNN$TTZ"B\Y=[;7G>(SX2$_6WPCN*:,"
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M<=VWN%93MZQ8N!XY>E;]VU*9W$+P)ZPWY$;V!O-,-;2MQ9CPVXX-M-0:Q7+
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M!=?7FHW8)\UA/X2H_)J\F)VC \=Q0G5['SH$HM]D5Z:DG]Z\!_\:"6)EY4'
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M&-'.#I+J4&P=)#RI"2#&H4E1X,8NP"\I"V_\I1+[&9>9Q4JK1K)V!)%3\;S
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M9=_N\$&H'67;&?E19L4L5$U&(RDIL#!B>M1:J:*Y(>RQNTAH 3&2?DLEMUT
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M_*),[&\HR,(_,<SC%&M+';]?Y5]A^\E,%M*6#B942I^*EG-31!,Z<:TOL1_
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MCRFE3V&:(?>Y(90F[T4@25=U,VE%9G2&R!P")45 ,)92"Y$URR"?\@(L$//
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M Y$VVYALZ>GVZ-,$W;51!Z>ALNI(6'H-W&]AVYWGH.GRD,QI&_(C2\/TT9#
M8$3 ^\$ZRR132 KT)FM&K72SB>G7A)$]T*[7ZUH;GR13+<Z=)*O__-3=JL/'
MG_[Q].GQZ>FK-W#VO/K]]='+?WZH5-T\!60"38]6Y*7_0K"F49"_@SKZ'3L
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M=EJ$O\;]7MPPKH\4<905VT^>L7-\'2Y=JM>#D=+U>&$+/;7(%PS\5[_/= D
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M4+75I2MB2PIS2U7T9+ND>W"DJJ(2'HJ&U%]><;)7-V0 X\E[M_-F42UU+Z.
M_=\'U%)+P&@T4FX5,1H(@]?PPD0@:/:R).7::^/K:)";8#$6B":"P$2Z?H:1
M+1-5TYV%'DCAH!X.!$]4)K%N7VE222>S'"T'?61F8W>C=&9B-Q<J9>"LS(S@
M/RV0>%6NB8QJ)30$:L"8,U-B$LF1!*4K)W1_W-CB E7/$U2L:U.G$(6K"."M
M5APKC<PIX5ML?6M\UR(TIR*-54'HCIE>!RVC_*;>-@RI7M4N/PS30!U1P0\&
M%U@X(M5:R.2[:2 Y_-O>**3:8=3=<*S"+ IP+0P'&]4GVOVOBP$7DQFD?M=.
MOL17_$54W&M3Q FP$[GUHZ% &V3DWGP#+]!$F+N7?7A^ 54L]5P M ()6VX#
MN<PPN^HH3.2L LW2-/ZN;?-4".0PU79\J^8<<9N!2K]>+"+]#A#1O6U/FP8H
ML:^UR%:$FJ@Z,*;;GN;NOK*2H,-^O0,>U#D6TZIW[J%5\<C;C,16W-099"&Z
M*/00I;%2!4+U8&6_[CI,7P7HJ.*1Z>2HR!;T#@'J30ZX@JS$S(7[;&VO"/5]
M,^2A5+%JIS8'$>>3,:FASJS1-:7C4J4^8+?FT1^-%MP\]9[W FHW4L6Y0&W+
M29 61/F#%'HN;C#4%WK>'3%NF5*-=N&(BG(<J+EJ&H5H)NMTS!^SQF?FI0_(
M8U?;@EFLM3-=;ER[(YQ*=+MA6FP5,M3-K3(*Q8=5:/&%*(:J4B:(@8 E6K8%
MUJPXJP*)-<++B2X5BW#"'4J'8 "T'Q8-6A82RYL79+;N]CR8DA-$UTU35?0\
M"_;SO1>L4[M@;U[^5?O]3I3A.)R@W""%:-#O9Q@['DPS5=K U6[>EM6@"6\6
M[,8PI3;6\HEMSBDSE%S!]OXQC6_Y[;N^M_?RY5MMA3Q$X,%M656W\5M(W!!A
M]_) M6BIF[[A#:2F@?T(-#8X>=/<PWBA?HG\31!1\33G'A#W4QKWW_H/M5NO
M1N^>&9SX/F)-3U5<@BIGK\O(%8T6L%'42-^BHX<NA-H.P1U$^7]T?H7^O.W
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M]F!PS2Y]^=6:M4\WP+)4C2I&I&=P_4;QK5Q:\<ORT8/U]E,QV*-SK=@0$OD
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MQ@LJ)-=F1X;!RJL&;KEF,RU)\]A@8,,8RSII6&6KN\+!J7)3>,G-W"Q[J3@
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M9=#J7.M=JFN..D!*&$:=5*28&Y:"#(A:9A-E-;5;?1@[LKZX4]1D^:KL!M>
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M5[+JB/*=?03.RA:KI<MA.]N^A2<@W$4!@ LF(%)XI8X+5$ ?:BLH7X:%5X^
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M07L60B/LG,;!C6&IF8@>P)WZ(\V^ZU2>-!Q3?#>I[7%*6#-FR"@"PN O#,5
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M>#.CULM ^PL8J6Y=E;Y2"M-$TW1IL*)-&'VIG^RW6\@E,)$/Y1@EP*^0^>L
M99(*2KH!5>F"%&.P7\&R@AS]O!QA X:F#!G-Z:]C&-MD&L1WI-+1]+Z5?<C(
M(M+]&\CF)R5GDTX;"Y^UB>E(A4EYBE<WE,/:M*(-AA"IJ6C& H09YC"T&10E
MMC$#?G=?4>.R+:+'>>_AM5M;BAE9HZ6LKJR@=\@#[8,!R)XJ2 >&YMG4$6O0
M%M!!D2U%]\JI%U75BTL:N&MSK/JA@@<13)!*/"3AC2!#;J[26)4!89+(+Y8I
MHA;5K\S)-2?& ;Y^J@;(ZZ8P^Y4?(3I#YMGQ>BEV5;5R +I6KQ1Q80HDF$@N
M,DDS4>)_:\W[_D0L#YDPJ-],\NB($1!75JCC4]^T1/-=G@<Z"-@^-B]31]N^
MLBY-*HH#GUPP .3-)NJJ'CND:$XBKVV2Q-(CQ'2P^)P+QUM\\^JQL<56.*2U
MQ"I6ZSL[-*D2OGR9._TDK78M5GQ"AJ1T,WI&(.79Q"JNAX^H_:!@F$ QW (G
MK*48W&KF(6=G;"0]Q\=LK&H=3<!VE58JHE#EX>U6D37;UMB_6LTK9QPAR=W"
M-UY9WP#Q[*NJ7PY"^&XD>Y0.[!J0N:(VLV=5I *'4;TV&XI!4P$0\ MSE690
M)"?UVSQLE$3]>AHF>&2:ZGL1.=(--IKDQ,SR4DNVK$[UV'XEC:RYKT-NKAWD
M;FBIV'3HK5\!.6&&VZMH;-R)"C&\-PG?PIJT5N-8-Y%U^=5U([*J#051A4Z
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MGL8@P(/4.T>6T'5<^C2>CGK1:EQ0BPT\P7S)VHW[($4\XMH-^R/(.99BK=W
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M=6]WQSLJS,BRR6\B&$K0[V<@UD-8"/K[*(7/9B$>!&^ DX*5N;F*X'5Z;:[
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M*,4%^6("%P*;<:5[BY@"[9%^=.@&%%UT.8C,B!6X1!2X@ /&1D=U0Z8!HD]
M[E)H 1K7@UNSF%^B Z?.B]9-"-WIZ/V[Y:@MKFU@I1-V&>'4!"DU?0K,044A
M<\ESRX^'5E^=YI*4SZO$(&*SQ&T*2T,927A4>=.4TS)ZI @5%@]@4A!:R#$
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M>7Q1M,@7206]LS%'*NB9W,\[]^9^]JF?S=?;^OL\(_!"N2]G[^I-_.H.<?'
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M#&_08-@[OSPXO*2/[:S,)QM@99SL7EP=?G _/"@<=4FR1@1.Z7+'_G P8ZJ
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MNAJ:;N'?7A/-B P2,X;J;^]=[AS[-6?V"XU?G'M).S/]1G:<IV)K/T+E1E1
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M\M(62#1/;Y.056P1("(66D:W6:_0@P!+2V#YS.,,A@IXM 2/(ZYA$A,)EG#
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M .N$K6'CBB=B%#!H!(/?BA$/,9=5TUZ-A - ]=FN*WA>&M]32#\0OD[X?96
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M%& H &DZ;PI52NQD C+4SFUY%N@FC*V".=K9:'X.HT"<5C;EJ=+CI<BZ,^)
MI+Q >]<BONDTS;D5)6.PU;_,'4._/)Q!Y2:S? QYGDIEFL&8S48>1'5@!JRA
M]3 06MF',TCHB>!%L4BTQ^168$BND?D50Y) '-)8I#-(:O)0'8/((?#:B8S=
M]M!<@:\+>%($\S6*STYMPTEJ H@=Y),9*' WCH%%R'M47[@T_VD S_!*PUUP
MV"HCGR^:E+WLO=5EG"('$X+ECH(,P02D_"AV=&P8\82*E+IN0FE'_AD0;#X6
M^-&4/ I-W$)2BSNJ:VFT+)T W_[+JIH"<%LY4',3F8MOS89)'K&N51@=7A:3
MTW%]RK'FJFC^%H"<ZK<*KE]0?;: Z9. 5?6(LR',%*F(Q(J6JD8_?;OGM*KF
MQ=!).6E3%?9BM:[9J"F+X3V<F9T:$M/,0D.^5QM)02YA>6SNXZ/B@FH+#V@C
MU<027+HD F^!)@<.3VL#5U);9Y98[4,VE>(3X+FUK]NPY<S-X[/?07_-3D"S
MP>AO)P;6/ M$.?D3T[G<#S^*0<'6AXG@G]>' @81^SRXXS.%6P:=TRMV??8?
M(&4[*[9+VHS8_^4M_5EA-V?'@]-W*UOM]JN\"M\[.1^<7#W73L7CU$N-[Z&(
M(,(,\E0B^.B6@@!\S3CDZ/"5KA$$X.H#YG$@J3*=Y>9$S\ -\'@*Z1\V(\<'
MJI4SKD3<2G&G'4!F^C-6ZG2ENV"V!PS#U8I#/ORJ5KP4DCP=W^$I#- V:LPK
M\]K#1$)[M!-$& K55MEP*M-4!]N,5+TP=1T1(5A@&,?F6-RQW>7/.;V9[HU[
MJ/8-IK&8.L' 9B 3-TO.!1&+_,R#*UMGL(&%#Q7E>>AY<6'AUBCA&36;9FD&
M L(8*?\LM",&!0:OP[#NH#".V.!D7$BS@1<H/E6R9D6PFEL22'!@@6&M;'0!
MBQ?WN+08^ZV%Z[(*R$[.&-V!KI^8D#QB3ORU7@; CQQ5YD3\2%*P$12%W%2!
M.] +X 8DE WMJ7#";*O:P'GJ%HS6U\G=$(O^*"1XX#'7<0<$U'S4H$*%57'O
M 3=^H(ZVRF6=.+H3$)[R=#V/'2VK/OD"F-(O[G2@WP'CH37QT:B(6>+3KK#4
M@HAUB[+J8E2LR]L0JI$'$X'FS48B_LRDDBGMM6@*52,:]1R-M-JMRKF^->,D
M188'?$C@;@5$!QBDA)Y%,U^)#=;--4VK9*ZAIDHV5WZ;<E\ S<4=&H'\A[*_
M$()@:G#(1]$=HD#4$--*X;=R0F!T"?4+.\?0QDS=)I <;0KC&LX^BZ'7+\9Q
M'9KARO ;[<T>$*D+7=E@UI&/LH2:NU9 #6OX@6XQQ'T/+7$P8V,L[>25:NY!
MBH4K2J5G[=<PR[/KJA_,A?,->W:YX_,79"^640>:%I8)4ET%0E,PIJBL+7X$
M\" &9= V5<W&4:8D!4-W]QC+6?,/L[[IN2_Y4 ;H^^V"%0W0<\/?.)9L>==7
M$);0);HM'C# =93A!B-/H@#<Y<(Q=!7SS9NZ1LW&IU"2JU@ZGN[B[>MBUP5\
MM"I&O'"R*!S?-R0=K2;"E-/Z?;)C&P[JW.-(@',"X]9)E=UJ(,FH;*<-9Z3[
M(0/X(TND\J6MDB=T2U<O300BFZ4.IWRF;2$RV6RN/O-Q:>#>+K2+=DA+RF4D
MQP&JV7N2!88W0\Z<!1H?2F= (XV,)L2225DGJN4FD7$D( I_&(Q,@9N@BR/0
M%4B(H/,TB3A5:TVO1?@W/HY\_ZS9 #-/<-<>(+J'J$_^1+L0=)E%K,"Q$E)+
M2D&+VD\I733%,'$K=/H_RFB33 M)D\RQ;QDPB*SD6#"3#DB,7[ "J1NH*#UW
M//7&-QUN^%LNYHC*%.3>3;E&C"-8W99)AO)U(0U A;!K_"<0*^U_];6F!#I5
M)5\*F)OKJNNB4(;K;O0_LKO\Z./GCEH4\WD-TZGD$7-XK)CTGSK!HUG=H_Z)
M[>KHXNKXY&H=,I]^]_+Z9-_^LA2D*J(K3'?S;J6]PGHG_?YE]_CX[/Q#?GU]
MV>W9:S>KTO)<Z?R+O6,K3L8F0P59\SZ_C:1O'CRVC7=?%9,:'%=N[D&V]KM)
MUP"4/'73*=C6AMO$O55JY,+-R@BSOWN@YH!59#I9?F@%K(\8J;5@=#5%J=2Z
M39DJZUG1*;@^DN)[J5Q&B0?$@.*(0U%LT39'*,&/*_R!&O-3 1]' ;=_/ 6<
MF#)YD1?D^4 KCXE!SB(\PR*<>AZ6.$V6PX%VN96]>DVFK=&Y*N\RM242;ZK<
M+9MNE%(C[-=-C8J12T7O!;5XMV1/[-(#P7S*"?+D':@VQ$^;))9ZWL"2UD^S
M>C*SVGF!9C68+,N"OW!4L:I Q;:!5F=N*CP2\YA%&?]3:7/+R2_]# *3+23H
M0MORJ2T*,"[-^VD*WVX*NR_4%&HC"^8OJ"VD1?DFI6,KIG)=O^/Y$%5Z\HS!
M21LA1*+AZ?H#!#\^3G@\8:M;IC;&A]&MJ,V"B=G9JNT"ES ?*N%WF3BTK]FH
M\+XE\1-YY9"2'14% M#'^UEB*N96C)K:DBG[X&9&O& S8PYBYF+ZIF*Q3_[V
MAGUW8MM*_G-_Z3'4WBT+*'/(HK#:!5&%2&0B\MV1LU1,V>OVUNIP;75OC5*5
MJ[Q:\) CC?^T9Z86'1_!PDY9U$H=Q^SN:M+IYRDY.B&LD!3MY#0.S/8+UI6&
M6,4P9TJ&8A:9 &V[,P4FL"S=\7<H9MSH M-P1ML;HCAM,0*JCML:Y8+NHFTH
M'L)D]&M/IGWE3%Q/UYC8E:!-E_*!U*6'/]\4ZZ?/0=4?*-?E,;GL5"-MA:1+
M3OX1@8J,$II6*C\/,9(@<*%"'J=2C=F$[].FZ$>]L.9LF*F$%4>&:&-K+&\U
MW9(*7TPAT%M.530UZ\']J2PV&K#TXQPU0S<[CO3K)7JW5 $"D1+Y,DIE#<F^
M''&M3REKW'ZS[KMZNC597*1TMB'LT@,#G&;!F+ N:.6\'CLZN?V5=(T<6_DE
MNX+!58E5E7A9KH0.U.%GCTK\#M$-:Q)W:'XY+C.\@GX4CUH9%K ]]I4RF&%+
M].T:3 &6))BU"@'*@SN].)V<GIQ].!V \*]=T9]-[$VU^<67%EU$+:73 ?M'
M9!T[/UG'HV'9.<J/N+&S[_+^+4A0>TR.T5D[(]"3OOEZ[XD@X,V&?4L-CW[T
M-_H;/7QYI[)IN;@Z]\2OJQHIS3N1'L>:@7F_J"*B]XPO[N9215-A7]?LCH$(
MS #"?N]K\7LN4;\&OJ=<4_NF:[-AL+L2$XV+'O\4J)#$!!VHQ(V ?#8)R])^
M$\I/.*,>GP+(LJP0^1';8 1DB*O42MULN-OU+T%H@%M7#-!AXR:Z(V"!]8.%
M?DI]KI/ZG+9 ?T"9!6C%#R:W/@5BOCG@1Y'W3OQP.->X#O8")?XH?.F!P[B>
M@9N>*B>Z.'(^8VQ!!YR'E1[FPR]',KVV/7,^X^6JXTW%6DI1[5HDMS"-!^+Y
MI,RF^H492UC$^R"B.DTA=>4(W',*WAT.2TP!:?<E":4/Q]F5=W>]GU@YNZ<?
ML;!#9X7*DEU^7[EB<9][16,D96&>WSR.T#P()#+E[XS0<:3DYURMFPTMR#/Z
MM>.K7NX;K*M]F#X_DW,H4_)NAB>?6B]%F1;*>?S^Y@4*B:X4*_,WR%X?YAV>
M33 *6R3+]Q?LE <!]/'92;N_NX\O2BCX+4!A=%O4ZR\^!WP2$9_/"T /4;IG
MD995A+45@6\06A^>>GZI?_UE:Z]]P 8)O\4-\+"&37T=\$^INY?Y"^XOBZ/0
MP/C= ?2E8+V7852#4THR><BZ81J!9"_%9^/7DFD/5*BDU3;ZNKF 77(5%82X
MGCC4[S5T-O%[-^%#^K;._P-02P,$%     @  6M%4?SPEA<M$   @EX   \
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M74J,_^/JDWN=DUEF& 1*&3,<L&OKEL0-]( &50&(E&!%-/J,$+[#B8< %>1
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MJ\R%&8,BH^8^9#*55M.Y)=.BCP<I#<7QA UAL*0\E\;#L"#SP4L"L S&V1!
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M>*]ODK749N_N[ >(A"0T%,$2H!3=OW[/.0!(4**=N(VSVEB=U".2()Z_\SX
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M9&5X,3$N:'1M4$L! A0#%     @  6M%47:EE4_\"0$ 7;,&  \
M     ( !RJ$  &0Q,C8U.61E>#0R+FAT;5!+ 0(4 Q0    (  %K15% V6+\
MR"0  )_@ 0 /              "  ?.K 0!D,3(V-3ED97@U,2YH=&U02P$"
M% ,4    "  !:T517S/<GZX1  "T4P  #P              @ 'HT $ 9#$R
M-C4Y9&5X-3(N:'1M4$L! A0#%     @  6M%4?SPEA<M$   @EX   \
M         ( !P^(! &0Q,C8U.61E>#4S+FAT;5!+ 0(4 Q0    (  %K15$H
ML??T?1(  *]T   /              "  1WS 0!D,3(V-3ED97@U-"YH=&U0
M2P$"% ,4    "  !:T51<# %$F8#   X#   $               @ ''!0(
M96AC+3(P,C P.3,P+GAS9%!+ 0(4 Q0    (  %K15&R^]VN9 8  $A$   4
M              "  5L) @!E:&,M,C R,# Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   (  %K15%SPQ!;P 0  !,K   4              "  ?$/ @!E:&,M,C R
C,# Y,S!?<')E+GAM;%!+!08     "@ * &L"  #C% (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
